[
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-001",
    "ProcessValidationReport": "PVR1516-00",
    "ProcessValidationProtocol": "PVP1516-00",
    "BMR": "ALI-T-001-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Ltd - Unit I/Hetero Labs Ltd - Unit IX",
    "Batchsize": "178.750 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-002",
    "ProcessValidationReport": "PVR-FD-0596-01",
    "ProcessValidationProtocol": "PVP-FD-0596-00",
    "BMR": "ALI-T-002-01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Ltd - Unit I/Hetero Labs Ltd - Unit IX",
    "Batchsize": "130.000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-003",
    "ProcessValidationReport": "PVR1521-00",
    "ProcessValidationProtocol": "PVP1521-00",
    "BMR": "ALI-T-002-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Ltd - Unit I/Hetero Labs Ltd - Unit IX",
    "Batchsize": "130 000 tablets (178.750 kg Blend)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-004",
    "ProcessValidationReport": "PVR-FD-0846-00",
    "ProcessValidationProtocol": "PVP-FD-0846-00",
    "BMR": "ALI-T-002-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Ltd. Unit-I (Abacavir Sulfate, Ph. Eur.)\nHetero Labs Ltd. Unit-IX (Lamivudine, Ph. Eur.)",
    "Batchsize": "130 000 tablets (178.750 kg Blend)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "TAB",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit IV",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-005",
    "ProcessValidationReport": "PVR-FD-1346-00",
    "ProcessValidationProtocol": "PVP-FD-1346-00",
    "BMR": "ALI-T-005-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Ltd. Unit-I (Abacavir Sulfate, Ph. Eur.)\nHetero Labs Ltd. Unit-IX (Lamivudine, Ph. Eur.)",
    "Batchsize": "550.000 kg",
    "Process": "Blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abacavir/Lamivudin Heumann 600 mg/300 mg Filmtabletten",
    "Dosageform": "TAB",
    "MA_No": "2200030.00.00",
    "CMOSite": "Hetero Labs Limited - Unit IV & Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABA/LAMI-006",
    "ProcessValidationReport": "PVR-FD-1352-00",
    "ProcessValidationProtocol": "PVP-FD-1352-00",
    "BMR": "ALI-T-006-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Ltd. Unit-I (Abacavir Sulfate, Ph. Eur.)\nHetero Labs Ltd. Unit-IX (Lamivudine, Ph. Eur.)",
    "Batchsize": "400.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Abirateron Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205347.00.00",
    "CMOSite": "Aizant",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ABIR-001",
    "ProcessValidationReport": "PVR032/21-0",
    "ProcessValidationProtocol": "PVP032/21-2",
    "BMR": "BMR-0363-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Aurisco Pharmaceuticals",
    "Batchsize": "60 000 units (65.400 kg)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.08.2022",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Acemetacin 30 KAP",
    "Dosageform": "KAP",
    "MA_No": "33737.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01715\nCR-02672",
    "MPVReviewNo": "MPV-ACE-001",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "PRVP/BCA.159.01-3LaE/23/01",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "10.01.2025",
    "Due_Date": "27.03.2025",
    "Completed": "",
    "comments": "re-launch\n21.01.25 nach Bericht und Protokoll angefragt Dfo(Vishal)\n10.02.25 Reminder geschickt an Vishal Dfo\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n27.03.25: Protokoll erhalten, Bericht steht noch aus DFo"
  },
  {
    "Status": "Documents requested",
    "Productname": "Acemetacin 60 KAP",
    "Dosageform": "KAP",
    "MA_No": "33737.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01715\nCR-02672",
    "MPVReviewNo": "MPV-ACE-002",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "PRVP/BCA.160.01-5LaE/23/01",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "10.01.2025",
    "Due_Date": "27.03.2025",
    "Completed": "",
    "comments": "re-launch\n21.01.25 nach Bericht und Protokoll angefragt Dfo( Vishal)\n10.02.25 Reminder geschickt an Vishal Dfo\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n28.03.25 Protokoll erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "28453.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ACI-003",
    "ProcessValidationReport": "PRVR/BTA.320.04-1.7E/18/01-01",
    "ProcessValidationProtocol": "PRV/BTA.320.04-1.7E/18/01-01",
    "BMR": "BTA.320.05-1.7E Edition 05.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "175000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2021",
    "comments": "Awaiting release      -    New validation at site with batch size of 175,000 tablet due to change of process and incorporation of new compression machine TC 105"
  },
  {
    "Status": "Open",
    "Productname": "Aciclovir 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "28453.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-02080\nCR-02414",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.01.2025",
    "Due_Date": "24.10.2025",
    "Completed": "",
    "comments": "validation report attached to CR-02414 (07.02.25 MaWa)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir 400 Heumann",
    "Dosageform": "TAB",
    "MA_No": "28453.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ACI-001",
    "ProcessValidationReport": "PVR/BTA.319.01-4.5E/16",
    "ProcessValidationProtocol": "PV/BTA.319.01-4.5E/15",
    "BMR": "BTA.319.01-4.5E Ed 2.4",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "450,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir 400 Heumann",
    "Dosageform": "TAB",
    "MA_No": "28453.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ACl-004",
    "ProcessValidationReport": "PRVR/BTA.319.05-4.5E/22/01-01",
    "ProcessValidationProtocol": "PRV/BTA.319.05-4.5E/21/01-01",
    "BMR": "BTA.319.05-4.5E, Edition No. 05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "450,000 Tab",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2022",
    "comments": "Validation Report was initiated for utilization of compression machine M/S “Fette” (ID No. TC 107 & TC 139, D Tooling) instead of compression machine M/S “Cadmic” (ID No. TC 81, D Tooling) with Batch Size of 450 000 tablets for Europe market, under which manufacturing stages were validated"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir 800 Heumann",
    "Dosageform": "TAB",
    "MA_No": "33542.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ACI-002",
    "ProcessValidationReport": "PVR/BTA.321.01-2.25E/15",
    "ProcessValidationProtocol": "PV/BTA.321.01-2.25E/15",
    "BMR": "BTA.321.03-2.25E Ed 3",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "225,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir 800 Heumann",
    "Dosageform": "TAB",
    "MA_No": "33542.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ACI-005",
    "ProcessValidationReport": "PRVR/BTA.321.04-2.25E/22/01-01",
    "ProcessValidationProtocol": "PRV/BTA.321.04-2.25E/21/01-01",
    "BMR": "BTA.321.04-2.25E, Edition 04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "225,000 Tab",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.10.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "22210.00.01",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-CPM-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.07.2020",
    "comments": "PVD-CPM-01 covers only product Diclofenac Heumann Gel, Panthenol CRE and Aciclovir CRE are not covered."
  },
  {
    "Status": "QP Approval",
    "Productname": "Aciclovir Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "22210.00.01",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-CPM-04",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "NA",
    "Reason_for_validation": "NA",
    "API_Manufacturer": "NA",
    "Batchsize": "NA",
    "Process": "NA",
    "OOX": "NA",
    "Receipt_Date": "21.02.2025",
    "Due_Date": "NA",
    "Completed": "24.02.2025",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Aciclovir Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "22210.00.02",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "CR-02476",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "NA",
    "Due_Date": "06.02.2025",
    "Completed": "",
    "comments": "07.01.25 MaWa: Reminder\n03.03.25 MaWa: new QP statement provided and reviewed, PVD-CPM-004 on 06.02.25. Execution of Process Verification to be discussed"
  },
  {
    "Status": "QP Approval",
    "Productname": "Alendronate Sodium Tablets 70mg",
    "Dosageform": "TAB",
    "MA_No": "2204420.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALEN-001",
    "ProcessValidationReport": "VR-PV-S-2010-00-249",
    "ProcessValidationProtocol": "VP-PV-S-2010-00-249",
    "BMR": "EA20007910-MSO-03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Polpharma S.A.",
    "Batchsize": "500.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.12.2022",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Alendronate Sodium Tablets 70mg",
    "Dosageform": "TAB",
    "MA_No": "2204420.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "CR-01637\nCR-01599",
    "MPVReviewNo": "MPV-ALEN-001",
    "ProcessValidationReport": "VR-PV-S-2010-00-249",
    "ProcessValidationProtocol": "VP-PV-S-2010-00-249",
    "BMR": "EA20007910-MSO-03",
    "Reason_for_validation": "",
    "API_Manufacturer": "Polpharma S.A.",
    "Batchsize": "500 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "26.06.2024",
    "Due_Date": "28.02.2025",
    "Completed": "",
    "comments": "03.02.25: Validation Documents in TWD are incomplete; requested MaWa\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n26.03.25 Reminder Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Alendronsäure Heumann plus Colecalciferol 70 mg/2800 I.E. Tabletten",
    "Dosageform": "FTA",
    "MA_No": "95928.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-003",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Alendronsäure Heumann plus Colecalciferol 70 mg/2800 I.E. Tabletten",
    "Dosageform": "FTA",
    "MA_No": "95928.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALENCHOL-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ALCHL/POL/2800IU / Version 002 / 17-07-2018",
    "ProcessValidationProtocol": "QPR-QC-001-ALCHL/POL/2800IU / Version 001 / 05-03-2018",
    "BMR": "TDR-PR-022-01280 / Version 01 / 06-03-2019",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Polpharma S.A. / Pharmathen International S.A. (Fermenta)",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.07.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Alendronsäure Heumann plus Colecalciferol 70 mg/5600 I.E. Tabletten",
    "Dosageform": "FTA",
    "MA_No": "95929.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-003",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Alendronsäure Heumann plus Colecalciferol 70 mg/5600 I.E. Tabletten",
    "Dosageform": "FTA",
    "MA_No": "95929.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALENCHOL-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ALCHL/POL/5600IU / Version 002 / 17-07-2018",
    "ProcessValidationProtocol": "QPR-QC-001-ALCHL/POL/5600IU / Version 001 / 05-03-2018",
    "BMR": "TDR-PR-022-01281 / Version 001 / 05-03-2018",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Polpharma S.A. / Pharmathen International S.A. (Fermenta)",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.07.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Allopurinol 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "6580345.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALL-001",
    "ProcessValidationReport": "PVR/BTA.144.00-24LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTA.144.00-24LaE/18/01-01",
    "BMR": "BTA.144.02-24LaE/02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "2.400.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.06.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Allopurinol 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "6580345.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CC-21-0324\nCC-21-0325",
    "MPVReviewNo": "MPV-ALL-005",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Allopurinol 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7013044.00.00",
    "CMOSite": "Harman Finochem",
    "Country": "Non-EU",
    "Reference": "CC-22-1835",
    "MPVReviewNo": "MPV-ALL-004",
    "ProcessValidationReport": "PPQR/2023/009",
    "ProcessValidationProtocol": "PPQP/2023/009",
    "BMR": "BMR/31000003/0001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "5 200 000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "01.02.2025",
    "Completed": "28.11.2024",
    "comments": "24.10.24 MaWA: Validierung für US und UK produkt ist äquivalent mit HEU"
  },
  {
    "Status": "In Review",
    "Productname": "Allopurinol 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7013044.00.00",
    "CMOSite": "Harman Finochem",
    "Country": "",
    "Reference": "CR-02239",
    "MPVReviewNo": "MPV-ALL-007",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.2024",
    "Due_Date": "31.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVP und PVR angefragt Dfo"
  },
  {
    "Status": "Open",
    "Productname": "Allopurinol 200",
    "Dosageform": "TAB",
    "MA_No": "",
    "CMOSite": "Harman Finochem",
    "Country": "Non-EU",
    "Reference": "CR-01698",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "11.06.2024",
    "Due_Date": "01.06.2026",
    "Completed": "",
    "comments": "21.08.24: Due_Date change according to  Launch Overview 11.07.24"
  },
  {
    "Status": "QP Approval",
    "Productname": "Allopurinol 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7013045.00.00",
    "CMOSite": "Harman Finochem",
    "Country": "Non-EU",
    "Reference": "CC-22-1835",
    "MPVReviewNo": "MPV-ALL-003",
    "ProcessValidationReport": "PPQR/2023/010",
    "ProcessValidationProtocol": "PPQP/2023/010",
    "BMR": "BMR/31000004/0001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "1 733 333 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "01.02.2025",
    "Completed": "",
    "comments": "24.10.24 MaWA: Validierung für US und UK produkt ist äquivalent mit HEU"
  },
  {
    "Status": "In Review",
    "Productname": "Allopurinol 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7013045.00.00",
    "CMOSite": "Harman Finochem",
    "Country": "",
    "Reference": "CR-02239",
    "MPVReviewNo": "MPV-ALL-008",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.2024",
    "Due_Date": "31.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVP und PVR angefragt Dfo"
  },
  {
    "Status": "TBD",
    "Productname": "Allopurinol 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "6580345.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CC-21-0324\nCC-21-0325",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Allopurinol 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "6580345.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALL-002",
    "ProcessValidationReport": "PVR/BTA.145.00-8LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTA.145.00-8LaE/18/01-01",
    "BMR": "BTA.145.03-8LaE/03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "ALMOTRIPTAN HEUMANN bei Migräne 12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93644.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALM-001",
    "ProcessValidationReport": "PVR-180",
    "ProcessValidationProtocol": "PVP-245",
    "BMR": "CM269/1",
    "Reason_for_validation": "",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "11,500 kg",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "ALMOTRIPTAN HEUMANN bei Migräne 12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93644.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ALM-002",
    "ProcessValidationReport": "PVR-181",
    "ProcessValidationProtocol": "PVP-246",
    "BMR": "CM269/1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "115.000 tablets (11,845 kg)",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ambrisentan 10 mg FTA",
    "Dosageform": "FTA",
    "MA_No": "2202376.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMBRI-002",
    "ProcessValidationReport": "ALP/F/PVR/3282-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3282-00",
    "BMR": "ALPBMR3513-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "66 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.03.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ambrisentan 5 mg FTA",
    "Dosageform": "FTA",
    "MA_No": "2202375.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMBRI-001",
    "ProcessValidationReport": "ALP/F/PVR/3281-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3281-00",
    "BMR": "ALPBMR3512-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "132 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.03.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ambroxol 75 retard Heumann",
    "Dosageform": "REK",
    "MA_No": "7863.00.00",
    "CMOSite": "Osmopharm SA.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMB-001",
    "ProcessValidationReport": "VPP.AB.HE.75.001",
    "ProcessValidationProtocol": "VPP.AB.HE.75.001",
    "BMR": "B/N 1-HE/VAL and B/N 2-HE/VAL",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Ven Petrochem & Pharma Pvt. Ltd.",
    "Batchsize": "1 100 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ambroxol 75 retard Heumann",
    "Dosageform": "REK",
    "MA_No": "7863.00.00",
    "CMOSite": "Osmopharm SA.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Osmopharm-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.01.24",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Ambroxol 75 retard Heumann",
    "Dosageform": "REK",
    "MA_No": "7863.00.00",
    "CMOSite": "Osmopharm SA.",
    "Country": "EU",
    "Reference": "CR-02582",
    "MPVReviewNo": "MPV-AMB-003",
    "ProcessValidationReport": "VPR.AB.HE.75.003",
    "ProcessValidationProtocol": "VPP.AB.HE.75.003",
    "BMR": "BR.AB.HE.75.06",
    "Reason_for_validation": "API\ndrying process\nanalyitcal method",
    "API_Manufacturer": "Shilpa",
    "Batchsize": "1,100,000 capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "13.02.2025",
    "Due_Date": "NA",
    "Completed": "20.03.25",
    "comments": "13.02.2025: revalidation due to recall\n10.03.2025: Bericht erhalten"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amiodaron 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "40158.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMI-001",
    "ProcessValidationReport": "VR/MFC/4007889/01",
    "ProcessValidationProtocol": "PV/MFC//4007889/00",
    "BMR": "BTA.107.04-9LaE/04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "900.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amiodaron 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "40158.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMI-002",
    "ProcessValidationReport": "VR/BTA.131.00-9.0LaE/16",
    "ProcessValidationProtocol": "PV/BTA.131.00-9.0LaE/16",
    "BMR": "BTA.131.01-9LaE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": "900.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amiodaron 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "40158.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMI-003",
    "ProcessValidationReport": "PRVR/BTA.169.01-17LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTA.169.01-17LaE/23/01",
    "BMR": "BTA.169.01-17LaE\nBTA.169.02-17LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": "1,700,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.09.2023",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Amiodaron 200 Heumann",
    "Dosageform": "TAB",
    "MA_No": "40158.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01472",
    "MPVReviewNo": "MPV-AMI-004",
    "ProcessValidationReport": "PRVR/BTA.174.00-17LaE",
    "ProcessValidationProtocol": "PRVP/BTA.174.00-17LaE/24/01",
    "BMR": "BTA.174.00-17LaE",
    "Reason_for_validation": "change in equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "17 00 000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.10.2024",
    "Due_Date": "17.10.2025",
    "Completed": "",
    "comments": "13.02.25: PVP muss angefragt werden (MaWa)\n14.02.25: Nach Protokoll angefragt Dfo\n14.02.25 Protokoll erhalten Dfo\n19.02.25: OOX berichte erhalten MaWa"
  },
  {
    "Status": "Completed",
    "Productname": "Amlodipin besilat Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65378.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00972\nCR-01804",
    "MPVReviewNo": "MPV-AML-003",
    "ProcessValidationReport": "PRVR/BTA.83.08-5E/23/01",
    "ProcessValidationProtocol": "PRVP/BTA.83.08-5E/23/01",
    "BMR": "BTA.83.08-5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Glochem Industries Pvt.Lts",
    "Batchsize": "500 000 Tablets",
    "Process": "compression",
    "OOX": "NA",
    "Receipt_Date": "06.02.2024",
    "Due_Date": "30.05.2025",
    "Completed": "21.03.2025",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n05.03.25: Protokoll und Bericht erhalten Dfo\n06.03.25 : Nach sampling Location angefragt da im Bericht/ Protokoll  nicht enthalten (Hiren Patel) Dfo\n14.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 10 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99899.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-003",
    "ProcessValidationReport": "MPL/N2/PPQR/20/025/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/025/00",
    "BMR": "Main Part : MPL/BMR/AM1/1/00 \nDispensing Part: MPL/BMR/AM1/1-BOM/00\nDry Mixing Part: MPL/BMR/AM1/1-GP/1/00\nCompression Part: MPL/BMR/AM1/1-CP/1/00\nCoating , Inspection Part: MPL/BMR/AM1/1-CIP/1/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)/Macleods Sarigam",
    "Batchsize": "360 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 10 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99899.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-004",
    "ProcessValidationReport": "MPL/N2/PPQR/21/058/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/058/00",
    "BMR": "MPL/BMR/AM1/2/00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Drugs Ltd./Macleods Pharmaceuticals Ltd.",
    "Batchsize": "600 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.10.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 10 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99899.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-009",
    "ProcessValidationReport": "MPL/N2/PPQR/22/052/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/22/052/00",
    "BMR": "MPL/BMR/AM1/4/00\nMPL/BMR/AM1/4/02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "900,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.01.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 10 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99899.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01385",
    "MPVReviewNo": "MPV-AML-VAL-012",
    "ProcessValidationReport": "MPL/N2/PPQR/22/052/01",
    "ProcessValidationProtocol": "MPL/N2/PPQP/22/052/00-A1",
    "BMR": "MPL/BMR/AM1/5/04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Valsartan: Macleods Pharmaceuticals LTD\nAmlodipin Besilat: Hetero Drugs LTD",
    "Batchsize": "9 00 000 Tablets",
    "Process": "Compression & coating",
    "OOX": "NA",
    "Receipt_Date": "06.09.2024",
    "Due_Date": "31.01.2025",
    "Completed": "03.02.2025",
    "comments": "Validation report still not compiled as soon as compliled will shared the documnets , Antwort 30.10.2024 Dfo, Reminder geschickt am 11.11.2024 Dfo,Antwort am 12.11.2024 ( siehe Mail von Sudhir)\n29.11.24 erneut nach aktuellen Status nachgefragt Dfo\n04.12.24 erneut Reminder geschickt \n06.12.24 Bericht noch nicht erstellt ( siehe Mail Harsh Raman)\n02.01.2025: reminder geschickt Dfo\n02.01.25 Bericht und Protokoll erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99898.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-002",
    "ProcessValidationReport": "MPL/N2/PPV/AL9/2/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/AL9/2/00",
    "BMR": "MPL/BMR/AL9/2/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)/Macleods Sarigam",
    "Batchsize": "180.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.06.2020",
    "comments": "PVP and PVR in one document"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99898.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-010",
    "ProcessValidationReport": "MPL/N2/PPQR/22/051/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/22/051/00\nMPL/N2/PPQP/22/051/01",
    "BMR": "MPL/BMR/A9/6/00\nMPL/BMR/A9/6/00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "900,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.01.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99898.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML-VAL-006",
    "ProcessValidationReport": "MPL/N2/PPQR/21/057/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/057/00",
    "BMR": "MPL/BMR/AL9/3/00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "360 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.11.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99898.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML-VAL-007",
    "ProcessValidationReport": "MPL/N2/PPQR/21/057/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/057/00",
    "BMR": "MPL/BMR/AL9/3/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "360 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2022",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99898.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01385",
    "MPVReviewNo": "MPV-AML-VAL-013",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.09.2024",
    "Due_Date": "31.01.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99897.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-001",
    "ProcessValidationReport": "MPL/N2/PPV/AL8/1/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/AL8/1/00",
    "BMR": "MPL/BMR/AL8/1/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)/Macleods Sarigam",
    "Batchsize": "180.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.06.2020",
    "comments": "PVP and PVR in one document"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99897.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL-008",
    "ProcessValidationReport": "MPL/N2/PPQR/21/056/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/056/00",
    "BMR": "MPL/BMR/AL8/2/03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "400 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99897.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML-VAL-005",
    "ProcessValidationReport": "MPL/N2/PPQR/21/056/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/056/00",
    "BMR": "MPL/BMR/AL8/2/00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "400 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.11.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan Heumann 5 mg/80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99897.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00677",
    "MPVReviewNo": "MPV-AML/VAL-011",
    "ProcessValidationReport": "MPL/N2/PPQR/22/050/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/22/050/00\nMPL/B2/PPQP/22/050/00-A1",
    "BMR": "MPL/BMR/AL8/4/00\nMPL/BMR/AL8/4/02",
    "Reason_for_validation": "batch size\nnew area\nequipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd. (Valsartan)\nHetero Drugs Ltd. (Amlodipine Besilate)",
    "Batchsize": "1,200,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "29.01.2024",
    "Due_Date": "26.07.2024",
    "Completed": "02.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202200.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-008",
    "ProcessValidationReport": "MPL/N2/PPQR/21/046/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/046/00",
    "BMR": "MPL/BMR/AP1/2/00 and  MPL/BMR/AP1/2/01 \nDispensing part – MPL/BMR/AP1/2-BOM/01\nGranulation – MPL/BMR/AP1/2-GP/1/00\nCompression – MPL/BMR/AP1/2-CP/1/00\nCoating and Inspection – MPL/BMR/AP1/2-CIP/1/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2021",
    "comments": "As per change control No. PR#70354 new manufacturing area (with compaction, blending, compressin and coating machines)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202200.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-004",
    "ProcessValidationReport": "MPL/N2/PPQR/20/018/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/018/00",
    "BMR": "MPL/BMR/AP1/1/00",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.02.2021",
    "comments": "As per change control No. PR#10879, three consecutive batches of Amlodipine, Valsartan and Hydrochlorothiazide Tablets 10+160+12.5mg were prepared for commercial introduction to Europe Market."
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202200.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-021",
    "ProcessValidationReport": "MPL/N2/PPQR/21/046/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/046/00-A2",
    "BMR": "MPL/BMR/AP1/2/05\nMPL/BMR/AP1/2/06",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.06.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202200.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01644",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/048/01:",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n25.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "AML/VAL/HCT-003",
    "ProcessValidationReport": "MPL/N2/PPQR/20/019/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/019/00",
    "BMR": "MPL/BMR/AP2/1/00 \nDispensing part – MPL/BMR/AP2/1-BOM/00\nGranulation – MPL/BMR/AP2/1-GP/00\nCompression – MPL/BMR/AP2/1-CP/00\nCoating and Inspection – MPL/BMR/AP2/1-CIP/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "misc",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2021",
    "comments": "PV valid for process step: Granulation, Compression, Coating and Inspection stages"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-009",
    "ProcessValidationReport": "MPL/N2/PPQR/21/048/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/048/00",
    "BMR": "MPL/BMR/AP2/2/00 and  MPL/BMR/AP2/2/01 \nDispensing part – MPL/BMR/AP2/2-BOM/01\nGranulation – MPL/BMR/AP2/2-GP/1/00\nCompression – MPL/BMR/AP2/2-CP/1/00\nCoating and Inspection – MPL/BMR/AP2/2-CIP/1/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2021",
    "comments": "As per change control No. PR#70354 new manufacturing area (with compaction, blending, compressin and coating machines)"
  },
  {
    "Status": "Documents requested",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01525",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/048/00-A3:",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "26.06.2024",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n25.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL/HCT-016",
    "ProcessValidationReport": "MPL/N2/PPQR/21/048/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/048/00-A1",
    "BMR": "MPL-BMR/AP2/2/03\nMPL/BMR/AP2/2/04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01382\nCR-01030",
    "MPVReviewNo": "MPV-AMLVALHCT-024",
    "ProcessValidationReport": "MPL/N2/PPQR/21/048/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/048/00-A2",
    "BMR": "MPL/BMR/AP2/2/05",
    "Reason_for_validation": "",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.",
    "Batchsize": "600000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.04.2024",
    "Due_Date": "29.11.2024",
    "Completed": "",
    "comments": "20.02.25: OOS report angefordert, MaWa"
  },
  {
    "Status": "Documents requested",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202201.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01644",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n25.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01059",
    "MPVReviewNo": "MPV-AMLVALHCT-023",
    "ProcessValidationReport": "MPL/N2/PPQR/23/079/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/079/00\nMPL/N2/PPQP/23/079/00-A1",
    "BMR": "MPL/BMR/AM3/4/00",
    "Reason_for_validation": "batch size\ninclusion of sampling activity",
    "API_Manufacturer": "Amlodipin Besylate: Hetero Drugs Ltd.\nValsartan: Macleods Pharmaceuticals Ltd.\nHydrochlorothiazid: CTX Life Sciences",
    "Batchsize": "550,000 tablets",
    "Process": "entire process",
    "OOX": "OOS\nBatch BAM32331",
    "Receipt_Date": "08.07.2024",
    "Due_Date": "02.09.2024",
    "Completed": "10.07.2024",
    "comments": "Addendum to MPL/N2/PPQP/23/079/00-A1 to be prepared an executed with two validation batches"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-010",
    "ProcessValidationReport": "MPL/N2/PPQR/21/049/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/049/01",
    "BMR": "MPL/BMR/AM3/3/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "252 000 kg (300 000 Tablets)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2021",
    "comments": "As per change control No. PR#70354 new manufacturing area (with compaction, blending, compresing and coating machines)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL/HCT-002",
    "ProcessValidationReport": "MPL/N2/PPQR/20/014/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/014/00",
    "BMR": "MPL/BMR/CB164/2/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "252 000 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.12.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL/HCT-017",
    "ProcessValidationReport": "MPL/N2/PPQR/21/049/01",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/049/01-A1",
    "BMR": "MPL/BMR/AM3/3/03\nMPL/BMR/AM3/3/04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "300,000 Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-023",
    "ProcessValidationReport": "MPL/N2/PPQR/23/079/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/079/00\nMPL/N2/PPQP/23/079/00-A1",
    "BMR": "MPL/BMR/AM3/4/00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "300,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.07.2024",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 10 mg/320 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202202.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01644",
    "MPVReviewNo": "MPV-AMLVALHCT-025",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-001",
    "ProcessValidationReport": "MPL/N2/PPQR/20/015/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/015/00",
    "BMR": "MPL/BMR/AM2/2/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-006",
    "ProcessValidationReport": "MPL/N2/PPQR/21/045/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/045/00",
    "BMR": "MPL/BMR/AM2/3/00 and  MPL/BMR/AM2/3/01 \nDispensing part – MPL/BMR/AM2/3-BOM/01\nGranulation – MPL/BMR/AM2/3-GP/1/00\nCompression – MPL/BMR/AM2/3-CP/1/00\nCoating and Inspection – MPL/BMR/AM2/3-CIP/1/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2021",
    "comments": "As per change control No. PR#70354 new manufacturing area (with compaction, blending, compresing and coating machines)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AML/VAL/HCT-002",
    "ProcessValidationReport": "MPL/N2/PPQR/20/014/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/014/00",
    "BMR": "MPL/BMR/CB164/2/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "252 000 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.12.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-015",
    "ProcessValidationReport": "MPL/N2/PPQP/21/045/01",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/045/00-A1",
    "BMR": "MPL/BMR/AM2/3/04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600,000 Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-020",
    "ProcessValidationReport": "MPL/N2/PPQR/21/045/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/045/00-A2",
    "BMR": "MPL/BMR/AM2/3/05\nMPL/BMR/AM2/3/06",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.06.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202198.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01644",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n25.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202199.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-005",
    "ProcessValidationReport": "MPL/N2/PPQR/20/017/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/017/00",
    "BMR": "MPL/BMR/AM4/2/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.07.2021",
    "comments": "Not launched"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202199.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV/AML/VAL/HCT-007",
    "ProcessValidationReport": "MPL/N2/PPQR/21/047/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/047/00",
    "BMR": "MPL/BMR/AM4/3/00\nMPL/BMR/AM4/3/01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.11.2021",
    "comments": "As per change control No. PR#70354 new manufacturing area (with compaction, blending, compresing and coating machines)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202199.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLVALHCT-020",
    "ProcessValidationReport": "MPL/N2/PPQR/21/045/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/045/00-A2",
    "BMR": "MPL/BMR/AM2/3/05\nMPL/BMR/AM2/3/06",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Ltd/Macleods Pharmaceuticals Ltd/CTX life sciences PVT Ltd",
    "Batchsize": "600,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.06.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Amlodipin/Valsartan/HCT Heumann 5 mg/160 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202199.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "",
    "Reference": "CR-01644",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "19.02.2025: PV not yet complete (s. Mail Macleods)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n25.03.25: erneut angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amorolfin Nagelkur Heumann 5% wirkstoffhaltiger Nagellack",
    "Dosageform": "NAW",
    "MA_No": "81980.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMOR-001",
    "ProcessValidationReport": "PVR-254",
    "ProcessValidationProtocol": "PVP-326",
    "BMR": "CM288/2",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Hisoar Pharmaceutical Co., Ltd",
    "Batchsize": "200 kg (230 L)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amoxicillin Heumann 500mg/ 5ml Pulver zur Herstellung einer Supsension zum Einnehmen",
    "Dosageform": "POS",
    "MA_No": "94551.00.00",
    "CMOSite": "Haupt Pharma Latina S.r.l",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-HPL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "Minor typo in site name accepted"
  },
  {
    "Status": "QP Approval",
    "Productname": "Amoxicillin/Clavulansäure Heumann 500 mg/125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "92450.00.00",
    "CMOSite": "PenCef Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-PenCef-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amoxicillin/Clavulansäure Heumann 875mg/125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "92451.00.00",
    "CMOSite": "PenCef Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-PenCef-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Amoxicillin/Clavulansäure Heumann 875mg/125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "92451.00.00",
    "CMOSite": "PenCef Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-01751",
    "MPVReviewNo": "PVD-PenCef-01",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "NA",
    "Reason_for_validation": "NA",
    "API_Manufacturer": "NA",
    "Batchsize": "NA",
    "Process": "NA",
    "OOX": "NA",
    "Receipt_Date": "27.08.2024",
    "Due_Date": "22.01.2025",
    "Completed": "30.10.2024",
    "comments": "angefragt am 29.10.24 Dfo\n30.10.24 MaWa: Feedback Centrient - CC2024-005 does not have regulatory or validation impact. This is related to the Qualification of New supplier. This statement related to validation is not applicable for this change."
  },
  {
    "Status": "QP Approval",
    "Productname": "Anagrelid Heumann 0,5 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "98985.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ANAG-001",
    "ProcessValidationReport": "PVR/CA.15.06-3E/20/01-01",
    "ProcessValidationProtocol": "PVR/CA.15.06-3E/19/01-01\nPVR/CA.15.06-3E/19/01-02 – To extend two additional batches in PV",
    "BMR": "CA.15.06-3E/06",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "300.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.03.2020",
    "comments": "Minor Change in manufacturing process after blending & lubrication stage and change in composition of binder quantity (reduction -0,50%)\nValidation was covered additionally four consecutive batches to complete process validation matrix."
  },
  {
    "Status": "Open",
    "Productname": "Anagrelid Heumann 1mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01282",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "21.06.2024",
    "Due_Date": "26.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Anastrozol Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "70402.00.00",
    "CMOSite": "Natco Pharma Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ANA-001",
    "ProcessValidationReport": "PVR/487-00",
    "ProcessValidationProtocol": "PVP/487-00",
    "BMR": "MFG/E/788-00",
    "Reason_for_validation": "",
    "API_Manufacturer": "Natco Pharma Limited Mekaguda",
    "Batchsize": "1600000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.05.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Anastrozol Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Bileshwapura",
    "Country": "Non-EU",
    "Reference": "CC-19-2382",
    "MPVReviewNo": "MPV-ANA-002",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "13.05.2024",
    "Due_Date": "NA",
    "Completed": "",
    "comments": "19.02.25: DEV und OOS Report erhalten, MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Antiveno 360mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7010642.00.00",
    "CMOSite": "Wiewelhove GmbH Dörnebrink",
    "Country": "EU",
    "Reference": "DEV-01225",
    "MPVReviewNo": "MPV-Antiveno-003",
    "ProcessValidationReport": "V_Bericht_26091001",
    "ProcessValidationProtocol": "Verifizierung_Plan_26091001-2-2",
    "BMR": "26091001-2-2",
    "Reason_for_validation": "CAPA of MPV-Antiveno-002",
    "API_Manufacturer": "Finzelberg Extr. Vitis vinif. e fol. aq. sic (Fi0383147)",
    "Batchsize": "1,000,000 tablets",
    "Process": "blending",
    "OOX": "NA",
    "Receipt_Date": "14.05.2024",
    "Due_Date": "",
    "Completed": "03.02.2025",
    "comments": "Verifizierungsplan erhalten (HEU + Wiewelhove signed); Bericht ausstehend;Hallo Herr Waiz,\n\nnach aktueller Planung können Sie ca. zu KW 02/2025 mit der Zustellung des Berichtes für die beiden Verifizierungschargen rechnen.\n\nEinen genaueren Zeitpunkt können wir momentan aufgrund der Feiertage zum Jahreswechsel noch nicht benennen.\n\nBeste Grüße nach Nürnberg!\n\nMaren Zerling -> Antwort 30.10.2024 MaWa/ DFO"
  },
  {
    "Status": "Invalid",
    "Productname": "Antiveno 360mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7010642.00.00",
    "CMOSite": "Wiewelhove GmbH Dörnebrink",
    "Country": "EU",
    "Reference": "NA",
    "MPVReviewNo": "MPV-Antiveno-001",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "26091001-2-1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Finzelberg",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "OOS \nBatch 0001/23",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "18.03.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Antiveno 360mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7010642.00.00",
    "CMOSite": "Wiewelhove GmbH Dörnebrink",
    "Country": "EU",
    "Reference": "NA",
    "MPVReviewNo": "MPV-Antiveno-002",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "26091001-2-1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Finzelberg",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "OOS \nBatch 0001/23",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "15.05.2024",
    "comments": "Deviations and results out of specification MPV-Antiveno-001 specification clarified with CMO; PV found to be accepted in combination with DEV-01225"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 125 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201791.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-APR-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-APT/125/ENCAP, Version 002",
    "ProcessValidationProtocol": "QPR-QC-001-APT/125/ENCAP, Version 001",
    "BMR": "TDR-PR-022-01392",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Optimus Drugs Private Limited",
    "Batchsize": "110,000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020 Discrepency in license reference MA Number given as 2201790.00.00"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 125 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201791.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 125 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201791.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 125 mg Hartkapseln\nAprepitantHeumann 80mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201792.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 40 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201920.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201790.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201790.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-APR-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-APT/80/ENCAP, Version 002",
    "ProcessValidationProtocol": "QPR-QC-001-APT/80/ENCAP, Version 001",
    "BMR": "TDR-PR-022-01391 / Version 002 / 22-04-2019",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Optimus Drugs Private Limited",
    "Batchsize": "171.875 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.10.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aprepitant Heumann pellets",
    "Dosageform": "HKP",
    "MA_No": "2201790.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-APR-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-APT/PEL/38.5kg, version 001",
    "ProcessValidationProtocol": "QPR-QC-001-APT/PEL/38.5kg, version 001",
    "BMR": "TDR-PR-022-01391 V_2 \nTDR-PR-022-01392 V_2.",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Optimus Drugs Private Limited",
    "Batchsize": "38.5 kg (blend load size)",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.10.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2200876.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 15 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2200877.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92461.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-007",
    "ProcessValidationReport": "PVR/BTA.242.02-6E/16",
    "ProcessValidationProtocol": "PV/BTA.242.02-6E/16",
    "BMR": "BTA.242.04-6E/4.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "600.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92461.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-008",
    "ProcessValidationReport": "PRVR/BTA.242.05-6E/22/01-01",
    "ProcessValidationProtocol": "PRV/BTA.242.05-6E/21/01-01",
    "BMR": "BTA.242.05-6E, Edition No.05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "600.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2022",
    "comments": "Validation Report was initiated for Revalidation Activities based on Retrospective assessment of process performance qualification and life cycle data with usage of compression machine M/S “Fette” (ID No. TC 107, B Tooling) instead of compression machine M/S “Cadmach” (ID No. TC 27, B Tooling) for Europe Market – Point 3.0 Purpose"
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 30 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2200878.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Aripiprazol Heumann 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2200875.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92907.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/10/1.2M (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/10/1.2M (Version 001)",
    "BMR": "TDR-PR-022-01095/1.2M (Version 003)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "1.200.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.12.2019\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92907.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/10/1.2M (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/10/1.2M (Version 001)",
    "BMR": "TDR-PR-022-01095 / GRA4 (Version 001)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "1.200.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.12.2019\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nFor BMR TDR-PR-022-01095/GRA4 only granulation step is with additional granulation machine. Compression is same as MPV-ARI-002."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92907.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-009\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ARIP/DIS/10&30/GRA4/Version 002 (13-01-2020)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/10&30/GRA4/Version 001 (26-02-2019)",
    "BMR": "TDR-PR-022-01095 / GRA4 (Version 001)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "240.000 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.04.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nValidation for alternative granulation machine PHI2-GRA4-004."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92907.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 15 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92908.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/15/800K (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/15/800K (Version 001)",
    "BMR": "TDR-PR-022-01096/800K (Version 004)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 15 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92908.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/15/800K (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/15/800K (Version 001)",
    "BMR": "TDR-PR-022-01096/GRA4 (Version 001)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "800.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nFor BMR TDR-PR-022-01096/GRA4 only granulation step is with additional granulation machine. Compression is same as MPV-ARI-003."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 15 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92908.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ARIP/DIS/15/800K/GRA4 (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/15/800K/GRA4 (Version 001)",
    "BMR": "TDR-PR-022-01096/GRA4 (Version 001)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "800.000 tablets",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 15 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92908.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 30 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92909.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/30/400K, Version 002",
    "ProcessValidationProtocol": "QPR-QA-001-ARIP/DIS/30/400K, Version 001",
    "BMR": "TDR-PR-022-01097/400K (Version 003)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "400.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 30 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92909.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/30/400K, Version 002",
    "ProcessValidationProtocol": "QPR-QA-001-ARIP/DIS/30/400K, Version 001",
    "BMR": "TDR-PR-022-01097/GRA4 (Version 001)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "400.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nFor BMR TDR-PR-022-01097/GRA4 only granulation step is with additional granulation machine. Compression is same as MPV-ARI-005."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 30 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92909.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-006\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ARIP/DIS/10&30/GRA4, Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/GRA/300, Version 001",
    "BMR": "TDR-PR-022-01097/GRA4 (Version 002)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "240.000 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 30 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92909.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92906.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/5/1.2M (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/5/1.2M (Version 001)",
    "BMR": "TDR-PR-022-01094/1.2M (Version 004)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "1.200.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.12.2019\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92906.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ARIP/DIS/5/1.2M (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/5/1.2M (Version 001)",
    "BMR": "TDR-PR-022-01094/GRA4 (Version 001)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "1.200.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.12.2019\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nFor BMR TDR-PR-022-01094/GRA4 only granulation step is with additional granulation machine. Compression is same as MPV-ARI-001."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92906.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ARI-008\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ARIP/DIS/5/1.2M/GRA4/Version 001 (16-07-2019)",
    "ProcessValidationProtocol": "QPR-QC-001-ARIP/DIS/5/1.2M/GRA4/Version 001 (26-02-2019)",
    "BMR": "TDR-PR-022-01094/GRA4 (Version 001)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "1.200.000 tablets",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.04.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020. \nValidation for alternative granulation machine PHI2-GRA4-004."
  },
  {
    "Status": "QP Approval",
    "Productname": "Arpoya 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "92906.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atazanavir Heumann 150 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201333.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATA-001",
    "ProcessValidationReport": "PVR-FB-0458-00",
    "ProcessValidationProtocol": "PVP-FB-0458-00",
    "BMR": "MPR No. BMR/3007185-01-05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "175.500 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.02.2021",
    "comments": "POST VALIDATION: The effort of this validation was summarized, reviewed the data generated in the prospective process validation as per protocol No. PVP-FB-0458-00 and to conclude that the process validation is successful and give an assurance that the product met the predetermined parameters and quality attributes of the product Atazanavir Capsules 150 mg, 200 mg and 300 mg (Common Blend) in Module - III and V of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Atazanavir Heumann 200 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201334.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATA-001",
    "ProcessValidationReport": "PVR-FB-0458-00",
    "ProcessValidationProtocol": "PVP-FB-0458-00",
    "BMR": "MPR No. BMR/3007185-01-05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "175.500 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.02.2021",
    "comments": "POST VALIDATION: The effort of this validation was summarized, reviewed the data generated in the prospective process validation as per protocol No. PVP-FB-0458-00 and to conclude that the process validation is successful and give an assurance that the product met the predetermined parameters and quality attributes of the product Atazanavir Capsules 150 mg, 200 mg and 300 mg (Common Blend) in Module - III and V of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Atazanavir Heumann 200 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201334.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATA-003",
    "ProcessValidationReport": "PVR-FB-0463-00",
    "ProcessValidationProtocol": "PVP-FB-0463-00",
    "BMR": "MPR No. BMR/3007182-02-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "150 000 Capsules",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2021",
    "comments": "The ProcessValidationReport (PVR) described the product (Point 2.0 - Objective) and the validation batches at Point 3.0 - Manufacturing Schedule. \nThe Batch Manufacturing Record used in the manufacture of the three batches– MPR No. BMR/3007182-02-01.\nAt PVP the Product was also detail at Point 5.0 - Product Overview.\nThe effort of this validation is to summarize, review the data generated in the prospective process validation as per protocol No. PVP-FB-0462-00 and to conclude that the process validation is successful and gives an assurance that the product meets the predetermined parameters and quality attributes of the product Atazanavir Capsules 300 mg (Bulk Capsules with the batch size of 150,000 capsules in Module VI of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Atazanavir Heumann 300 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201335.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATA-001",
    "ProcessValidationReport": "PVR-FB-0458-00",
    "ProcessValidationProtocol": "PVP-FB-0458-00",
    "BMR": "MPR No. BMR/3007185-01-05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "175.500 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.02.2021",
    "comments": "POST VALIDATION: The effort of this validation was summarized, reviewed the data generated in the prospective process validation as per protocol No. PVP-FB-0458-00 and to conclude that the process validation is successful and give an assurance that the product met the predetermined parameters and quality attributes of the product Atazanavir Capsules 150 mg, 200 mg and 300 mg (Common Blend) in Module - III and V of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Atazanavir Heumann 300 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201335.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATA-002",
    "ProcessValidationReport": "PVP-FB-0462-00",
    "ProcessValidationProtocol": "PVP-FB-0462-00",
    "BMR": "MPR No. BMR/3007175-04-01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "225.000 Cap",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.02.2021",
    "comments": "POST VALIDATION The effort of this validation was summarized, reviewed the data generated in the prospective process validation as per protocol No. PVP-FB-0462-00 and concluded that the process validation was successful and gave an assurance that the product met the predetermined parameters and quality attributes of the product Atazanavir Capsules 300 mg (Bulk Capsules with the batch size of 225 000 capsules in Module VI of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 100 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-003",
    "ProcessValidationReport": "F/PVR/BPR/01/2011",
    "ProcessValidationProtocol": "F/PVP/BPP/01/2011",
    "BMR": "ATH/BPP/M/002-02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "1.000.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 100 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-006",
    "ProcessValidationReport": "F/PVR/BPQ/02/2006 (batch BPP6007F) and F/PVR/BPQ/01/2008 (batches BPP80ülF and BPP8002F)",
    "ProcessValidationProtocol": "F/PVP/BPQ/02/2006",
    "BMR": "ATH/BPP/M/002-00 (batch BPP6007F)\nATH/BPP/M/002-01 batches BPP8001F and BPP8002F)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "1.000.000 tablets",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 100 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-008",
    "ProcessValidationReport": "PPQR/ATH/FTM/2021/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTM/2020/00",
    "BMR": "ATH/FTM/M/001-02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "1 000 000 Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.10.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 100 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "CR-00010\nCR-01841",
    "MPVReviewNo": "MPV-ATE-012",
    "ProcessValidationReport": "PPQR/ATH/FTM/2024/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTM/2024/00",
    "BMR": "ATH/FTM/M//001-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Ltd.",
    "Batchsize": "1 000 000 tablets",
    "Process": "Coating",
    "OOX": "NA",
    "Receipt_Date": "13.07.2024",
    "Due_Date": "30.09.2024",
    "Completed": "13.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 25 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-001",
    "ProcessValidationReport": "F/PVR/BPR/01/2011",
    "ProcessValidationProtocol": "F/PVP/BPR/01/2011",
    "BMR": "ATH/FTK/M/001-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "2.000.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 25 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-004",
    "ProcessValidationReport": "F/PVR/BPR/01/2009",
    "ProcessValidationProtocol": "F/PVP/BPR/01/2009",
    "BMR": "ATH/BPR/M/002-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "2.000.000 tablets",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 25 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-011",
    "ProcessValidationReport": "PPQR/ATH/FTK/2023/00",
    "ProcessValidationProtocol": "PPQP_ATH_FTK_2023_00",
    "BMR": "ATH/FTK/M/001-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "200,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 50 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-002",
    "ProcessValidationReport": "F/PVR/BPR/01/2011",
    "ProcessValidationProtocol": "F/PVP/BPQ/01/2011",
    "BMR": "ATH/BPQ/M/002-01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "3.000.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 50 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-005",
    "ProcessValidationReport": "F/PVR/BPQ/02/2068 (Batch BPQ6011 F) and F/PVR/BPQ/01/2008 (Batches BPQ7006F and BPQ7007F)",
    "ProcessValidationProtocol": "F/PVP/BPQ/01/2006",
    "BMR": "ATH/BPQP/M/002-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "3.000.000 tablets",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 50 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-007",
    "ProcessValidationReport": "PPQR/ATH/FTL/2020/00 and Addendum -I",
    "ProcessValidationProtocol": "PPQP/ATH/FTL/2020/00",
    "BMR": "ATH/FTL/M/001-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "3.000.000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 50 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-009",
    "ProcessValidationReport": "PPQR/ATH/FTL/2021/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTL/2020/00",
    "BMR": "ATH/FTL/M/001-04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "3 000 000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.03.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atenolol 50 Heumann",
    "Dosageform": "FTA",
    "MA_No": "10735.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATE-010",
    "ProcessValidationReport": "PPQR/ATH/FTL/2023/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTL/2023/00",
    "BMR": "ATH/FTL/M/001-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "300,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.08.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin common granules 25mg & 100mg",
    "Dosageform": "Blend",
    "MA_No": "2201806.00.00\n2201810.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-011",
    "ProcessValidationReport": "PPQR/ATH/FTM/2024/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTM/2024/00",
    "BMR": "NA",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "25mg: 87,500g (1,000,000 capsules)\n100mg: 87,500g (250,000 capsules)",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "05.09.2024",
    "comments": "31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n13.01.25: QP change end of 2024; adapted in review"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin common granules 40mg, 60mg, 80mg",
    "Dosageform": "Blend",
    "MA_No": "2201807.00.00\n2201808.00.00\n2201809.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-012",
    "ProcessValidationReport": "PPQR/ATH/FTM/2024/00",
    "ProcessValidationProtocol": "PPQP/ATH/FTM/2024/00",
    "BMR": "ATH/FTM/M//001-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "1,000,000 tablets",
    "Process": "coating",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "05.09.2024",
    "comments": "31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 10 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201804.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Atomoxetin Heumann 10 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201804.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-016",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "",
    "comments": "30.07.24: PV pending according CMO\n31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n03.09.24: Reminder\n22.11.24 : angeftagt MaWa\n26.03.25 abwarten was bei Meetings rauskommt MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 10 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201804.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ATX/10/ENCAP / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATX/10/ENCAP / Version 001",
    "BMR": "TDR-PR-022-01160 / Version 002",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "250.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 10 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201804.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-005",
    "ProcessValidationReport": "QRC-QA-001-PVR/ATMC/BLEND8750 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATMC/PVP / Version 001",
    "BMR": "TDR-PR-022-01160 / Version 002",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "8,750 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 100 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201810.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 100 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201810.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-015",
    "ProcessValidationReport": "REP-8065",
    "ProcessValidationProtocol": "QPR-1471",
    "BMR": "TDR-022-01159",
    "Reason_for_validation": "batch size\nequipment",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "250,000 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "14.01.2025",
    "comments": "30.07.24: PV pending according CMO\n31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n03.09.24: Reminder\n22.11.24 : angeftagt MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 100 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201810.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 18 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201805.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 18 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201805.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 18 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201805.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-008",
    "ProcessValidationReport": "REP-7714",
    "ProcessValidationProtocol": "QPR-1462",
    "BMR": "TDR-PR-022-01161",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "638 889 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "05.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 25 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201806.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 25 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201806.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ATX/25/ENCAP / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATX/25/ENCAP / Version 001",
    "BMR": "TDR-PR-022-01162 / Version 002",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "100.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 25 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201806.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-005",
    "ProcessValidationReport": "QRC-QA-001-PVR/ATMC/BLEND8750 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATMC/PVP / Version 001",
    "BMR": "TDR-PR-022-01162 / Version 002",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "8,750 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 25 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201806.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-009",
    "ProcessValidationReport": "REP-7655",
    "ProcessValidationProtocol": "QPR-1464",
    "BMR": "TDR-PR-022-01162",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "1 000 000 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "05.09.2024",
    "comments": "31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n13.01.25: QP change end of 2024; adapted in review"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 40 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201807.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 40 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201807.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-010",
    "ProcessValidationReport": "REP-7751",
    "ProcessValidationProtocol": "QPR-1466",
    "BMR": "TDR-PR-022-01165",
    "Reason_for_validation": "Encapsulation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "750,000 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "23.01.2025",
    "comments": "31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\nDissolution levels below specification limit (NLT 90%)\nS2 levels requested - Reminder 03.09.24"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 40 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201807.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ATX/40/ENCAP / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATX/40/ENCAP / Version 001",
    "BMR": "TDR-PR-022-01163 / Version 001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "150.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 40 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201807.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-006",
    "ProcessValidationReport": "QRC-QA-001-PVR/ATMC/BLEND21000 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATMC/PVP / Version 001",
    "BMR": "TDR-PR-022-01163 / Version 001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "21,000 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 60 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201808.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 60 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201808.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-013",
    "ProcessValidationReport": "REP-8042",
    "ProcessValidationProtocol": "QPR-1468",
    "BMR": "TDR-PR-022-01164/1M",
    "Reason_for_validation": "Encapsulation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "1,000,000 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "13.01.2025",
    "comments": "30.07.24: PV pending according CMO\n31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n03.09.24: Reminder\n22.11.24 : angefragt MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 60 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201808.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201809.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201809.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CR-01929",
    "MPVReviewNo": "MPV-ATOM-014",
    "ProcessValidationReport": "REP-8043",
    "ProcessValidationProtocol": "QPR-1466",
    "BMR": "TDR-PR-022-01163",
    "Reason_for_validation": "Encapsulation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "1,500,000 capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "30.07.2024",
    "Due_Date": "24.01.2025",
    "Completed": "14.01.2025",
    "comments": "30.07.24: PV pending according CMO\n31.07.24 MaWa: related to RFI-DE-24031; external CR OSD-2024-01038\n03.09.24: Reminder\n22.11.24 : angefragt MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201809.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-ATX/80/ENCAP / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATX/80/ENCAP / Version 001",
    "BMR": "TDR-PR-022-01165 / Version 001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "143.750 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Atomoxetin Heumann 80 mg Hartkapseln",
    "Dosageform": "HKP",
    "MA_No": "2201809.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATOM-007",
    "ProcessValidationReport": "QRC-QA-001-PVR/ATMC/BLEND40250 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-ATMC/PVP / Version 001",
    "BMR": "TDR-PR-022-01165 / Version 001",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-1",
    "Batchsize": "40,250 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atorvastatin Heumann 20mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88816.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATO-001",
    "ProcessValidationReport": "PVR/BTA.339.01-13.5E/16",
    "ProcessValidationProtocol": "PV/BTA.339.01-13.5E/15",
    "BMR": "BTA.339.02-13.5E",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "1350000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atorvastatin Heumann 40mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88817.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATO-002",
    "ProcessValidationReport": "PVR/BTA.290.02-2.2E/15",
    "ProcessValidationProtocol": "PV/BTA.290.02-2.2E/14",
    "BMR": "BTA.290.05-2.2E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "220000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Atorvastatin Heumann 40mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88817.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ATO-003",
    "ProcessValidationReport": "PVR/BTA.340.01-18E/16",
    "ProcessValidationProtocol": "PV/BTA.340.01-18E/15",
    "BMR": "BTA.340.03-18E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Cadila Healthcare Limited Zydeus",
    "Batchsize": "1800000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azathioprin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93350.00.00",
    "CMOSite": "Douglas Manufacturing Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Douglas-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azathioprin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93348.00.00",
    "CMOSite": "Douglas Manufacturing Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Douglas-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azathioprin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "63079.00.00",
    "CMOSite": "Douglas Manufacturing Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Douglas-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azathioprin Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93349.00.00",
    "CMOSite": "Douglas Manufacturing Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Douglas-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azithromycin Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84355.00.00",
    "CMOSite": "Bluepharma Industria Farmaceutica, S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Bluepharma-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Azithromycin Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84356.00.00",
    "CMOSite": "Bluepharma Industria Farmaceutica, S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Bluepharma-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bicalutamid Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74029.00.00",
    "CMOSite": "TPL Bileshwapura",
    "Country": "Non-EU",
    "Reference": "CC-19-2384",
    "MPVReviewNo": "MPV-BIC-002",
    "ProcessValidationReport": "PPQR/FB.003.01-1.04E/23/01",
    "ProcessValidationProtocol": "PPQP/FB.003.01-1.04E/23/01",
    "BMR": "FB.003.01-1.04E",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aarti Industries Limited",
    "Batchsize": "104,000 tablets",
    "Process": "entire process",
    "OOX": "OOT Batch NPM2K001",
    "Receipt_Date": "02.05.24",
    "Due_Date": "NA",
    "Completed": "01.07.2024",
    "comments": "27.05.24 MaWa: only two validation batches manufacured; refer to CR-01745"
  },
  {
    "Status": "QP Approval",
    "Productname": "Bicalutamid Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74029.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bicalutamid Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "67926.00.00",
    "CMOSite": "Douglas Manufacturing Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Douglas-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bicalutamid Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "67926.00.00",
    "CMOSite": "TPL Bileshwapura",
    "Country": "Non-EU",
    "Reference": "CC-19-2383",
    "MPVReviewNo": "MPV-BIC-001",
    "ProcessValidationReport": "PPQR/FB.002.02-3.12E/23/01",
    "ProcessValidationProtocol": "PPQP/FB.002.01-3.12E/22/01",
    "BMR": "FB.002.01-3.12E\nFB.002.02-3.12E",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aarti Industries Limited",
    "Batchsize": "312,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "02.05.24",
    "Due_Date": "NA",
    "Completed": "01.07.2024",
    "comments": "27.05.24 MaWa: only two validation batches manufacured; refer to CR-01745"
  },
  {
    "Status": "In Review",
    "Productname": "Bilastin 20mg",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Unison",
    "Country": "Non-EU",
    "Reference": "CR-00607",
    "MPVReviewNo": "MPV-BIL-001",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.24",
    "Due_Date": "27.06.2025",
    "Completed": "",
    "comments": "29.07.24 MaWa: Launch\n07.03.25: nach Protokoll und Bericht angefragt Dfo\n10.03.25 PVP und PVR erhalten Dfo\n25.03.025 : Siehe Mail von Nikunj ( muss mit QP abgeklärt werden)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99373.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-002\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Aİ.1262/00",
    "ProcessValidationProtocol": "PVP.Aİ.1262/00",
    "BMR": "IP.Y1477/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "4,5 kg (25.000 tablets)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99373.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-003\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Ai.R1261/01",
    "ProcessValidationProtocol": "PVP.Ai.R1261/00",
    "BMR": "IP.R1476-6.750/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "6,75 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 125 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99373.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-004\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Ai.R1261-4.500/00",
    "ProcessValidationProtocol": "PVP.Ai.R1261-4.500/00",
    "BMR": "IP.R1476/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "4,5 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 62,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99372.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-001\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Aİ.1261/01",
    "ProcessValidationProtocol": "PVP.Aİ.1261/00",
    "BMR": "IP.Y1476/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "2,25 kg (25.000 tablets)",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 62,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99372.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-003\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Ai.R1261/01",
    "ProcessValidationProtocol": "PVP.Ai.R1261/00",
    "BMR": "IP.R1476-6.750/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "6,75 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Bosentan Heumann 62,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99372.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BOS-004\nPVD-Abdi-01",
    "ProcessValidationReport": "PVR.Ai.R1261-4.500/00",
    "ProcessValidationProtocol": "PVP.Ai.R1261-4.500/00",
    "BMR": "IP.R1476/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Malladi Drugs & Pharmaceuticals Limited, Unit-3",
    "Batchsize": "4,5 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020\n11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid Heumann 10 mg/ml Augentropfensuspension",
    "Dosageform": "LSG",
    "MA_No": "87732.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BRI-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "PTVR-R-0030_01",
    "ProcessValidationProtocol": "PPV-R-0199_01",
    "BMR": "BPRP-R-0264_04",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Neuland Laboratories LTD Unit II",
    "Batchsize": "24.000 vials (120L)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.03.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid Heumann 10 mg/ml Augentropfensuspension",
    "Dosageform": "LSG",
    "MA_No": "87732.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BRI-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "PTVR-R-0131_01",
    "ProcessValidationProtocol": "PTVP-R-0058_01",
    "BMR": "BPRP-R-0264_04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Megafine Pharma (P) Limited",
    "Batchsize": "24.000 vials (120L)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.03.2020\n11.02.2020",
    "comments": "Reason_for_validation: Additional second processing line; TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid Heumann 10 mg/ml Augentropfensuspension",
    "Dosageform": "LSG",
    "MA_No": "87732.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-BRI-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "PTVR-R-0131_01",
    "ProcessValidationProtocol": "PTVP-R-0058_01",
    "BMR": "BPRP-R-0264_04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Neuland Laboratories LTD Unit II",
    "Batchsize": "24.000 vials (120L)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.03.2020\n11.02.2020",
    "comments": "Reason_for_validation: Additional second processing line; TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid Heumann 10 mg/ml Augentropfensuspension",
    "Dosageform": "LSG",
    "MA_No": "87732.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid Heumann 10 mg/ml Augentropfensuspension",
    "Dosageform": "LSG",
    "MA_No": "87732.00.00",
    "CMOSite": "Famar S.A. Plant A",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid/Timolol Heumann 10 + 5 mg/ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "7017481.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "CR-00521",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "NA",
    "Reason_for_validation": "Site shift",
    "API_Manufacturer": "NA",
    "Batchsize": "NA",
    "Process": "NA",
    "OOX": "NA",
    "Receipt_Date": "28.06.2024",
    "Due_Date": "27.12.2024",
    "Completed": "19.03.2025",
    "comments": "Launch\n14.02.25: Draft QP Statement erhalten; Signed Statement nachfordern, MaWa\n20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Brinzolamid/Timolol Heumann 10 + 5 mg/ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "7017481.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Butylscopolaminbromid 10mg",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01824",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "26.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Butylscopolaminbromid 20mg",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01284",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "26.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Calcium D3 Heumann Brausetabletten",
    "Dosageform": "BTA",
    "MA_No": "46147.00.00",
    "CMOSite": "Hermes Arzneimittel GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-HAG-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.07.2020",
    "comments": "Product release is the responsibility of the contract reciever QP"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-005",
    "ProcessValidationReport": "PRV/BTC.80.00-10LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BTC.80.00-10LaE/18/01-01",
    "BMR": "BTC.80.01-10LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.07.20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-008",
    "ProcessValidationReport": "PRVR/BTC391.04-15E/21/01-01",
    "ProcessValidationProtocol": "PRV/ BTC391.04-15E/20/01-03",
    "BMR": "BTC.391.05-15E",
    "Reason_for_validation": "MSc",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceuticals Co.",
    "Batchsize": "1 500 000 Tablets",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.10.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-012",
    "ProcessValidationReport": "PVR/BTC.80.05-10LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTC.80.05-10LaE/21/01-01",
    "BMR": "BTC.80.06-10LaE, Ed. 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceuticals",
    "Batchsize": "1 000 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.03.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-013",
    "ProcessValidationReport": "PVR/BTC.414.01-15E/22/01-01",
    "ProcessValidationProtocol": "PV/BTC.414.01-15E/22/01-01",
    "BMR": "BTC.414.02-15E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,500,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.07.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-017",
    "ProcessValidationReport": "PRVR/BTC.95.02-10LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTC.95.02-10LaE/22/01\nPRV/BTC.95.00-10LaE/21/01-01",
    "BMR": "BTC.95.03-10LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2023",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02084",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.2024",
    "Due_Date": "15.01.2026",
    "Completed": "",
    "comments": "Protokoll Seiten teilweise in CR-0237"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82320.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01663\nCR-01813",
    "MPVReviewNo": "MPV-CAN-023",
    "ProcessValidationReport": "PRVR/BTC.430.01-10E/24/01",
    "ProcessValidationProtocol": "PRVP/BTC.430.01-10E/24/01",
    "BMR": "BTC.430.01-10E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang huahai pharmaceuticalos co.",
    "Batchsize": "1000000 tablets",
    "Process": "compression",
    "OOX": "NA",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "25.11.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82277.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82277.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 16 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82277.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 2 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82317.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-010",
    "ProcessValidationReport": "PVR/BTC.410.01-30E/21/01-02",
    "ProcessValidationProtocol": "PV/BTC.410.01-30E/20/01-01",
    "BMR": "BTC.410.03-30E, Edition No. 3",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co.",
    "Batchsize": "3 000 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.02.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-003",
    "ProcessValidationReport": "PV/BTC.81.00-10E/18/01-01",
    "ProcessValidationProtocol": "PVR/BTC.81.00-10LaE/19/01-01",
    "BMR": "BTC.81.00-10LaE, Edition: 00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-014",
    "ProcessValidationReport": "PVR/BTC.81.04-10LaE/22/01-01",
    "ProcessValidationProtocol": "PRV/BTC.81.04-10LaE/21/01-01",
    "BMR": "BTC.81.06-10LaE, Edition No. 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.07.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-015",
    "ProcessValidationReport": "PVR/BTC.413.01-10E/22/02",
    "ProcessValidationProtocol": "PV/BTC.413.01-10E/21/02-01",
    "BMR": "BTC.413.01-10E/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,000,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-016",
    "ProcessValidationReport": "PRVR/BTC.101.00-10LaE/22/01",
    "ProcessValidationProtocol": "PVRP/BTC.101.00-10LaE/22/01\nPRVP/BTC.101.00-10LaE/22/01.01",
    "BMR": "BTC.101.01-10LaE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.12.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82278.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-021",
    "ProcessValidationReport": "PRVR/BTC.101.00-10LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTC.101.00-10LaE/22/01",
    "BMR": "BTC.101.00-10LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "100,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.08.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CC-22-0345",
    "MPVReviewNo": "MPV-CAN-022",
    "ProcessValidationReport": "PRVR/BTC.392.03-10E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTC.392.03-10E/18/01-01 (not available)\nPRV/BTC.392.03-10E/20/01-02 (not available)",
    "BMR": "BTC.392.03-10E\nBTC.392.08-10E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co.",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "20.09.2024",
    "Completed": "19.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82278.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82278.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 32 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82278.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-001",
    "ProcessValidationReport": "PVR/BTC.377.01-10E/17/01-01",
    "ProcessValidationProtocol": "PV/BTC.377.01-10E/17/01-01",
    "BMR": "BTC.377.02-10E/02.5",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-002",
    "ProcessValidationReport": "PRVR/BTC.389.01-15E/18/01-01",
    "ProcessValidationProtocol": "PRV/BTC.389.01-15E/18/01-01",
    "BMR": "BTC.389.02-15E/02.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.500.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-004",
    "ProcessValidationReport": "PRVR/BTC.389.03-15E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTC.389.03-15E/20/01-01",
    "BMR": "BTC.389.03-15E/03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1.500.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-007",
    "ProcessValidationReport": "PVR/BTC.78.00-10LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BTC.78.00-10LaE/18/01-01",
    "BMR": "BTC.78.01-10LaE, Edition 1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "10,00,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-009",
    "ProcessValidationReport": "PVR/BTC.78.04-10LaE/21/01-02",
    "ProcessValidationProtocol": "PRV/BTC.78.04-10LaE/21/01-01",
    "BMR": "BTC.78.05-10LaE Ed. 05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1 000 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-019",
    "ProcessValidationReport": "PRVR/BTC.91.01-10LaE",
    "ProcessValidationProtocol": "PRVP/BTC.91.01-10LaE",
    "BMR": "BTC.91.01-10LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "100,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.08.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Candesartan Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82318.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "",
    "Reference": "CR-01663",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "and till date no batches are manufactured for Candesartan cilexetil tablets 4 mg [SFG : 4010646]  -> Email Antwort29.10.2024 Dfo , Reminder geschickt am 11.11.2024 Dfo->Antwort 12.11.2024 Dfo:  in Bezug auf CCF/B/2024/0189 bis heute keine Chargen für Candesartan  4 mg [SFG : 4010646] hergestellt.\n29.11.24 nach aktuellen Stand gefragt Dfo \n29.11.24 Till date no batches are manufactured for Candesartan cilexetil tablets 4 mg [SFG : 4010646] with respect to CCF/B/2024/0189. (siehe mail Girish)\n10.12.24 auf TBD gesetzt Dfo + MWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82319.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-006",
    "ProcessValidationReport": "PVR/ BTC.79.00-13.5LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BTC.79.00-13.5LaE/18/01-01",
    "BMR": "BTC.79.00-13.5LaE Edition: 00",
    "Reason_for_validation": "Site shift",
    "API_Manufacturer": "Zhejiang huahai Phamaceuticals co.",
    "Batchsize": "1350000 tabs",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82319.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-011",
    "ProcessValidationReport": "PVR/BTC.79.04-13.5LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTC.79.04-13.5LaE/21/01-01",
    "BMR": "BTC.79.05-13.5LaE, Ed. 05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceuticals",
    "Batchsize": "1 350 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.03.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82319.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-018",
    "ProcessValidationReport": "PRVR/BTC.390.01-13.5E/18/01-01",
    "ProcessValidationProtocol": "PRV/BTC.390.01-13.5E/18/01-01",
    "BMR": "BTC.390.06-13.5E, Edition No. 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao",
    "Batchsize": "1,350,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82276.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN-020",
    "ProcessValidationReport": "PRVR/BTC.92.01-13.5LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTC.92.01-13.5LaE/22/01",
    "BMR": "BTC.92.01-13.5LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 350 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.08.2023",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82319.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-02166",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "20.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82276.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82276.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan Heumann 8 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82276.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 16 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82323.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-001",
    "ProcessValidationReport": "PVR/BTC.382.01-10E/17/01-01",
    "ProcessValidationProtocol": "PV/BTC.382.01-10E/17/01-01 and PV/BTC.382.01-10E/17/01-02 (revision to incorporate compression machine TC118)",
    "BMR": "BTC.382.01 ed 2.4",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1000000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 16 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82323.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-006",
    "ProcessValidationReport": "PVR/BTC.84.00-10.0E/19/01-01",
    "ProcessValidationProtocol": "PV/BTC.84.00-10.0E/18/01-01",
    "BMR": "BTC.84.01-10.0LaE ed 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1000000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 16 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82323.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-008",
    "ProcessValidationReport": "PVR/BTC.408.01-15E/20/01-02",
    "ProcessValidationProtocol": "PV/BTC.408.01-15E/20/01-01",
    "BMR": "BTC.408.02-15E ed 02",
    "Reason_for_validation": "new area, new Batchsize",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1 500 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.11.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Candesartan/HCT Heumann 16 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82323.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "",
    "Reference": "CR-00109",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.08.2024",
    "Due_Date": "30.09.2024",
    "Completed": "",
    "comments": "This is for your information that Candesartan Cilexetil & Hydrochlorothiazide Tablets 16+12.5 mg, SFG Code : 4013822, Batch size 2500000 Tablets planned with higher batch size  in Granulation-VIII \nhas been discontinued due to change in strategy. 25.10.24 MaWa + DFo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 32 mg/25 mg",
    "Dosageform": "TAB",
    "MA_No": "90664.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-004",
    "ProcessValidationReport": "PVR/BTC.385.01-9E/18/01-01",
    "ProcessValidationProtocol": "PV/BTC.385.01-9E/17/01-01",
    "BMR": "BTC.385.02/2.1",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "900 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 32 mg/25 mg",
    "Dosageform": "TAB",
    "MA_No": "90664.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-004",
    "ProcessValidationReport": "PVR/BTC.384.01-200.07E/18/01-01",
    "ProcessValidationProtocol": "PV/BTC.384.01-200.07E/17/01-01",
    "BMR": "BTC.384.02/2.2",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "200.070 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 32 mg/25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "90664.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-007",
    "ProcessValidationReport": "PVR/BTC.88.00-200.070 KgE/19/01-01 – Granules PVR/BTC.90.00-9.0LaE/19/01-01  - Tablets",
    "ProcessValidationProtocol": "PV/BTC.88.00-200.070KgE/19/01-01  – Granules\nPV/BTC.90.00-9.0LaE/19/01-01  - Tablets",
    "BMR": "BTC.88.01-200.070KgE Ed: 01\nBTC.90.01-9.0LaE Ed: 01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "900 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 8 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-005",
    "ProcessValidationReport": "PVR/BTC.83.00-10LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BTC.83.00-10LaE/18/01-01",
    "BMR": "BTC.83.01-10LaE ed 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 8 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-002",
    "ProcessValidationReport": "PVR/BTC.383.01-10E/17/01-01",
    "ProcessValidationProtocol": "PV/BTC.383.01-10E/17/01-01",
    "BMR": "BTC.383.02-10E ed 2.3",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Candesartan/HCT Heumann 8 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "82322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CAN/HCT-009",
    "ProcessValidationReport": "PVR/BTC.409.01-14E/21/01-01",
    "ProcessValidationProtocol": "PV/BTC.409.01-14E/20/01-01",
    "BMR": "BTC.409.02-14E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Zhejiang Huahai Xunqiao / Unichem",
    "Batchsize": "1400000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.04.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Caspofungin Heumann 50mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": "",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Caspofungin Heumann 70mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": "",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cefuroxime 250mg Film coated tablets",
    "Dosageform": "FTA",
    "MA_No": "2205106.00.00",
    "CMOSite": "Nectar Lifesciences Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CEF-002",
    "ProcessValidationReport": "RPT/PV/CFUTBE/01/00",
    "ProcessValidationProtocol": "PRT/PV/CFUTBE/01/00",
    "BMR": "MFC/CFUTBE/01-00\nMFC/CFUTBE/02-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Nectar Lifesciences, Unit 2",
    "Batchsize": "80.000 tablets\n120.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.01.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cefuroxime 500mg Film coated tablets",
    "Dosageform": "FTA",
    "MA_No": "2205107.00.00",
    "CMOSite": "Nectar Lifesciences Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CEF-003",
    "ProcessValidationReport": "RPT/PV/EULAE/01/00",
    "ProcessValidationProtocol": "PRT/PV/EULAE/01/00",
    "BMR": "MRE/EULAE/02-00\nMRE/CUTBE/02-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Nectar Lifesciences, Unit 2",
    "Batchsize": "550,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.01.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Celecoxib Heumann 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92342.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CELE-001",
    "ProcessValidationReport": "MPL/N2/PPV/CN/1/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/CN/1/00",
    "BMR": "MPL/BMR/CN/1/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "500.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Celecoxib Heumann 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92342.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CELE-005",
    "ProcessValidationReport": "MPL/N2/PPQR/21/021/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/021/00",
    "BMR": "MPL/BMR/CB9/1/03\nMPL/&BMR/CB9/1-GP/2/02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "500,000 capsules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.10.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Celecoxib Heumann 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92342.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01362",
    "MPVReviewNo": "MPV-CELE-006",
    "ProcessValidationReport": "MPL/N2/PPQR/24/035/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/24/035/00",
    "BMR": "MPL/BMR/CN/4/00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.",
    "Batchsize": "1000000 Capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "08.07.2024",
    "Due_Date": "20.03.2025",
    "Completed": "04.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Celecoxib Heumann 200 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92343.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CELE-002",
    "ProcessValidationReport": "MPL/N2/PPV/CO/2/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/CO/2/00",
    "BMR": "MPL/BMR/CO/2/06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "1.200.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Celecoxib Heumann 200 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92343.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CELE-003",
    "ProcessValidationReport": "MPL/N2/PPQR/20/031/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/20/031/00",
    "BMR": "MPL/BMR/CC1/1/04 \n(Used in the Validation Process – US Market)\nMPL/BMR/CO/2/07\n(Most Recent Version – EU Market)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "1.200.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cetirizin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "47308.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CET-001",
    "ProcessValidationReport": "VR/MFC/4004447/01\nPVR/BTC.27.05-10.5LaE/18/01-01 (revalidation of tablet coating due to use of new coater F/TCM-09)",
    "ProcessValidationProtocol": "PV/MFC/4004447/00\nPRV/BTC.27.05-10.5LaE/18/01-01 (revalidation of tablet coating due to use of new coater F/TCM-09)",
    "BMR": "BTC.27.00-lO.5LaE\nBTC.27.07-lO.5LaE (edition no. 07) -\nblank\nBTC.27.04-lO.5LaE (edition no. 04) -\nbatch no. CO55004",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops I",
    "Batchsize": "1050000Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.01.2021",
    "comments": "New introduction/New product at TPL Baddi.\nRe-validation on coater F/TCM-09."
  },
  {
    "Status": "QP Approval",
    "Productname": "Cetirizin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "47308.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CET-002",
    "ProcessValidationReport": "PRVR/BTC.104.00-10.5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTC.104.00-10.5LaE/24/01",
    "BMR": "BTC.104.00-10.5LaE\nBTC.104.01-10.5LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops I",
    "Batchsize": "1,050,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann (all strenghts) Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201679.00.00 / 2201680.00.00 / 2201681.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01632",
    "MPVReviewNo": "MPV-CIN-004",
    "ProcessValidationReport": "PPQR/BCT.419.01-227E/22/02",
    "ProcessValidationProtocol": "PPQP/BTC.419.01-227E/22/01",
    "BMR": "BTC.419.02-227E/02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "227 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201679.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CIN-003",
    "ProcessValidationReport": "PVR/BTG.130.01-35.5E/20/01-01 – Granules\nPVR/BTC.405.01-3E/20/01-01 - Tablets",
    "ProcessValidationProtocol": "PV/BTG.130.01-35.5E/20/01-01 – Granules\nPV/BTC.405.01-3E/20/01-01 - Tablets",
    "BMR": "BTG.130.02-35.5E Ed. 02\n(Post Validation for Granules)\nBTC.405.01-3E Ed. 01\n(Validation for Tablets)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Drugs Limited",
    "Batchsize": "300 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201679.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01632",
    "MPVReviewNo": "MPV-CIN-005",
    "ProcessValidationReport": "PPQR/BCT.422.01-111.901E/22/01",
    "ProcessValidationProtocol": "PPQP/BTC.422.01-111.901E/22/01",
    "BMR": "BTC.422.02-111.901E/02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "639.437 kg",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201680.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CIN-002",
    "ProcessValidationReport": "PVR/BTG.131.01-71E/20/01-01 - Granules \nPVR/BTC.406.01-3E/20/01-01 Tablets",
    "ProcessValidationProtocol": "PV/BTG.131.01-71E/20/01-01 - Granules \nPV/BTC:406.01-3E/20/01-01 - Tablets",
    "BMR": "BTG.131.02-71E Ed 02 ( post validation for Granules)\nBTC.406.01-3E Ed 01 ( Vaöidation for Tab)",
    "Reason_for_validation": "",
    "API_Manufacturer": "Hetero Drugs Limited",
    "Batchsize": "Granules: 71.000 Kg (SFG:4012583)\nTablets: 300,000 Tablets (SFG: 4012576)",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201680.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01632",
    "MPVReviewNo": "MPV-CIN-006",
    "ProcessValidationReport": "PPQR/BCT.424.01-111.901E/22/01",
    "ProcessValidationProtocol": "PPQP/BTC.424.01-111.901E/22/01",
    "BMR": "BTC.424.02-111.901E/02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201681.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CIN-001",
    "ProcessValidationReport": "PVR/BTG.132.01-71E/20/01-01 – Granules\nPVR/BTC.407.01-2E/20/01-01 - Tablets",
    "ProcessValidationProtocol": "PV/BTG.132.01-71E/20/01-01 – Granules\nPV/BTC.407.01-2E/20/01-01 - Tablets",
    "BMR": "BTG.132.02-71E Ed 02 (post validation for Granules)\nBTC.407.01-2E Ed 01 (Validation for Tab)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Drugs Limited",
    "Batchsize": "Granules: 71.000 Kg (SFG: 4012584)\nTablets: 200,000 Tablets (SFG: 4012577)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinacalcet Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201681.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01632",
    "MPVReviewNo": "MPV-CIN-007",
    "ProcessValidationReport": "PPQR/425.01-111.9E/23/01",
    "ProcessValidationProtocol": "PPQP/BTC.425.01-111.9E/22/01",
    "BMR": "BTC.425.01-111.9E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "213,144 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.10.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Cinnarizin/Dimenhydrinat Heumann 20mg/40mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7008937.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CIN/DIME-001",
    "ProcessValidationReport": "PPQR/BTC.94.012.1LaE/23/01",
    "ProcessValidationProtocol": "PPQP/BTC.94.012.1LaE/23/01",
    "BMR": "BTC.94.01-2.1LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Fleming Laboratories Limited (Cinnarizin)\nRecordati Industria Chimica (Dimenhydrinat)",
    "Batchsize": "210,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.08.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Cinnarizin/Dimenhydrinat Heumann 20mg/40mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7008937.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "",
    "Reference": "CR-02578",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "1,300,000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74692.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93600.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Cadila Healthcare Limited Dabhasa",
    "Batchsize": "800.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "last batch 1805192 from 06/2018"
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93600.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Saurav Chemicals Limited Unit-III",
    "Batchsize": "800.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "change to bigger Batchsize"
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93600.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01051 / Version 10 / 18-05-2016",
    "Reason_for_validation": "",
    "API_Manufacturer": "Saurav Chemicals Limited Unit-III",
    "Batchsize": "1.000.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93600.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Charioteer Pharmaceutical Co. Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "last batch 1802513 from 03/2018"
  },
  {
    "Status": "QP Approval",
    "Productname": "Clopidogrel Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93600.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Common Blend for Cefuroxime Acetil  250mg/500mg",
    "Dosageform": "Blend",
    "MA_No": "2205106.00.00\n2205107.00.00",
    "CMOSite": "Nectar Lifesciences Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-CEF-001",
    "ProcessValidationReport": "RPT/PV/CFUTLE/01/00",
    "ProcessValidationProtocol": "PRT/PV/CFUTLE/01/00",
    "BMR": "MFC/CUFTLE/01-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Nectar Lifesciences, Unit 2",
    "Batchsize": "90.0 kg\n162.0 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.01.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201813.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201813.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201862.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201862.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201814.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DARU-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-DAR/400 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-DAR/400 / Version 001",
    "BMR": "TDR-PR-022-01310 / Version 002 / 21-06-2019",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited - Unit XI",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201814.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 600 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201815.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DARU-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-DAR/600 / Version 001",
    "ProcessValidationProtocol": "REP-QA-001-DAR/600 / Version 001",
    "BMR": "TDR-PR-022-01311 / Version 002 / 04-07-2019",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited - Unit XI",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 600 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201815.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201812.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201812.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 800 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201816.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DARU-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-DAR/800 / Version 001",
    "ProcessValidationProtocol": "QPR-QC-001-DAR/800 / Version 001",
    "BMR": "TDR-PR-022-01313 / Version 002 / 08-07-2019",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited - Unit XI",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Darunavir Heumann 800 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201816.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205991.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 140 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205992.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205987.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205988.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 70 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205989.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dasatinib Heuman 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205990.00.00",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Synthon-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann  180 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205631.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-002",
    "ProcessValidationReport": "F1\\VR\\000065, Version No.: 1.0",
    "ProcessValidationProtocol": "F1\\VP\\000051, Version No.: 1.0",
    "BMR": "ALBMR3806-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "70 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.02.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann  180 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205631.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-006",
    "ProcessValidationReport": "F1/VR/000647",
    "ProcessValidationProtocol": "F1/VP/000083",
    "BMR": "ALPBMR3806-03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd. Unit I",
    "Batchsize": "70,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann  360 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205632.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-003",
    "ProcessValidationReport": "F1\\VR\\000063, Version No.: 1.0",
    "ProcessValidationProtocol": "F1\\VP\\000046, Version No.: 1.0",
    "BMR": "ALBMR3807-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "70 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.02.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann  360 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205632.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-005",
    "ProcessValidationReport": "F1/VR/000099",
    "ProcessValidationProtocol": "F1/VR/000075",
    "BMR": "ALPBMR3807-01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd. Unit I",
    "Batchsize": "70,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205630.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-001",
    "ProcessValidationReport": "F1\\VR\\000064, Version No.: 1.0",
    "ProcessValidationProtocol": "F1\\VP\\000049, Version No.: 1.0",
    "BMR": "ALBMR3805-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "100 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.02.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Deferasirox Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205630.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DEF-004",
    "ProcessValidationReport": "F1/VR/000248",
    "ProcessValidationProtocol": "F1/VP/000080",
    "BMR": "ALPBMR3805-02",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd. Unit I",
    "Batchsize": "100,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Desloratadin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84585.00.00",
    "CMOSite": "Iberfar - Indústria Farmacêutica S.A.",
    "Country": "EU",
    "Reference": "CR-01584",
    "MPVReviewNo": "MPV-DES-001",
    "ProcessValidationReport": "RVP-972",
    "ProcessValidationProtocol": "PVP-972",
    "BMR": "Not available",
    "Reason_for_validation": "",
    "API_Manufacturer": "Vasudha Pharma Chem Limited",
    "Batchsize": "2 000 000  Tablets",
    "Process": "Entire process",
    "OOX": "",
    "Receipt_Date": "23.07.2024",
    "Due_Date": "22.11.2024",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Dexibuprofen 200mg",
    "Dosageform": "FTA",
    "MA_No": "2203195.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-00525",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2024",
    "Due_Date": "30.08.2024",
    "Completed": "",
    "comments": "13.06.24: Product not yet manufactured (CH)\n15.07.24: Launch information sheet - PO placed but not confirmed. Potential Timeline MAR 25\n06.08.24: MA re-transferred to Fairmed on 27.06.2024 (effective date); product was not marketed by Heumann                                                                                                                            Produktlaunch  (not yet in Trackwise.)   04.11.24 DFo                                                         Laut Launchmeeting am 11.11.2024, Produktion für Januar 2025 geplant 18.11.2024 DFo     \n09.12.24 Laut Launchmeeting Blockiert bis Strides finales Feedback gegeben hat, Produktion erst weit nach Februar 2025 geplant, Timeline erstmal offen für nächstes Businessjahr geplant; BfaRm Antwort wohl auch noch offen dazu/ Texte stehen noch nicht fest   Dfo +MWa\n10.12.24 auf TBD gesetzt Dfo + MWa     \n15.01.24 kein Update bzgl. Launch Timeline; PVD-Statement nur gültig für Schlaftabletten (Manufacturing site: Germany)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Diclofenac 100 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "11524.00.02",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DIC-001",
    "ProcessValidationReport": "VR/BTD.115.00-8.0LaE/16",
    "ProcessValidationProtocol": "PV/BTD.115.00.8.0LaE/15",
    "BMR": "BTD.115.02-8.0LaE; edition 02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Amoli Organics Pvt. Ltd.",
    "Batchsize": "800000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Diclofenac 100 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "11524.00.02",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DIC-003",
    "ProcessValidationReport": "PRVR/BTD.115.06-8.0LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTD.115.06-8.0LaE/22/01",
    "BMR": "BTD.115.06-8.0LaE Edition 06\nBTD.115.07-8.0LaE Edition 07",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Amoli Organics Pvt. Ltd.",
    "Batchsize": "800,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Diclofenac 50 Heumann",
    "Dosageform": "TMR",
    "MA_No": "11524.01.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DIC-002",
    "ProcessValidationReport": "Report for protocol no PV/BTD.6602-6E/07 – complete PV \nPVR/BTD.90.05.6E/18/01-01 – Re-Validation for EC stage",
    "ProcessValidationProtocol": "PV/BTD.6602-6E/07  - complete PV \nPV/BTD.90.04.6E/17/01-01 – PV for change of Enteric coating stage\nPV/BTD.90.05.6E/18/01-01 – PV for change of EC based on OOS-CAPA",
    "BMR": "BTD.90.05-6E; edition 05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Amoli Organics Pvt. Ltd.",
    "Batchsize": "600000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.03.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Diclofenac Heumann Gel",
    "Dosageform": "GEL",
    "MA_No": "19199.00.00",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-CPM-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.04.2020",
    "comments": "PVD-CPM-01 covers only product Diclofenac Heumann Gel, Panthenol CRE and Aciclovir CRE are not covered."
  },
  {
    "Status": "TBD",
    "Productname": "Diclofenac Heumann Gel",
    "Dosageform": "GEL",
    "MA_No": "19199.00.00",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "CR-02476",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "06.02.2025",
    "Completed": "",
    "comments": "07.01.25 MaWa: Reminder"
  },
  {
    "Status": "TBD",
    "Productname": "Dimenhydrinat 50mg (Reisetabletten 50mg)",
    "Dosageform": "TAB",
    "MA_No": "",
    "CMOSite": "?",
    "Country": "",
    "Reference": "CR-01061",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "05.09.2024",
    "Due_Date": "01.08.2025",
    "Completed": "",
    "comments": "laut launchmeeting am 11.11.2024 Site Shift Ende 2025 geplant Launch mit Artesan sicher . 18.11.2024 Dfo\n09.12.24 Laut Launchmeeting Hersteller steht weiterhin nicht fest (Balpharma oder Artesan). Wir warten auf finale bestätigung von Fairmed, erst dann wird mit der Einreichung Dfo+ Mwa\n10.12.24 auf TBD gesetzt dfo + MWa\n15.01.25: Unklar wer CMO (Artesan oder Bal Pharma); Validierungschargen Start Produktion Mai 2025"
  },
  {
    "Status": "Open",
    "Productname": "Dimethylfumarat 120mg",
    "Dosageform": "KAP",
    "MA_No": "",
    "CMOSite": "Sanovel",
    "Country": "Non-EU",
    "Reference": "CC-22-0875",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": 0,
    "Receipt_Date": "NA",
    "Due_Date": "01.01.2028",
    "Completed": "",
    "comments": "laut Launchmeeting am 11.11.2024 vermutlich 2028 wenn überhaupt Dfo 18.11.2024"
  },
  {
    "Status": "Open",
    "Productname": "Dimethylfumarat 240mg",
    "Dosageform": "KAP",
    "MA_No": "",
    "CMOSite": "Sanovel",
    "Country": "Non-EU",
    "Reference": "CC-22-0876",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "NA",
    "Due_Date": "01.01.2028",
    "Completed": "",
    "comments": "laut Launchmeeting am 11.11.2024 vermutlich 2028 wenn überhaupt Dfo 18.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Diphenhydramin 50mg Tabletten (Schlaftabletten Heumann 50mg)",
    "Dosageform": "TAB",
    "MA_No": "2799.98.98",
    "CMOSite": "Fairmed Healthcare GmbH\nMfg. Site: Artesan Pharma GmbH & Co. KG",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Fairmed-01",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "NA",
    "Reason_for_validation": "NA",
    "API_Manufacturer": "NA",
    "Batchsize": "NA",
    "Process": "NA",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Donepezilhydrochlorid Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "81515.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DON-001",
    "ProcessValidationReport": "PVR/BTD.111.04-8.5E/15 – Re-Validation for new compression machine PVR/BTD.111.01-8.5E/12 – Original process validation for Batchsize",
    "ProcessValidationProtocol": "PV/BTD.111.04-8.5E/15 – Re-Validation for new compression machine PV/BTD.111.01-8.5E/12 – Original process validation for Batchsize",
    "BMR": "BTD.111.05-8.5E, Edition: 05.4",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "850000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.07.2020",
    "comments": "PVR/BTD.111.04-8.5E/15 – Re-validation for incorporation of new compression machine\nPVR/BTD.111.01-8.5E/12 – Original validation for batch size at Indrad"
  },
  {
    "Status": "QP Approval",
    "Productname": "Donepezilhydrochlorid Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "81514.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DON-002",
    "ProcessValidationReport": "VR/BTD.81.00-7.5LaE/17",
    "ProcessValidationProtocol": "PV/BTD.81.00-7.5LaE/14",
    "BMR": "BTD.81.03-7.5LaE, Edition: 03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "750000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Donepezilhydrochlorid Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "81514.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DON-003",
    "ProcessValidationReport": "PVR/BTD.117.01-6E/13 - Original Validation  PV/BTD.117.03-6E/15 - Re-validation of compression stage due to change of compression machine TC-67",
    "ProcessValidationProtocol": "PV/BTD.117.01-6E/12 - Original Validation  PV/BTD.117.03-6E/13 - Re-validation of compression stage due to change of compression machine TC-67",
    "BMR": "BTD.117.04-6E, Edition: 04.4",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "600000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dorzolamid Heumann 20 mg/ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "72412.00.00",
    "CMOSite": "S.C. Rompharm Company SRL",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DOR-001",
    "ProcessValidationReport": "AC-RPRvalid-1199_2/Edition 1",
    "ProcessValidationProtocol": "AC-PRvalid-1199_2/Edition 2",
    "BMR": "DS 1374/Edition 03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Crystal Pharma S.A.",
    "Batchsize": "100L",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dorzolamid/Timolol Heumann 20mg/ml + 5mg/ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "2203914.00.00",
    "CMOSite": "Famar S.A. Plant A",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Doxazosin 1 Heumann",
    "Dosageform": "TAB",
    "MA_No": "41279.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DOXA-001",
    "ProcessValidationReport": "VR/MFC/4003768/01",
    "ProcessValidationProtocol": "PV/MFC/4003768/00",
    "BMR": "BTD.46.05-1LaE/05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops IV",
    "Batchsize": "100 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Doxazosin 2 Heumann",
    "Dosageform": "TAB",
    "MA_No": "41279.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DOXA-002",
    "ProcessValidationReport": "VR/MFC/4003769/01",
    "ProcessValidationProtocol": "PV/MFC/4003769/00",
    "BMR": "BTD.47.07-4LaE; edition 07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops IV",
    "Batchsize": "400000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Doxazosin 4 Heumann",
    "Dosageform": "TAB",
    "MA_No": "41279.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DOXA-003",
    "ProcessValidationReport": "VR/MFC/4003770/01",
    "ProcessValidationProtocol": "PV/MFC/4003770/00",
    "BMR": "BTD.48.07-5LaE; edition 07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops IV",
    "Batchsize": "500000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Doxazosin 4 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "51072.00.01",
    "CMOSite": "Acino",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Doxazosin 4 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "51072.00.01",
    "CMOSite": "Acino",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Duloxetin  Heumann 20mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-02208",
    "MPVReviewNo": "MPV-DUL-028",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.10.2024",
    "Due_Date": "19.12.2024",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo,\n Antwort am 15.11.24(Mail von  Suresh) PPQP erhalten \n29.11.24 erneut nach Bericht angefragt Dfo \n10.12.24 erneut nach Bericht angefragt Dfo\n02.01.25: reminder geschickt ( Nach Produktionsdatum angefragt) , siehe Mail an Suresh\n21.01.25 erneut angefragt DFo\n27.01.25 Antwort : We have checked manufacturing plan for product Duloxetine 20mg & 40mg with our PPIC team. \nStill no any order available, So currently no feasibility of production date to manufacture this product."
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93561.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-003",
    "ProcessValidationReport": "ALP/F/APVR/2625-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2625-00",
    "BMR": "ALPBMR2668-04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "600 kg pellets",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.08.2020",
    "comments": "Change in ROS of API"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93561.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-004",
    "ProcessValidationReport": "ALP/F/PVR/1507-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1507-01",
    "BMR": "ALPBMR1846-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "600 kg pellets",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.08.2020",
    "comments": "Original Peletization validation"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93561.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-009",
    "ProcessValidationReport": "ALP/F/APVR/2712-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2712-00",
    "BMR": "ALPBMR2799-02",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150,000 Capsules/ 140.850 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.11.2020",
    "comments": "Change in ROS of API"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93561.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-010",
    "ProcessValidationReport": "ALP/F/APVR/2625-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2625-00",
    "BMR": "ALPBMR2668-01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "600 000 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.11.20",
    "comments": "Change in ROS of API"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93561.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-011",
    "ProcessValidationReport": "ALP/F/PVR/1858-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1858-00 and Addendum 1 for PVP No. ALP/F/PVP/1858-00",
    "BMR": "ALPBMR2134-00\nALPBMR2451-01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Pharmaceuticals Limited",
    "Batchsize": "140.850 kg",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.11.2020",
    "comments": "(Concurrent Validation)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "N/A",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-014",
    "ProcessValidationReport": "ALP/F/APVR/2625-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2625-00",
    "BMR": "ALPBMR2668-04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division II)",
    "Batchsize": "600 000 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "N/A",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-015",
    "ProcessValidationReport": "ALP/F/APVR/2956-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2956-00",
    "BMR": "ALPBMR2668-04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "600 000 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-022",
    "ProcessValidationReport": "ALP/F/APVR/2770-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2770-00",
    "BMR": "ALPBMR2852-00\nALPBMR2852-04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "250,400 kg",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04. Aug 23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-2210",
    "MPVReviewNo": "MPV-DUL-023",
    "ProcessValidationReport": "F1/VR/000450 1.0",
    "ProcessValidationProtocol": "F1/VP/000236 1.0",
    "BMR": "ALPBMR3962-00",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "600,000 kg",
    "Process": "granulation\nEnteric Coating",
    "OOX": "NA",
    "Receipt_Date": "28.10.2024",
    "Due_Date": "14.11.2024",
    "Completed": "29. Okt 24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann (All strengths) magensaftresistente Hartkapseln",
    "Dosageform": "GRA",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-2210",
    "MPVReviewNo": "MPV-DUL-026",
    "ProcessValidationReport": "F1/VR/001313 1.0",
    "ProcessValidationProtocol": "F1/VP/000536 1.0",
    "BMR": "F1/BMR/00819 & 1.0",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "250,400 kg",
    "Process": "granulation\nEnteric Coating",
    "OOX": "NA",
    "Receipt_Date": "28.10.2024",
    "Due_Date": "14.11.2024",
    "Completed": "30. Okt 24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 20 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-005",
    "ProcessValidationReport": "ALP/F/PVR/1859-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1859-00",
    "BMR": "ALPBMR2800-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "150,000 Capsules/ 21.500 kg",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.11.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 20 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-007",
    "ProcessValidationReport": "ALP/F/APVR/2713-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2713-00",
    "BMR": "ALPBMR2800-04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150,000 Capsules/ 21.500 kg",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.11.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 20 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-017",
    "ProcessValidationReport": "ALP/F/APVR/2300-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2300-00",
    "BMR": "ALPBMR2800-04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150,000 Capsules/ 21.500 kg",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2022",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Duloxetin Heumann 20 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-01295",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "05.06.2024",
    "Due_Date": "28.02.2025",
    "Completed": "",
    "comments": "27.11.24  in Trackwise :not available at the moment, to be provided Dfo\n10.12.24 auf TBD gesetztz Dfo + Mwa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-001",
    "ProcessValidationReport": "ALP/F/PVR/2491-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2628-00",
    "BMR": "ALPBMR2453-02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.10.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-012",
    "ProcessValidationReport": "ALP/F/PVR/2491-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2491-00",
    "BMR": "ALPBMR2670-05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-018",
    "ProcessValidationReport": "ALP/F/APVR/2771-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2771-00",
    "BMR": "ALPBMR2671-05",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "450 000 capsules (92.925 kg)",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-020",
    "ProcessValidationReport": "ALP/F/PVR/1504-00 and ADDENDUM REPORT For Report No. ALP/F/PVR/1504-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1504-00;ALP/F/PVR/1504-00",
    "BMR": "ALPBMR2671-05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "450 000 capsules (92.925 kg)",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22. Dez 22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-02210",
    "MPVReviewNo": "MPV-DUL-024",
    "ProcessValidationReport": "F1/VR/001317 1.0",
    "ProcessValidationProtocol": "F1/VP/000541 1.0",
    "BMR": "ALPBMR3967-00",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "450,000 Capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "28.10.2024",
    "Due_Date": "29.10.2024",
    "Completed": "29. Okt 24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 30 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93560.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-02210",
    "MPVReviewNo": "MPV-DUL-027",
    "ProcessValidationReport": "F1/VR/001259 1.0",
    "ProcessValidationProtocol": "F1/VP/000694 1.0",
    "BMR": "ALPBMR3965-00",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "150,000 Capsules",
    "Process": "encapsulation",
    "OOX": "NA",
    "Receipt_Date": "28.10.2024",
    "Due_Date": "30.10.2024",
    "Completed": "30. Okt 24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 40 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93596.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-006",
    "ProcessValidationReport": "ALP/F/PVR/1860-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1860-00",
    "BMR": "ALPBMR2801-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150,000 Capsules/ 40.750 kg",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.11.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 40 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93596.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-008",
    "ProcessValidationReport": "ALP/F/APVR/2714-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2714-00",
    "BMR": "ALPBMR2801-04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150,000 Capsules/ 40.750 kg",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.10.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "TBD",
    "Productname": "Duloxetin Heumann 40 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93596.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-01295",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "05.06.2024",
    "Due_Date": "28.02.2025",
    "Completed": "",
    "comments": "27.11.24 in Trackwise :not available at the moment, to be provided Dfo\n10.12.24 auf TBD gesetzt Dfo + Mwa"
  },
  {
    "Status": "TBD",
    "Productname": "Duloxetin Heumann 40mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93595.00.00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-02208",
    "MPVReviewNo": "MPV-DUL-029",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "31.10.2024",
    "Due_Date": "19.12.2024",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo,\n Antwort am 15.11.24(Mail von  Suresh) PPQP erhalten \n29.11.24 erneut nach Bericht angefragt Dfo\n10.12.24 erneut nach Bericht angefragt Dfo\n02.01.25: reminder geschickt und nach Produktionsdatum angefragt , siehe Mail an Suresh Dfo\n21.01.25 erneut angefragt DFo\n27.01.25 Antwort  We have checked manufacturing plan for product Duloxetine 20mg & 40mg with our PPIC team. \nStill no any order available, So currently no feasibility of production date to manufacture this product."
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-021",
    "ProcessValidationReport": "ALP/F/PVR/1505-00 and ADDENDUM REPORT For Report No. ALP/F/PVR/1505-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1505-00",
    "BMR": "ALPBMR2674-05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "575 000 capsules (223.675 kg)",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22. Dez 22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-002",
    "ProcessValidationReport": "ALP/F/APVR/2631-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2631-00",
    "BMR": "ALPBMR2674-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "575.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.10.2020",
    "comments": "Basic process validation completed for all strengths under MPV-DUL-003, 004 & 009"
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-013",
    "ProcessValidationReport": "ALP/F/PVR/2492-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2492-00",
    "BMR": "ALPBMR2673-05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "150.000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-DUL-019",
    "ProcessValidationReport": "ALP/F/APVR/2772-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2772-00",
    "BMR": "ALPBMR2674-05",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "575 000 capsules (223.675 kg)",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22. Dez 22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-02210",
    "MPVReviewNo": "MPV-DUL-025",
    "ProcessValidationReport": "F1/VR/001260 1.0",
    "ProcessValidationProtocol": "F1/VP/000695 1.0",
    "BMR": "ALPBMR3966-00",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "150000 capsules",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "04.06.2024",
    "Due_Date": "28.02.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Duloxetin Heumann 60 mg magensaftresistente Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "93561.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-02210",
    "MPVReviewNo": "MPV-DUL-030",
    "ProcessValidationReport": "F1/VR/001331 1.0",
    "ProcessValidationProtocol": "F1/VP/000542 1.0",
    "BMR": "ALPBMR3968-00",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Huahai pharmaceutical Co. Ltd.",
    "Batchsize": "575000 capsules",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Dutasterid/Tamsulosin Heumann 0.5 mg/0.4 mg Hartkapseln",
    "Dosageform": "N/A",
    "MA_No": "N/A",
    "CMOSite": "Laboratorios Leon Farma S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-CLF-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.07.2020",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Dutasterid/Tamsulosin Heumann 0.5 mg/0.4 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "",
    "CMOSite": "Laboratorios Leon Farma S.A.",
    "Country": "",
    "Reference": "CR-01025",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "28.05.2024",
    "Due_Date": "25.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Efavirenz/Emtricitabin/Tenofovir 600/200/245",
    "Dosageform": "FTA",
    "MA_No": "2200701.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EFA/EMT/TEN-001",
    "ProcessValidationReport": "MPL/PTF/RPV/EC5/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV/EC5/00",
    "BMR": "MPL/PTF/BMR/EC5/04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceutical Ltd.\nLaurus Labs Limited",
    "Batchsize": "350 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.07.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Efavirenz/Emtricitabin/Tenofovir 600/200/245",
    "Dosageform": "FTA",
    "MA_No": "2200701.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EFA/EMT/TEN-002",
    "ProcessValidationReport": "MPL/PTF/RPV/EC5/01",
    "ProcessValidationProtocol": "MPL/PTF/RPV/EC5/01",
    "BMR": "MPL/PTF/BMR/EC5/04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceutical Ltd.\nLaurus Labs Limited",
    "Batchsize": "350 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.07.2022",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Eltrombopag",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Synthon Hispania S.L.",
    "Country": "EU",
    "Reference": "CR-01502",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.2025",
    "Due_Date": "01.09.2025",
    "Completed": "",
    "comments": "15.01.25: CR in assessment"
  },
  {
    "Status": "QP Approval",
    "Productname": "Emtricitabin/Tenofovirdisoproxil Heumann 200 mg/245 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200703.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00369",
    "MPVReviewNo": "MPV-EMTTEN-003",
    "ProcessValidationReport": "MPL/PTF/RPV1/EC4/01 (interim)\nMPL/PTF/RPQ/EC4/00 (verification)",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/EC4/01 (interim)\nMPL/PTF/PPQ/EC4/00 (verification)",
    "BMR": "MPL/PTF/BMR1/EC4/02\nMPL/PTF/BMR1/EC4/01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Emtricitabine: Macleods Pharmaceuticals Ltd.\nTenofovir Disoproxil fumarate: Macleods Pharmaceuticals Ltd",
    "Batchsize": "450,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.10.2023",
    "Due_Date": "30.08.2024",
    "Completed": "20.02.2025",
    "comments": "20.02.25: An ABa geschickt MaWa\n14.03.25 erneut an QP geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Emtricitabin/Tenofovirdisoproxil Heumann 200 mg/245 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200703.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EMT/TEN-001",
    "ProcessValidationReport": "MPL/PTF/RPQ/EC4/00 (verification)",
    "ProcessValidationProtocol": "MPL/PNR/PPV1/EC4/00",
    "BMR": "MPL/PTF/BMR1/EC4/01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "115 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Emtricitabin/Tenofovirdisoproxil Heumann 200 mg/245 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200703.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EMTTEN-002",
    "ProcessValidationReport": "MPL/PNR/RPV/EC4/00",
    "ProcessValidationProtocol": "MPL/PNR/PPV/EC4/00",
    "BMR": "MPL/PNR/BMR/EC4/00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceutical Ltd.",
    "Batchsize": "450.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Emulus 25mg/g + 25 mg/g Creme",
    "Dosageform": "CRE",
    "MA_No": "94455.00.00",
    "CMOSite": "Rafarm S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-RAF-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.07.2020",
    "comments": "TA with Verisfield, Rafarm are manufacturer"
  },
  {
    "Status": "QP Approval",
    "Productname": "Enalapril/Lercanidipin Tabletten 10mg/10mg",
    "Dosageform": "FTA",
    "MA_No": "7007830.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01547\nCC-17-0209",
    "MPVReviewNo": "MPV-ENALER-001",
    "ProcessValidationReport": "PPQR/BTP.288.03-36.156E/24/01 (Premix)\nPPQR/BTS.208.03-40.296E/24/01 (Granules)\nPPQR/BTF.265.03-2.3E/24/01 (Tablets)",
    "ProcessValidationProtocol": "PPQP/BTP.288.03-36.156E/24/01 (Premix)\nPPQP/BTS.208.03-40.296E/24/01 (Granules)\nPPQP/BTE.265.03-2.3E/24/01 (Tablets)",
    "BMR": "BTP.288.03-36.156E (Premix)\nBTS.208.03-40.296E (Granules)\nBTE.265.03-2.3E (Tablets)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Neuland Laboratories Ltd.\nTorrent Pharmaceutical Ltd.",
    "Batchsize": "36.156 kg (Premix)\n40.296 kg (Granules)\n230,000 (Tablets)",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "12.08.2024",
    "Due_Date": "30.09.2024",
    "Completed": "19.08.2024",
    "comments": "paperbased Launch CC; BMR Update is to transfer recommendations from PV"
  },
  {
    "Status": "QP Approval",
    "Productname": "Enalapril/Lercanidipin Tabletten 10mg/20mg",
    "Dosageform": "FTA",
    "MA_No": "7007831.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01547\nCC-17-0210",
    "MPVReviewNo": "MPV-ENALER-002",
    "ProcessValidationReport": "PPQR/BTS.148.04-22.275E/24/01 (Granules)\nPPQR/BTE.155.04-1.1E/24/01 (Tablets)",
    "ProcessValidationProtocol": "PPQP/BTS.148.04-22.275E/24/01 (Granules)\nPPQP/BTE.155.04-1.1E/24/01 (Tablets)",
    "BMR": "BTS.148.04-22.275E (Granules)\nBTE.155.04-1.1E (Tablets)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Neuland Laboratories Ltd.\nTorrent Pharmaceutical Ltd.",
    "Batchsize": "22.275kg (Granules)\n110,000 (Tablets)",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "12.08.2024",
    "Due_Date": "30.09.2024",
    "Completed": "19.08.2024",
    "comments": "paperbased Launch CC; BMR Update is to transfer recommendations from PV"
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98145.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ENT-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01200 / Version 1 / 11-07-2017",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "250.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.05.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98145.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ENT-003",
    "ProcessValidationReport": "from Dossier",
    "ProcessValidationProtocol": "N/A",
    "BMR": "TDR-PR-022-01200 / Version 1 / 11-07-2017",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "250.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.06.2020",
    "comments": "common blend was missing at the first check of PV"
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98145.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 1,0 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98146.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ENT-004",
    "ProcessValidationReport": "from Dossier",
    "ProcessValidationProtocol": "N/A",
    "BMR": "TDR-PR-022-01201 / Version 1 / 18.07.2017",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "125.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.06.2020",
    "comments": "common blend was missing at the first check of PV"
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 1,0 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98146.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01200 / Version 1",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "125.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Entecavir Heumann 1,0 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98146.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Eplerenon Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93869.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Eplerenon Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93869.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Eplerenon Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93870.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Eplerenon Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93870.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 100  mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203099.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-003",
    "ProcessValidationReport": "PVR-FE-0059-03",
    "ProcessValidationProtocol": "PVP-FE-0059-00",
    "BMR": "ERL-T-025-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "11.250 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 11.250 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla.\nThe Reason_for_validation is commercial batches for Europe market change in batch size from 50.625 kg to 11.250 kg"
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 100  mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203099.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-004",
    "ProcessValidationReport": "PVR-FE-0057-02",
    "ProcessValidationProtocol": "PVP-FE-0057-00",
    "BMR": "ERL-T-022-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "9.375 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 9.375 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla."
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203099.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-002",
    "ProcessValidationReport": "PVR-FE-0058-03",
    "ProcessValidationProtocol": "PVP-FE-0058-00",
    "BMR": "ERL-T-024-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)",
    "Batchsize": "31250 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.03.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 150  mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203100.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-003",
    "ProcessValidationReport": "PVR-FE-0059-03",
    "ProcessValidationProtocol": "PVP-FE-0059-00",
    "BMR": "ERL-T-025-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "11.250 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 11.250 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla.\nThe Reason_for_validation is commercial batches for Europe market change in batch size from 50.625 kg to 11.250 kg"
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 150  mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203100.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-004",
    "ProcessValidationReport": "PVR-FE-0057-02",
    "ProcessValidationProtocol": "PVP-FE-0057-00",
    "BMR": "ERL-T-022-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "9.375 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 9.375 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla."
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 150  mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203100.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-005",
    "ProcessValidationReport": "PVR-FE-0060-03",
    "ProcessValidationProtocol": "PVP-FE-0060-00",
    "BMR": "ERL-T-026-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "25.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Erlotinib Tablets 150 mg report with three consecutive validation batches for the batch size of 25:000 tablets due to change in batch size (from 5500 tablets to 25000 tablets) in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla for Europe commercial."
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203098.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-003",
    "ProcessValidationReport": "PVR-FE-0059-03",
    "ProcessValidationProtocol": "PVP-FE-0059-00",
    "BMR": "ERL-T-025-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "11.250 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 11.250 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla.\nThe Reason_for_validation is commercial batches for Europe market change in batch size from 50.625 kg to 11.250 kg"
  },
  {
    "Status": "QP Approval",
    "Productname": "Erlotinib 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2203098.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ERL-004",
    "ProcessValidationReport": "PVR-FE-0057-02",
    "ProcessValidationProtocol": "PVP-FE-0057-00",
    "BMR": "ERL-T-022-01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "9.375 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2021",
    "comments": "The objective of this Validation Process is to evaluate the process performance qualification activity of Common Blend for Erlotinib Tablets 25 mg, 100 mg and 150 mg with three consecutive validation batches for the batch size of 9.375 kg in the manufacturing facility (Block VB) of Hetero Labs Limited (Unit-V) Jadcherla."
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86753.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-001",
    "ProcessValidationReport": "PVR/BTE.210.01-12E/14",
    "ProcessValidationProtocol": "PV/BTE.210.01-12E/14",
    "BMR": "BTE.210.05-512E/05.6",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.200.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86753.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-006",
    "ProcessValidationReport": "PRVR/BTE.279.01-12E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTE.279.01-12E/21/01-01",
    "BMR": "BTE.210.07-12E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1 200 000 Tablets",
    "Process": "Coating Stage",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.10.2021",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86753.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-009",
    "ProcessValidationReport": "PVR/BTE.100.01-10.5LaE/21/01-01",
    "ProcessValidationProtocol": "PV/BTE.100..01-10.5LaE/21/01-01",
    "BMR": "BTE.100.01-10.5LaE",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "105,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86753.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "No batch intiated, kommt eventuell 2025, Due_Date in Trackwise stimmt nicht DFo 25.10.24( siehe Mail  von Karam Singh)\n10.12.24 auf TBD gesetzt Dfo + Mwa"
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86753.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "No batch intiated, kommt eventue ll 2025, Due_Date in Trackwise stimmt nicht DFo 25.10.24(siehe Mail von Karam Singh)\n10.12.24 auf TBD gesetzt Dfo+Mwa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86754.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-003",
    "ProcessValidationReport": "PVR/BTC.314.01-93.6E/17 (Granules) PRVR/BTE.249.01-4.8E/18/01-01 (Batch size & compression)",
    "ProcessValidationProtocol": "PV/BTC.314.01-93.6E (Granules) PRV/BTE.249.01-4.8E/18/01-01 (Batch size & compression)",
    "BMR": "BTE.249.02-4.8E/ 02.1",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "480000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2020",
    "comments": "Two re-validations considered, one for addition of peristaltic pump and change to drying time and one for alternate batch size and compression stage"
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86754.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-010",
    "ProcessValidationReport": "PVR/BTE.101.01-07LaE/22/01-01",
    "ProcessValidationProtocol": "PV/BTE.101.01-07LaE/21/01-01",
    "BMR": "BTE.101.01-7.0LaE",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)",
    "Batchsize": "700,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86754.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "No batch intiated, kommt eventue ll 2025, Due_Date in Trackwise stimmt nicht DFo 25.10.24(siehe Mail von Karam Singh)\n10.12.24 auf TBD gesetzt Dfo+ Mwa"
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86754.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "No batch intiated, kommt eventue ll 2025, Due_Date in Trackwise stimmt nicht DFo 25.10.24(siehe Mail von Karam Singh)\n10.12.24 auf TBD gesetzt Dfo+ Mwa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86755.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-002",
    "ProcessValidationReport": "PVR/BTE.209.01-10e/14",
    "ProcessValidationProtocol": "PV/BTE.209.01-10E/14",
    "BMR": "BTE.209.04-10E/04.6",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86755.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-007",
    "ProcessValidationReport": "PRV/BTE.278.01-10E/21/01-01",
    "ProcessValidationProtocol": "PRVR/BTE.278.01-10E/21/01-01",
    "BMR": "BTE.278.01-10E/01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1 000 000 Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.11.2021",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86755.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "noch nicht geplant mit neuer API, es wird einen neuen Change dafür  geben, Yes, yet no batches manufactured at TPL Baddi  with alternate API Source Neuland as per CCF/TRC/2023/1470.\nProcess validation for Escitalopram with API from Neuland will be done whenever manufacturing to be planned at TPL Baddi 25.10.2024 Dfo\n10.12.24 auf TBD gesetzt DFo + MWa"
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86755.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "",
    "Reference": "CR-02676",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 20 mg/ml Tropfen zum Einnehmen, Lösung",
    "Dosageform": "TRO",
    "MA_No": "86825.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-005",
    "ProcessValidationReport": "PVR-187",
    "ProcessValidationProtocol": "PVP-212",
    "BMR": "CM266/1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "300 L",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86752.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01201\nCR-01272\nCR-01506",
    "MPVReviewNo": "MPV-ESC-011",
    "ProcessValidationReport": "PRVR/BTE.110.00-5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTE.110.00-5LaE/24/01",
    "BMR": "BTE.110.00-5.0LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited (Unit I )",
    "Batchsize": "500 000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86752.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-004",
    "ProcessValidationReport": "PVR/BTE.245.01-16E/18/01-01",
    "ProcessValidationProtocol": "PV/BTE.245.01-16E/17/01-01",
    "BMR": "BTE.245.02-16E/02.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "1600000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Escitalopram Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86752.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESC-008",
    "ProcessValidationReport": "PVR/BTE.99.00-5.0LaE/21/01-01",
    "ProcessValidationProtocol": "PV/BTE.99.00-5.0LaE/21/01-01",
    "BMR": "BTE.99.00-5.0LaE",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "500,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Escitalopram Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86752.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01201",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.07.2024",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": ",noch nicht geplant mit neuer API, es wird einen neuen Change dafür  geben, Yes, yet no batches manufactured at TPL Baddi  with alternate API Source Neuland as per CCF/TRC/2023/1470.\nProcess validation for Escitalopram with API from Neuland will be done whenever manufacturing to be planned at TPL Baddi 25.10.2024 Dfo\n10.12.24 auf TBD gesetzt DFo +MWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Eslicarbazepin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2204355.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESL-002 (tableting)\nMPV-ESL-001 (common granules)",
    "ProcessValidationReport": "PVR/BTE.29.02-1.4E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTE.29.02-1.4E/21/01-01",
    "BMR": "BTE.29.02-1.4E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Jubilant Generics Ltd.",
    "Batchsize": "140 000 Tablets",
    "Process": "Lubrication and Compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.11.21",
    "comments": "Launch"
  },
  {
    "Status": "QP Approval",
    "Productname": "Eslicarbazepin Heumann 800 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2204358.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESL-003 (tableting)\nMPV-ESL-001 (common granules)",
    "ProcessValidationReport": "PVR/BTE.28.02-1.4E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTE.28.02-1.4E/21/01-01",
    "BMR": "BTE.28.02-1.4E",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Jubilant Generics Ltd.",
    "Batchsize": "140 000 Tablets",
    "Process": "Lubrication and Compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.11.21",
    "comments": "Launch"
  },
  {
    "Status": "QP Approval",
    "Productname": "Eslicarbazepin Heumann 800 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2204358.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESL-004",
    "ProcessValidationReport": "PRVR/BTE.24.02-1.85E/22/01",
    "ProcessValidationProtocol": "PRV/BTE.24.02-1.85E/22/01-02",
    "BMR": "BTE.24.02-1.85E, Edition No. 02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Jubilant Generics Ltd.",
    "Batchsize": "185 000 Tablets",
    "Process": "Lubrication and Compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.11.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Esomeprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "81793.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESO-001",
    "ProcessValidationReport": "Gastro-Resistant Tablets : Report with ref. protocol PV/BTE.83.02-7E/11 (BO351001-5)\nEnteric coated pellet: Report with ref. protocol PV/BTE.79.02-389.88E/11 (BO221001-3)\nBarrier coated pellet: Report with ref. protocol PV/BTE.78.02-185.661E/11 (BO181001-3)\nDrug coated pellets: Report with ref. protocol PV/BTE.73.02-158.73E/11 (BO121001-3)\nSeal coated pellets: Report with ref. protocol PV/BTE.68.02-55.004/11 (BO031001-3)",
    "ProcessValidationProtocol": "Gastro-Resistant Tablets : PV/BTE.83.02-7E/11 \nEnteric coated pellet: PV/BTE.79.02-389.88E/11 \nBarrier coated pellet: PV/BTE.78.02-185.661E/11 \nDrug coated pellets: PV/BTE.73.02-158.73E/11 \nSeal coated pellets: PV/BTE.68.02-55.004/11",
    "BMR": "Gastro-Resistant Tablets : BTE.83.10-7E Ed: 10 \nEnteric coated pellet: BTE.79.05-389.88E Ed: 05.6 \nBarrier coated pellet: BTE.78.08-185.661E Ed: 08.5 \nDrug coated pellets: BTE.73.08-158.73E Ed: 08.6 \nSeal coated pellets: BTE.68.07-55.004E Ed: 07.3",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "700.000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2021",
    "comments": "Needed prior to release"
  },
  {
    "Status": "QP Approval",
    "Productname": "Esomeprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "81794.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ESO-002",
    "ProcessValidationReport": "Gastro-Resistant Tablets : Report with ref. protocol PV/BTE.82.02-3.5E/11 (BO361001-5)\nEnteric coated pellet: Report with ref. protocol PV/BTE.79.02-389.88E/11 (BO221001-3)\nBarrier coated pellet: Report with ref. protocol PV/BTE.78.02-185.661E/11 (BO181001-3)\nDrug coated pellets: Report with ref. protocol PV/BTE.73.02-158.73E/11 (BO121001-3)\nSeal coated pellets: Report with ref. protocol PV/BTE.68.02-55.004/11 (BO031001-3)",
    "ProcessValidationProtocol": "Gastro-Resistant Tablets : PV/BTE.82.02-3.5E/11 \nEnteric coated pellet: PV/BTE.79.02-389.88E/11 \nBarrier coated pellet: PV/BTE.78.02-185.661E/11 \nDrug coated pellets: PV/BTE.73.02-158.73E/11 \nSeal coated pellets: PV/BTE.68.02-55.004/11",
    "BMR": "Gastro-Resistant Tablets : BTE.82.12-3.5E Ed: 12 \nEnteric coated pellet: BTE.79.05-389.88E Ed: 05.6 \nBarrier coated pellet: BTE.78.08-185.661E Ed: 08.5 \nDrug coated pellets: BTE.73.08-158.73E Ed: 08.6 \nSeal coated pellets: BTE.68.07-55.004E Ed: 07.3",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "700.000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2021",
    "comments": "All product expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etericoxib Heumann 120 mg",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-01721",
    "MPVReviewNo": "MPV-ETO-013",
    "ProcessValidationReport": "ALP/F/PVR/3183-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3183-00",
    "BMR": "ALPBMR3311-00",
    "Reason_for_validation": "",
    "API_Manufacturer": "Alembic Limited (API Division I )",
    "Batchsize": "150 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.11.2024",
    "Due_Date": "20.02.2025",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo-> erledigt am 15.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etericoxib Heumann 30mg",
    "Dosageform": "FTA",
    "MA_No": "93514.00.00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-01721",
    "MPVReviewNo": "MPV-ETO-007",
    "ProcessValidationReport": "ALP/F/PVR/2380-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2380-00",
    "BMR": "ALPBMR-2490-04\nALPBMR-2490-05",
    "Reason_for_validation": "",
    "API_Manufacturer": "Alembic Limited (API Division I )",
    "Batchsize": "350 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.11.2024",
    "Due_Date": "20.02.2025",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo-> erledigt am 15.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etericoxib Heumann 60mg",
    "Dosageform": "FTA",
    "MA_No": "93515.00.00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-01721",
    "MPVReviewNo": "MPV-ETO-004",
    "ProcessValidationReport": "ALP/F/PVR/2328-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2328-00",
    "BMR": "ALPBMR2491-05\nALPBMR2491-06",
    "Reason_for_validation": "",
    "API_Manufacturer": "Alembic Limited (API Division I )",
    "Batchsize": "600 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.11.2024",
    "Due_Date": "20.02.2025",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo -> erledigt am 15.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etericoxib Heumann 90mg",
    "Dosageform": "FTA",
    "MA_No": "93516:00:00",
    "CMOSite": "Alembic Pharmaceuticals Ltd. - Panelav",
    "Country": "Non-EU",
    "Reference": "CR-01721",
    "MPVReviewNo": "MPV-ETO-002",
    "ProcessValidationReport": "ALP/F/APVR/2381-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2381-00",
    "BMR": "ALPBMR2492-05 \nALPBMR2492-06",
    "Reason_for_validation": "",
    "API_Manufacturer": "Alembic Limited (API Division I )",
    "Batchsize": "400 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.11.2024",
    "Due_Date": "20.02.2025",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo-> erledigt am 15.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-008",
    "ProcessValidationReport": "ALP/F/PVR/2300-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2300-00",
    "BMR": "ALPBMR2493-06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "300 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-009",
    "ProcessValidationReport": "ALP/F/PVR/2887-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2887-00",
    "BMR": "ALPBMR2493-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "300 000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.03.2020",
    "comments": "new coating machine ID PD/09/COT04 which is equivalent to the coating machine considered in initial validation"
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-011",
    "ProcessValidationReport": "ALP/F/PVR/2330-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2330-00",
    "BMR": "ALPBMR2493-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "300,000 tablets (123.600 kg)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-012",
    "ProcessValidationReport": "ALP/F/APVR/2887-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2887-00",
    "BMR": "ALPBMR2493-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "300,000 tablets (123.600 kg)",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-013",
    "ProcessValidationReport": "ALP/F/PVR/3183-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3183-00",
    "BMR": "ALPBMR3311-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "150,000 tablets (61.800 kg)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.12.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93514.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-006",
    "ProcessValidationReport": "ALP/F/PVR/2327-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2327-00",
    "BMR": "ALPBMR-2490-05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 350,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93514.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-007",
    "ProcessValidationReport": "ALP/F/PVR/2380-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2380-00",
    "BMR": "ALPBMR-2490-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 350,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.02.2020",
    "comments": "New compression machine PD/08/COM02 and new coater PD/09/COT09"
  },
  {
    "Status": "Open",
    "Productname": "Etoricoxib Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93514.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "",
    "Reference": "CR-02453",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "20.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 30 mg, 60 mg, 90 mg, 120 mg Filmtabletten",
    "Dosageform": "blend",
    "MA_No": "93514.00.00, 93515.00.00, 93516.00.00, 93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-010",
    "ProcessValidationReport": "ALP/F/PVR/3181-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3181-00",
    "BMR": "ALPBMR3309-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "120.000 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.11.2020",
    "comments": "New BMR was prepared for commercial batches with common blend approach for commercial product having batch size of 120.000 kg for Export Market.\nProspective Process Validation – commercial product with incorporation of common blend Approach."
  },
  {
    "Status": "Open",
    "Productname": "Etoricoxib Heumann 30 mg, 60 mg, 90 mg, 120 mg Filmtabletten",
    "Dosageform": "blend",
    "MA_No": "93514.00.00, 93515.00.00, 93516.00.00, 93517.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "",
    "Reference": "CR-02453",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "20.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93515.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-004",
    "ProcessValidationReport": "ALP/F/PVR/2328-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2328-00",
    "BMR": "ALPBMR2491-06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 600,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93515.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-005",
    "ProcessValidationReport": "ALP/F/APVR/2885-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2885-00",
    "BMR": "ALPBMR2491-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 600,
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93515.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-015",
    "ProcessValidationReport": "F1/VR/000325 Version 1.0",
    "ProcessValidationProtocol": "F1/VP/000527 Version 1.0",
    "BMR": "ALPBMR2491-09\nF1/BMR/00476 & 1.0",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "600,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.10.2023",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Etoricoxib Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93515.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "",
    "Reference": "CR-02453",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "20.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93516.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-001",
    "ProcessValidationReport": "ALP/F/PVR/2329-01",
    "ProcessValidationProtocol": "ALP/F/PVP/2329-00",
    "BMR": "ALPBMR2492-06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 400,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93516.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-002",
    "ProcessValidationReport": "ALP/F/APVR/2381-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2381-00",
    "BMR": "ALPBMR2492-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 400,
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93516.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-003",
    "ProcessValidationReport": "ALP/F/APVR/2886-00",
    "ProcessValidationProtocol": "ALP/F/APVP/2886-00",
    "BMR": "ALPBMR2492-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 400,
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Etoricoxib Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93516.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ETO-014",
    "ProcessValidationReport": "F1/VR/000520 Version 1.0",
    "ProcessValidationProtocol": "F1/VP/000324",
    "BMR": "ALPBMR2492-09\nF1/BMR/00477 & 1.0",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "400,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.10.2023",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Etoricoxib Heumann 90 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "93516.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "",
    "Reference": "CR-02453",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "20.12.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Exemestan Heumann 25 mg überzogene Tabletten",
    "Dosageform": "UTA",
    "MA_No": "78341.00.00",
    "CMOSite": "Oman Pharmaceutical Products Co. LLC",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EXE-001",
    "ProcessValidationReport": "PV/083A/02",
    "ProcessValidationProtocol": "PV/083A/02",
    "BMR": "BMR-117-04 + 05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cedarburg Pharmaceuticals, Inc.",
    "Batchsize": 600,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Exemestan Heumann 25 mg überzogene Tabletten",
    "Dosageform": "UTA",
    "MA_No": "78341.00.00",
    "CMOSite": "Oman Pharmaceutical Products Co. LLC",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EXE-002",
    "ProcessValidationReport": "PVR/334/00",
    "ProcessValidationProtocol": "PV/334/00",
    "BMR": "BMR-957-00",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Symbiotica",
    "Batchsize": 600,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "94936.00.00",
    "CMOSite": "Balkanpharma Dupnitsa AD / Watson Pharma Private Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": 600,
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "94936.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EZE-001",
    "ProcessValidationReport": "PVR/BTE.96.02-5.0LaE/20/01-02",
    "ProcessValidationProtocol": "PV/BTE.96.01-5.0LaE/20/01-01\nPV/BTE.96.02-5.0LaE/20/01-01",
    "BMR": "BTE.96.02-5.0LaE Ed. 02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Atorvastatin 10mg/10mg",
    "Dosageform": "FTA",
    "MA_No": "7013371.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-00692",
    "MPVReviewNo": "MPV-EZEATO-001",
    "ProcessValidationReport": "ISL/J/PVR/APU003",
    "ProcessValidationProtocol": "ISL/J/PV/APU003",
    "BMR": "BMR/APU03-00\nBMR/APU04-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Indswift Laboratories Limited",
    "Batchsize": "1,600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.04.2024",
    "Due_Date": "27.09.2024",
    "Completed": "12.09.2024",
    "comments": "08.08.24: CMO is going to send documents next week\n21.08.24: Reminder\n02.09.24: Reminder; Dev \"dispatch under quarantine\" to be clarified"
  },
  {
    "Status": "Open",
    "Productname": "Ezetimib/Atorvastatin 10mg/10mg",
    "Dosageform": "FTA",
    "MA_No": "7013371.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-02778",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "04.06.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Atorvastatin 10mg/20mg",
    "Dosageform": "FTA",
    "MA_No": "7013372.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-00692",
    "MPVReviewNo": "MPV-EZEATO-002",
    "ProcessValidationReport": "ISL/J/PVR/APV003",
    "ProcessValidationProtocol": "ISL/J/PV/APV003",
    "BMR": "BMR/APV03-00\nBMR/APV04-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Indswift Laboratories Limited",
    "Batchsize": "1,600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.04.2024",
    "Due_Date": "27.09.2024",
    "Completed": "12.09.2024",
    "comments": "08.08.24: CMO is going to send documents next week\n21.08.24: Reminder\n02.09.24: Reminder; Dev \"dispatch under quarantine\" to be clarified"
  },
  {
    "Status": "Open",
    "Productname": "Ezetimib/Atorvastatin 10mg/20mg",
    "Dosageform": "FTA",
    "MA_No": "7013372.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-02777",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "04.06.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Atorvastatin 10mg/400mg",
    "Dosageform": "FTA",
    "MA_No": "7013373.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-00692",
    "MPVReviewNo": "MPV-EZEATO-003",
    "ProcessValidationReport": "ISL/J/PVR/APW003",
    "ProcessValidationProtocol": "ISL/J/PV/APW003",
    "BMR": "BMR/APW03-00\nBMR/APW04-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Indswift Laboratories Limited",
    "Batchsize": "1,600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.04.2024",
    "Due_Date": "27.09.2024",
    "Completed": "12.09.2024",
    "comments": "08.08.24: CMO is going to send documents next week\n21.08.24: Reminder\n02.09.24: Reminder; Dev \"dispatch under quarantine\" to be clarified"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Atorvastatin 10mg/80mg",
    "Dosageform": "FTA",
    "MA_No": "7013374.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-00692",
    "MPVReviewNo": "MPV-EZEATO-004",
    "ProcessValidationReport": "ISL/J/PVR/APX001",
    "ProcessValidationProtocol": "ISL/J/PV/APX001\nISL/JPV/APX003",
    "BMR": "BMR/APX04-00\nBMR/APX05-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Indswift Laboratories Limited",
    "Batchsize": "1,600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.04.2024",
    "Due_Date": "27.09.2024",
    "Completed": "12.09.2024",
    "comments": "08.08.24: CMO is going to send documents next week\n21.08.24: Reminder\n02.09.24: Reminder; Dev \"dispatch under quarantine\" to be clarified"
  },
  {
    "Status": "Open",
    "Productname": "Ezetimib/Atorvastatin 10mg/80mg",
    "Dosageform": "FTA",
    "MA_No": "7013374.00.00",
    "CMOSite": "Ind-Swift Limited",
    "Country": "Non-EU",
    "Reference": "CR-02730",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Simvastatin Heumann 10 mg/10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004747.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EZE/SIM-001",
    "ProcessValidationReport": "PRVR/BTE.261.04-2.4E/21/02-01",
    "ProcessValidationProtocol": "PRV/BTE.261.04-2.4E/21/02-01",
    "BMR": "BTE.257.03-2.4E Edition No. 03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd./Biocon Ltd",
    "Batchsize": "240 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.01.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Simvastatin Heumann 10 mg/20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004748.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EZE/SIM-002",
    "ProcessValidationReport": "PVR/BTE.280.01-6.5E/21/01-01",
    "ProcessValidationProtocol": "PV/BTE.280.01-6.5E/21/01-01",
    "BMR": "BTE.283.01-6.5E Edition No. 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd./Biocon Ltd",
    "Batchsize": "650 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.01.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Simvastatin Heumann 10 mg/40 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004749.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EZE/SIM-003",
    "ProcessValidationReport": "PRVR/BTE.263.05-6E/22/02-02",
    "ProcessValidationProtocol": "PRV/BTE.263.05-6E/21/02-01",
    "BMR": "BTE.284.01-6E Edition No. 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd./Biocon Ltd",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.01.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ezetimib/Simvastatin Heumann 10 mg/80 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004750.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-EZE/SIM-004",
    "ProcessValidationReport": "PRVR/BTE.264.04-4.5EE/22/02-02",
    "ProcessValidationProtocol": "PRV/BTE.264.04-4.5E/21/02-01",
    "BMR": "BTE.285.02-4.5E Edition No. 02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd./Biocon Ltd",
    "Batchsize": "450 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.23",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Ezetimibe/Atorvastatin 10mg/40mg",
    "Dosageform": "FTA",
    "MA_No": "7013373.00.00",
    "CMOSite": "Ind-Swift Ltd.",
    "Country": "Non-EU",
    "Reference": "CR-02586",
    "MPVReviewNo": "MPV-EZEATO-005",
    "ProcessValidationReport": "ISL/J/PVR/APW004",
    "ProcessValidationProtocol": "ISL/J/PV/APW004",
    "BMR": "BMR/APW004-02",
    "Reason_for_validation": "Inspection finding",
    "API_Manufacturer": "Ezetimib: Syntimed Labs Pvt. Ltd.\nAtorvastatin Calcium Trihydrate: Synthimed Labs Pvt. Ltd.",
    "Batchsize": "1,600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "31.01.2025",
    "Due_Date": "27.04.2025",
    "Completed": "20.03.25",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n05.03.25 Protokoll erhalten, Bericht fehlt, melden sich sobald erhalten\n(lt Mail: Section 13.0 – CMA’s, CPP’s, and CQA’s \nSection 25.0 – Sampling Locations ), am 13.03.25 soll der Bericht kommen Dfo\n20.03.2025: PVR Draft in Review; mit AET abklären ob acceptable (Mail 20.03.25); Review kann geschlossen werden sobald PVR von Indswift signiert"
  },
  {
    "Status": "Documents requested",
    "Productname": "Fampridin 10mg extended release tablets",
    "Dosageform": "TAB",
    "MA_No": "",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "CR-01500",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.2025",
    "Due_Date": "23.05.2025",
    "Completed": "",
    "comments": "15.01.25: CR in assessment\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n26.03.25: Reminder Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99753.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEB-002",
    "ProcessValidationReport": "MPL/N2/PPV/FN/1/01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "MPL/BMR/FN/1/04",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.04.2021",
    "comments": "Not launched"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99753.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEB-004",
    "ProcessValidationReport": "MPL/N2/PPQR/23/059/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/059/00",
    "BMR": "MPL/BMR/FN/1/06\nMPL/BMR/FN/1/07",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "100,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99753.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00237",
    "MPVReviewNo": "MPV-FEB-008",
    "ProcessValidationReport": "MPL/N2/PER/21/E/017/00",
    "ProcessValidationProtocol": "MPL/N2/PEP/21/E/017/00",
    "BMR": "MPL/BMR/FN/2/00",
    "Reason_for_validation": "CIP in API",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited , Village Theda, Thesil Baddi, Himachal Pradesh",
    "Batchsize": "100000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "10.06.2024",
    "Due_Date": "30.08.2024",
    "Completed": "05.03.2025",
    "comments": "06.08.24: queries sent to CMO\n21.08.24: Reminder\n23.08.24: Draft MPV completed; in discussion with QP since only 1 validation batch manufactured"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200576.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99752.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEB-003",
    "ProcessValidationReport": "MPL/N2/PPQR/19/075/01-A1",
    "ProcessValidationProtocol": "MPL/N2/PPQP/19/075/01-A1",
    "BMR": "MPL/BMR/FM/3/05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "600,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99752.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEB-001",
    "ProcessValidationReport": "MPL/N2/PPQR/19/075/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/19/075/00",
    "BMR": "MPL/BMR/FM/3/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "600.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.03.2021",
    "comments": "Not launched"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99752.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00776",
    "MPVReviewNo": "MPV-FEB-006",
    "ProcessValidationReport": "MPL/N2/PPQR/19/075/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/19/075/01-A1",
    "BMR": "MPL/BMR/FM/3/05\nMPL/BMR/FM/3/06",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.",
    "Batchsize": "600,000 tablets",
    "Process": "Coating",
    "OOX": "NA",
    "Receipt_Date": "16.07.2024",
    "Due_Date": "16.07.2024",
    "Completed": "02.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99752.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00237",
    "MPVReviewNo": "MPV-FEB-007",
    "ProcessValidationReport": "MPL/N2/PER/21/E/016/00",
    "ProcessValidationProtocol": "MPL/N2/PEP/21/E/016/00",
    "BMR": "MPL/BMR/FM/4/00",
    "Reason_for_validation": "CIP in API",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited",
    "Batchsize": "100000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "10.06.2024",
    "Due_Date": "30.08.2024",
    "Completed": "05.03.2025",
    "comments": "06.08.24: queries sent to CMO\n21.08.24: Reminder\n23.08.24: Draft MPV completed; in discussion with QP since only 1 validation batch manufactured"
  },
  {
    "Status": "QP Approval",
    "Productname": "Febuxostat Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200575.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "Documents requested",
    "Productname": "Felodipin 10 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45633.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00323",
    "MPVReviewNo": "MPV-FEL-007",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.10.2023",
    "Due_Date": "04.04.2025",
    "Completed": "",
    "comments": "10.06.24: Validation is under process (see e-mail by Vijay)\n27.06.24: Reminder\n08.07.24: Reminder; Validation on going\n21.08.24: Reminder; Validation still on going - no batch under planning\n22.10.24 MaWa: Reminder; Validation ongioing and no batch under planning until now                                                                                                                                             06.11.2024 DFo: Reminder geschickt                                                                                              07.11.2024DFo: noch keine Charge in Planung (Mail von Vishal)\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt DFo\n26.03.25 Reminder Dfo\n27.03.25 Protokoll erhalten, Process is under validation DFo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Felodipin 10 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45633.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEL-003",
    "ProcessValidationReport": "PV/MFC/4001380/01",
    "ProcessValidationProtocol": "PV/MFC/4001380/00",
    "BMR": "BTF.13.11-2.5LaE; Edition 11",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "250000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Felodipin 2,5 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45632.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEL-002",
    "ProcessValidationReport": "VR/MFC/4001378/01",
    "ProcessValidationProtocol": "PV/MFC/4001378/00",
    "BMR": "BTF.11.09-2.5LaE; Edition 09",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "250000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Felodipin 2,5 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45632.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00323",
    "MPVReviewNo": "MPV-FEL-005",
    "ProcessValidationReport": "PRVR/BTF.26.01-11LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTF.26.00-11LaE/23/01",
    "BMR": "BTF.26.00-11LaE\nBTF.26.01-11LaE",
    "Reason_for_validation": "batch size\nequipment",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "1,100,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "09.10.2023",
    "Due_Date": "30.09.2024",
    "Completed": "08.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Felodipin 5 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45633.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FEL-001",
    "ProcessValidationReport": "VR/MFC/4001379/00",
    "ProcessValidationProtocol": "PV/MFC/4001379/00",
    "BMR": "BTF.12.09-11LaE; Edition 09",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "1100000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Felodipin 5 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "45633.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FELO-001",
    "ProcessValidationReport": "PRRP/BTF.12.13-11LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTF.12.13-11LaE/22/01",
    "BMR": "BTF.12.13-11LaE; Edition 14",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "1100000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat 200 Heumann",
    "Dosageform": "KAP",
    "MA_No": "3000146.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-001",
    "ProcessValidationReport": "VR/BCF.04.00-3LaE/16",
    "ProcessValidationProtocol": "PV/BCF.04.00-3LaE/15",
    "BMR": "BCF.04.02-3LaE/02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "300000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.02.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat 200 Heumann",
    "Dosageform": "KAP",
    "MA_No": "3000146.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-007",
    "ProcessValidationReport": "PVR/BCF.04.05-3LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BCF.04.05-3LaE/20/01-01",
    "BMR": "BCF.04.05-3LaE ed 05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "300000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.10.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat 250 retard Heumann",
    "Dosageform": "KAP",
    "MA_No": "36678.00.00",
    "CMOSite": "Nosch Labs PVT. Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-002",
    "ProcessValidationReport": "PV/FFB/001-01",
    "ProcessValidationProtocol": "PV/FFB/001-01",
    "BMR": "BMR/FFB/001-05",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "270.11 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat 250 retard Heumann",
    "Dosageform": "KAP",
    "MA_No": "36678.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-003",
    "ProcessValidationReport": "VR/MFC/4004757/02",
    "ProcessValidationProtocol": "PV/MFC/4004757/01",
    "BMR": "BCF.02.05-8LaE/05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "800,000 Capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat 250 retard Heumann",
    "Dosageform": "KAP",
    "MA_No": "36678.00.00",
    "CMOSite": "Nosch Labs PVT. Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-008",
    "ProcessValidationReport": "PV/FFB/001-02",
    "ProcessValidationProtocol": "PV/FFB/001-02",
    "BMR": "BMR/FFB/001-06",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Harman Finochem LTD",
    "Batchsize": "270.11 Kg",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.02.2021",
    "comments": "SCOPE: Entire manufacturing process of pelletization              REASON:  New validation due to change of process area to block II"
  },
  {
    "Status": "Open",
    "Productname": "Fenofibrat Heumann 160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95889.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01400\nCR-02332",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "11.07.2024",
    "Due_Date": "23.07.2025",
    "Completed": "",
    "comments": "ProcessValidationReport attached to CR-02332 (07.02.25 MaWa)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat Heumann 160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95889.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-004",
    "ProcessValidationReport": "PVR/BTS.81.01-83.730KgE/17/01-01",
    "ProcessValidationProtocol": "PV/BTS.81.01-83.730KgE/17/01-01",
    "BMR": "BTS.81.03-83.730KgE/03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "83.73 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat Heumann 160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95889.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-005",
    "ProcessValidationReport": "PVR/BTF.20.01-1.5LaE/17/01-01",
    "ProcessValidationProtocol": "PV/BTF.20.01-1.5LaE/17/01-01",
    "BMR": "BTF.20.05-1.5LaE/05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "150,000 tablets",
    "Process": "lubrication + compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat Heumann 160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95889.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-006",
    "ProcessValidationReport": "PVR/BTF.20.03-1.5LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTF.20.03-1.5LaE/18/01-01",
    "BMR": "BTF.20.05-1.5LaE/05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "150,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.04.2020",
    "comments": "partial validation for additional coater F/TCM/09"
  },
  {
    "Status": "QP Approval",
    "Productname": "Fenofibrat Heumann 160 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95889.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FENO-009",
    "ProcessValidationReport": "PVR/BTF.18.01-3.5LaE/21/01-01\nPVR/BTS.75.01-195.37KgE/21/01-01ö",
    "ProcessValidationProtocol": "PRV/BTF.18.01-3.5LaE/20/01-01 (Tablet Part)\nPRV/BTS.75.01-195.37KgE/20/01-01 (Sized Granules Part)",
    "BMR": "BTF.18.02-3.5LaE Ed. 02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Drugs Limited (Unit IX)",
    "Batchsize": "350 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.06.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Finasterid Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95090.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FIN-001",
    "ProcessValidationReport": "PVRG871-00",
    "ProcessValidationProtocol": "PVPG871-00",
    "BMR": "BMR/3002612-05-00\nBMR/3002613-05-00",
    "Reason_for_validation": "",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "600000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Finasterid Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87202.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FIN-002",
    "ProcessValidationReport": "PVRF645-00",
    "ProcessValidationProtocol": "PVPF645-01",
    "BMR": "BMR/3001964-05-03 (Blend)\nBMR/3001965-05-03 (Bulk)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "2.400.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.05.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Finasterid Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87202.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FIN-003",
    "ProcessValidationReport": "PVRF665-00",
    "ProcessValidationProtocol": "PVPGF665-00",
    "BMR": "BMR/3001965-05-04",
    "Reason_for_validation": "",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "2.400.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.11.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Fingolimod Heumann 0,5mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "2205594.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Fingolimod Heumann 0,5mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "2205594.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "DEV-01419",
    "MPVReviewNo": "MPV-FING-001",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "11.02.2025",
    "Due_Date": "09.05.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Fingolimod Heumann 0,5mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "2205594.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Furosemid 40 Heumann",
    "Dosageform": "TAB",
    "MA_No": "8327.00.02",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-FUR-001",
    "ProcessValidationReport": "VR/MFC/4003112/01",
    "ProcessValidationProtocol": "PV/MFC/4003112/00",
    "BMR": "BTF.14.05-9LaE Ed. 05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "IPCA Laboratories Ltd",
    "Batchsize": "900 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2021",
    "comments": "Last release 28 Aug 2018, expiry Sep 2022"
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 100 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-001",
    "ProcessValidationReport": "PPQR/ATH/IOP/2019/00",
    "ProcessValidationProtocol": "PPQP/ATH/IOP/2019/00 and Addendum to PPQP/ATH/IOP/2019/00",
    "BMR": "ATH/IOP/M/001-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hikal Limited",
    "Batchsize": "700 000 capsules",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.06.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 100 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-002",
    "ProcessValidationReport": "PPQR/ATH/FUP/2021/00",
    "ProcessValidationProtocol": "PPQP/ATH/FUP/2021/00",
    "BMR": "ATH/FUP/M/003-00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hikal Limited",
    "Batchsize": "700 000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.07.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 300 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-003",
    "ProcessValidationReport": "F/PVR/FUQ/01/2013",
    "ProcessValidationProtocol": "F/PVP/FUQ/01/2013",
    "BMR": "ATH/FUQ/M/001-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited\nShasun Pharmaceuticals Limited",
    "Batchsize": "350 000 capsules",
    "Process": "Granulation and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.07.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 300 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.01.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-006",
    "ProcessValidationReport": "PPQR/ATH/IOR/2019/00",
    "ProcessValidationProtocol": "PPQP/ATH/IOR/2019/00",
    "BMR": "ATH/IOR/M/001-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "M/S Hikal Ltd.",
    "Batchsize": "500 000 capsules",
    "Process": "Blending and \nEncapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.07.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 400 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-004",
    "ProcessValidationReport": "F/PVR/FUR/01/2013",
    "ProcessValidationProtocol": "F/PVP/FUR/01/2013",
    "BMR": "ATH/FUR/M/001-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited\nShasun Pharmaceuticals Limited",
    "Batchsize": "200 000 capsules",
    "Process": "Granulation and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.07.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Gabapentin Heumann 400 mg Kapseln",
    "Dosageform": "CAP",
    "MA_No": "58337.02.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GABA-005",
    "ProcessValidationReport": "PPQR/ATH/IOQ/2019/00",
    "ProcessValidationProtocol": "PPQP/ATH/IOQ/2019/00",
    "BMR": "ATH/IOQ/M/001-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "M/S Hikal Ltd.",
    "Batchsize": "500 000 capsules",
    "Process": "Blending and \nEncapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.07.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 16 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93162.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-GAL/GRA/TAB/AUR/900 (Version 1)",
    "ProcessValidationProtocol": "QPR- QC-001-GAL/GRA/TAB/AUR/900 (Version 1)",
    "BMR": "TDR-PR-022-00791/450K (Version 003)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "900.000 tablets",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 16 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93162.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-GAL/16/AUR/450 (Version 1)",
    "ProcessValidationProtocol": "QPR-QC-001-GAL/16/AUR/450 (Version 1)",
    "BMR": "TDR-PR-022-00791 / 450K / Version 003 / 27-09-2018",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "450.000 tablets",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 16 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93162.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 24 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93163.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-GAL/GRA/TAB/AUR/900 (Version 1)",
    "ProcessValidationProtocol": "QPR- QC-001-GAL/GRA/TAB/AUR/900 (Version 1)",
    "BMR": "TDR-PR-022-00792/300K (Version 003)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "900.000 tablets",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 24 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93163.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-GAL/24/AUR/300 (Version 1)",
    "ProcessValidationProtocol": "QPR-QC-001-GAL/24/AUR/300 (Version 1)",
    "BMR": "TDR-PR-022-00792 / 300K / Version 003 / 01-11-2018",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "300.000 tablets",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 24 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93163.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 8 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93161.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-PVR/GAL/GRA/TAB/AUR (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001-GAL/GRA/TAB/AUR (Version 001)",
    "BMR": "TDR-PR-022-00791/450K (Version 3)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "300.000 tablets",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 8 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93161.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GAL-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-GAL/8/AUR (Version 1)",
    "ProcessValidationProtocol": "QPR-QC-001-GAL/8/AUR (Version 1)",
    "BMR": "TDR-PR-022-00793 / Version 009 / 25-09-2018",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Aurobindo Pharma Limited",
    "Batchsize": "300.000 tablets",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.06.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Galantamin Heumann 8 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93161.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "GINKGOVITAL Heumann 120 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "78970.00.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH/ Swiss Caps",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "GINKGOVITAL Heumann 240 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "78971.00.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH/ Swiss Caps",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "GINKGOVITAL Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "78968.00.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH/ Swiss Caps",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "GINKGOVITAL Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "78969.00.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH/ Swiss Caps",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Glimepirid Heumann 1 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "72714.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GLI-001",
    "ProcessValidationReport": "VR/MFC/4004004/01",
    "ProcessValidationProtocol": "PV/MFC/4004004/00",
    "BMR": "BTG.09.04-8LaE/04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": 800000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": "Last batch expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Glimepirid Heumann 2 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "72715.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GLI-002",
    "ProcessValidationReport": "VR/BTG.26.00-8LaE/16",
    "ProcessValidationProtocol": "PV/BTG.26.00-8LaE/15",
    "BMR": "BTG.26.04-8LaE/04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": 800000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": "Not yet relesed"
  },
  {
    "Status": "QP Approval",
    "Productname": "Glimepirid Heumann 3 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "72716.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GLI-003",
    "ProcessValidationReport": "VR/MFC/4004005/01",
    "ProcessValidationProtocol": "PV/MFC/4004004/00",
    "BMR": "BTG.11.06-8LaE/06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": 800000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": "Awaiting release product on market"
  },
  {
    "Status": "QP Approval",
    "Productname": "Glimepirid Heumann 4 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "72717.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GLI-004",
    "ProcessValidationReport": "VR/BTG.27.00-8LaE/16",
    "ProcessValidationProtocol": "PV/BTG.27.00-8LaE/15",
    "BMR": "BTG.27.04-8LaE Ed: 04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": "800,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.12.2020",
    "comments": "Not marketed"
  },
  {
    "Status": "QP Approval",
    "Productname": "Glimepirid Heumann 6 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "72718.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-GLI-005",
    "ProcessValidationReport": "VR/BTG.28.00-8LaE/16",
    "ProcessValidationProtocol": "PV/BTG.28.00-8LaE/15",
    "BMR": "BTG.28.04-8LaE Ed: 04",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": "800,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.12.2020",
    "comments": "NOT ON MARKET EXPIRED"
  },
  {
    "Status": "QP Approval",
    "Productname": "Heparin 30.000 I.E. Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "6247597.00.00",
    "CMOSite": "Nordmark Arzneimittel GmbH & Co. KG",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-NORD-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020\n19.11.2020",
    "comments": "All current product expired, awaiting release."
  },
  {
    "Status": "QP Approval",
    "Productname": "Heparin 30.000 I.E. Heumann Creme",
    "Dosageform": "",
    "MA_No": "6247597.00.00",
    "CMOSite": "Nordmark Arzneimittel GmbH & Co. KG",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-NORD-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Heparin 60.000 I.E. Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "6417071.00.00",
    "CMOSite": "Nordmark Arzneimittel GmbH & Co. KG",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-NORD-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020\n19.11.2020",
    "comments": "All current product expired, from this source"
  },
  {
    "Status": "QP Approval",
    "Productname": "Heparin 60.000 I.E. Heumann Creme",
    "Dosageform": "",
    "MA_No": "6417071.00.00",
    "CMOSite": "Nordmark Arzneimittel GmbH & Co. KG",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-NORD-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 16 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85917.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.04.2020",
    "comments": "Expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 16 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85917.00.00",
    "CMOSite": "Acino",
    "Country": "",
    "Reference": "CR-01733",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 2 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85914.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.04.2020",
    "comments": "Expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 2 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85914.00.00",
    "CMOSite": "Acino",
    "Country": "",
    "Reference": "CR-01733",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 24 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85918.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.04.2020",
    "comments": "Expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 24 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85918.00.00",
    "CMOSite": "Acino",
    "Country": "",
    "Reference": "CR-01733",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 4 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85915.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.04.2020",
    "comments": "Expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 4 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85915.00.00",
    "CMOSite": "Acino",
    "Country": "",
    "Reference": "CR-01733",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 8 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85916.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.04.2020",
    "comments": "Expired"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydromorphon-HCI Heumann 8 mg Hartkapseln",
    "Dosageform": "REK",
    "MA_No": "85916.00.00",
    "CMOSite": "Acino",
    "Country": "",
    "Reference": "CR-01733",
    "MPVReviewNo": "PVD-Acino-04",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "14.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydroxychloroquin Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202690.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-HYDC-001",
    "ProcessValidationReport": "PPQR/ATH/IWO/2021/00",
    "ProcessValidationProtocol": "PPQP/ATH/IWO/2021/00",
    "BMR": "ATH/IWO/M/001-00",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": "2 400 000 Tablets",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.03.2022",
    "comments": "The Process Performance Qualification was carried out for changes in Granulation"
  },
  {
    "Status": "QP Approval",
    "Productname": "Hydroxychloroquin Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2202690.00.00",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-HYDC-002",
    "ProcessValidationReport": "PPQR/ATH/HTF/2019-00",
    "ProcessValidationProtocol": "N/A",
    "BMR": "ATH/HTF/M/002-00\nATH/IUV/M/001-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "IPCA Laboratories Limited Ratlam",
    "Batchsize": 2400000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.07.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Ibu-Lysin OTC",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "",
    "Reference": "CC-22-1753",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "",
    "comments": "15.01.25: Launch Meeting - timeline völlig unbekannt"
  },
  {
    "Status": "Open",
    "Productname": "Ibuprofen 400mg soft gel capsules",
    "Dosageform": "WKA",
    "MA_No": "",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "Non-EU",
    "Reference": "CR-01621",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "27.05.2024",
    "Due_Date": "30.06.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99….",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-007",
    "ProcessValidationReport": "PVP/TAB/2006439/20045/01",
    "ProcessValidationProtocol": "PVR/TAB/2006439/20045/00",
    "BMR": "BMP/2006439L1455/R2",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "6000000 Tabs",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-001",
    "ProcessValidationReport": "PVR/TAB/2006260/18119/00",
    "ProcessValidationProtocol": "PVP/TAB/2006260/18119/01",
    "BMR": "BMP/2006260U1306/R3",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Solara Active Pharma Sciences Limited",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-002",
    "ProcessValidationReport": "PVR/TAB/2006260/18129/01",
    "ProcessValidationProtocol": "PVP/TAB/2006260/18119/01",
    "BMR": "BMP/2006260U1306/R3",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Solara Active Pharma Sciences Limited",
    "Batchsize": "3.000.000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-003",
    "ProcessValidationReport": "PVR/TAB/2006439/19112/02",
    "ProcessValidationProtocol": "PVP/TAB/2006439/19112/00",
    "BMR": "BMP/2006439L1405/R0\nBMP/2006439L1405/R1",
    "Reason_for_validation": "API",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-004",
    "ProcessValidationReport": "PVR/TAB/2006439/20019/00",
    "ProcessValidationProtocol": "PVP/TAB/2006439/20019/00",
    "BMR": "BMP/2006439L1405/R2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "3.000.000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-005",
    "ProcessValidationReport": "PVR/TAB/2006439/20014/00",
    "ProcessValidationProtocol": "PVP/TAB/2006439/20014/00",
    "BMR": "BMP/2006439L1405/R2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "3.000.000",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBU-006",
    "ProcessValidationReport": "PVR/TAB/2006439/20024/00",
    "ProcessValidationProtocol": "PVP/TAB/2006439/20024/00",
    "BMR": "BMP/2006439L1405/R2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "3.000.000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen Heumann Schmerztabletten 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2129.97.99....",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IBUP-001",
    "ProcessValidationReport": "REP/PR/PRV/2023/R0",
    "ProcessValidationProtocol": "PRO/PR/PRV/2023/008/R0",
    "BMR": "BMR/2006439/L001/R0",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "IOL Chemicals and Pharmaceuticals Ltd",
    "Batchsize": "6.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.06.23",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Ibuprofen Natrium 400mg",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Strides Pharma Science Limited via Fair-Med",
    "Country": "",
    "Reference": "CR-01021",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "28.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen/Paracetamol 150mg/500mg (Duoval)",
    "Dosageform": "FTA",
    "MA_No": "2202581.00.00",
    "CMOSite": "Sigma Laboratories",
    "Country": "Non-EU",
    "Reference": "CR-01077",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.06.2024",
    "Due_Date": "27.12.2024",
    "Completed": "16.12.24",
    "comments": "12.06.24: Product Launch Duoval\n12.06.24: Manufacturing planned in August (according Launch One Note; checked 07.06.24) - contact partner AFT"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen/Paracetamol 150mg/500mg (Duoval)",
    "Dosageform": "FTA",
    "MA_No": "2202581.00.00",
    "CMOSite": "Sigma Laboratories",
    "Country": "Non-EU",
    "Reference": "CR-01077",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.06.2024",
    "Due_Date": "27.12.2024",
    "Completed": "02.01.25",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ibuprofen/Paracetamol 150mg/500mg (Duoval)",
    "Dosageform": "FTA",
    "MA_No": "2202581.00.00",
    "CMOSite": "Sigma Laboratories",
    "Country": "Non-EU",
    "Reference": "CR-01077",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.06.2024",
    "Due_Date": "27.12.2024",
    "Completed": "04.02.25",
    "comments": "02.01.25 MaWa: in diskussion mit QP zwecks Prüfpunkt Sampling locations\n07.01.25 MaWa: Sampling locations angefragt"
  },
  {
    "Status": "QP Approval",
    "Productname": "Imatinib Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "97050.00.00",
    "CMOSite": "Hetero Labs Limited - Unit VI",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IMA-002",
    "ProcessValidationReport": "O-PVR-PO-139-01",
    "ProcessValidationProtocol": "O-PVP-PO-139-01",
    "BMR": "BMR/3003904-2-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "21.645 kg/ 180 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020",
    "comments": "according checklist Parameters in BMR were checked for BMR/3003904-2-07"
  },
  {
    "Status": "QP Approval",
    "Productname": "Imatinib Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "97051.00.00",
    "CMOSite": "Hetero Labs Limited - Unit VI",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IMA-001",
    "ProcessValidationReport": "O-PVR-PO-140-01",
    "ProcessValidationProtocol": "O-PVP-PO-140-01",
    "BMR": "BMR/3003905-5-07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "60.606 kg/ 126 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-002",
    "ProcessValidationReport": "VR/MFC/4001764/01",
    "ProcessValidationProtocol": "PV/MFC/4001764/00",
    "BMR": "BTI.38.06-16LaE/06 (page 1.1)",
    "Reason_for_validation": "",
    "API_Manufacturer": "Bioindustria Laboratorio Italiano Medicinali SPA",
    "Batchsize": "1.600.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-003",
    "ProcessValidationReport": "VR/BTI.38.00-16LaE/15",
    "ProcessValidationProtocol": "PV/BTI:38.00-16LaE/15",
    "BMR": "BTI.38.06-16LaE/06 (page 1.1)",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Bioindustria Laboratorio Italiano Medicinali SPA",
    "Batchsize": "1.600.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-004",
    "ProcessValidationReport": "VR/BTI.37.00-16LaE/16",
    "ProcessValidationProtocol": "PV/BTI.37.00-16LaE/15",
    "BMR": "BTI.37.05-16LaE/05 (page 1.1)",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Laboratori Alchemia SRL",
    "Batchsize": "1.600.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.01.2020",
    "comments": "Based on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-005",
    "ProcessValidationReport": "VR/BTI.32.00-16LaE/14",
    "ProcessValidationProtocol": "PV/BTI.32.00-16LaE/13",
    "BMR": "BTI.37.05-16LaE/05 (page 1.1)",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Laboratori Alchemia SRL",
    "Batchsize": "1.600.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.03.2020",
    "comments": "compression machine (F/COM 02/06/14/18) and coating machine applicable to current BMR, granulation is not applicable as it´s done in another process area"
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-006",
    "ProcessValidationReport": "PVR/BTI.38.07-16LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BTI.38.07-16LaE/20/01-01",
    "BMR": "BTI.38.08-16LaE Edition: 08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Bioindustria Laboratorio Italiano Medicinali SPA",
    "Batchsize": "1.600.000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-007",
    "ProcessValidationReport": "VR/BTI.37.00-16LaE/16",
    "ProcessValidationProtocol": "PV/BTI.37.00-16LaE/15",
    "BMR": "BTI.37.07-16LaE Edition No. 07",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Laboratori Alchemia SRL",
    "Batchsize": "1.600.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.05.2021",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Indapamid Heumann 1,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "65033.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01845",
    "MPVReviewNo": "MPV-IND-008",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "11.12.2024",
    "Due_Date": "21.02.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n27.03.25 Protocol cum Report erhalten !!"
  },
  {
    "Status": "QP Approval",
    "Productname": "Indapamid Heumann 2,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "35625.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-IND-001",
    "ProcessValidationReport": "VR/BTI.43.00-13.5LaE/18",
    "ProcessValidationProtocol": "",
    "BMR": "BTI.43.02-13.5LaE/02 (1.1)",
    "Reason_for_validation": "",
    "API_Manufacturer": "Laboratori Alchemia SRL",
    "Batchsize": "1.350.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Indapamid Heumann 2,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "35625.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "",
    "Reference": "CR-02580",
    "MPVReviewNo": "MPV-IND-009",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": "13.03.2025: PV bericht in CR-02797; download MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84515.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01157\nCR-00722",
    "MPVReviewNo": "MPV-IRB-003",
    "ProcessValidationReport": "MPL/PTF/RPV1/IZ/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IZ/00",
    "BMR": "MPL/PTF/BMR1/IZ/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Divi’s Laboratories Limited, Unit II\nMacleods Pharmaceuticals Ltd",
    "Batchsize": "900000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "06.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "11.12.2024",
    "comments": "re-launch\n24.10.24 MaWa: Reminder\n Reminder am 13.11.2024 Dfo\nReminder am 25.11.24 Dfo\nerneut Reminder 29.11.24 DFo \n09.12.24 Laut Launchmeeting : Prio low, Launch eig. Januar 2025 geplant"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84515.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01157\nCR-00722",
    "MPVReviewNo": "MPV-IRB-005",
    "ProcessValidationReport": "MPL/PTF/RPV1/IZ/01",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IZ/01",
    "BMR": "MPL/PTF/BMR1/IZ/01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.\nDivi’s Laboratories Ltd.",
    "Batchsize": "900,000 tablets",
    "Process": "Compression & coating",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "25.10.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84516.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00722",
    "MPVReviewNo": "MPV-IRB-001",
    "ProcessValidationReport": "MPL/PTF/RPV1/IA1/00",
    "ProcessValidationProtocol": "MPL/PTF/RPV1/IA1/00",
    "BMR": "MPL/PTF/BMR1/IA1/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.\nDivi’s Laboratories Ltd.",
    "Batchsize": "600,000 tablets",
    "Process": "Compression & coating",
    "OOX": "NA",
    "Receipt_Date": "09.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "12.02.2025",
    "comments": "re-launch\n24.10.24 MaWa: Reminder,Validation protocols received 28.10.2024 Dfo\n09.12.24 Laut Launchmeeting : Prio low, Launch eig. Januar 2025 geplant"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84516.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00722",
    "MPVReviewNo": "MPV-IRB-006",
    "ProcessValidationReport": "MPL/PTF/RPV1/IA1/01",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IA1/01",
    "BMR": "MPL/PTF/BMR1/IA1/01",
    "Reason_for_validation": "Equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd.\nDivi’s Laboratories Ltd.",
    "Batchsize": "600,000 tablets",
    "Process": "Compression & coating",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "25.10.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan Heumann 75 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84514.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01159\nCR-00722",
    "MPVReviewNo": "MPV-IRB-002",
    "ProcessValidationReport": "MPL/PTM/RPV/IY/00",
    "ProcessValidationProtocol": "MPL/PTM/PPV/IY/00",
    "BMR": "MPL/PTM/BMR/IY/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceuticals Ltd",
    "Batchsize": "330000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "09.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "03.01.2025",
    "comments": "re-launch\n24.10.24 MaWa: Reminder \n Reminder am 13.11.2024 Dfo\nReminder am 25.11.24 Dfo\nerneut Reminder am 29.11.24 Dfo \n09.12.24 Laut Launchmeeting : Prio low, Launch eig. Januar 2025 geplant"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan tablets 300/150/75mg Common Blend",
    "Dosageform": "GRA",
    "MA_No": "84514.00.00\n84515.00.00\n84516.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01157\nCR-00722",
    "MPVReviewNo": "MPV-IRB-004",
    "ProcessValidationReport": "MPL/PTF/RPV/B58/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV/B85/00",
    "BMR": "MPL/PTF/BMR/B58/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Divi’s Laboratories Limited, Unit II\nMacleods Pharmaceuticals Ltd",
    "Batchsize": "345,60 kg",
    "Process": "Granulation",
    "OOX": "NA",
    "Receipt_Date": "09.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "10.12.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 150 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84914.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01158\nCR-00723",
    "MPVReviewNo": "MPV-IRBHCT-003",
    "ProcessValidationReport": "MPL/PTF/RPV1/IA3/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IA3/00",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "23.01.2025",
    "comments": "re-launch\n24.10.24 MaWa: Reminder,Validation protocols received 28.10.2024 Dfo\n09.12.24 Laut Launchmeeting : Prio low, Launch eig. Januar 2025 geplant"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 150 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84914.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01158\nCR-00723",
    "MPVReviewNo": "MPV-IRBHCT-004",
    "ProcessValidationReport": "MPL/PTF/RPV2/IA3/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV2/IA3/00",
    "BMR": "MPL/PTF/BMR1/IA3/01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Irbesartan: Macleods Pharmaceuticals Ltd. Divi’s Laboratories Ltd. Zhejiang Huahai Pharma\nHydrochlorothiazid: CTX life sciences",
    "Batchsize": "600,000 tablets",
    "Process": "Compression & coating",
    "OOX": "NA",
    "Receipt_Date": "06.02.2024",
    "Due_Date": "25.10.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 150 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77657.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84915.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00577\nCR-00723",
    "MPVReviewNo": "MPV-IRBHCT-002",
    "ProcessValidationReport": "MPL/PTF/RPV1/IA4/01",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IA4/01",
    "BMR": "",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.06.2024",
    "Due_Date": "30.10.2024",
    "Completed": "21.01.2025",
    "comments": "re-launch\n24.10.24 MaWa: Reminder, Validation protocols received 28.10.2024 Dfo\n15.11.24 Reminder\n09.12.24 Laut Launchmeeting : Prio low, Launch eig. Januar 2025 geplant"
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84915.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00577\nCR-00723",
    "MPVReviewNo": "MPV-IRBHCT-005",
    "ProcessValidationReport": "MPL/PTF/RPV/IA4/00",
    "ProcessValidationProtocol": "MPL/PTF/PPV/IA4/00",
    "BMR": "MPL/PTF/BMR/IA4/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Irbesartan: Divi’s Laboratories Ltd.\nHydrochlorthiazid: CTX life sciences",
    "Batchsize": "600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "06.06.2024",
    "Due_Date": "30.10.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77658.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84916.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-00073",
    "MPVReviewNo": "MPV-IRBHCT-001",
    "ProcessValidationReport": "MPL/PTF/RPV1/IA5/01",
    "ProcessValidationProtocol": "MPL/PTF/PPV1/IA5/01",
    "BMR": "MPL/PTF/BMR1/IA5/01\nMPL/PTF/BMR/IF5/01",
    "Reason_for_validation": "new area\nequipment",
    "API_Manufacturer": "Zhejian Huahai Pharmaceutical Ltd.\nCTX Life sciences PVT Ltd.",
    "Batchsize": "3250,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.07.2023",
    "Due_Date": "28.06.2024",
    "Completed": "05.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77659.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Irbesartan/Hydrochlorothiazid Heumann 300 mg/25 mg Tabletten",
    "Dosageform": "FTA",
    "MA_No": "84916.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01363",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.25",
    "Due_Date": "30.06.2025",
    "Completed": "",
    "comments": "07.03.25 Nach PVP und PVR angefragt Dfo\n10.03.25: PVP und PVR erhalten dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Itraconazol Heumann 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76776.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ivabradin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200665.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ivabradin Heumann 7,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200665.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lacosamid Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205404.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LACO-003 (tableting) \nMPV-LACO-001 (common granules)",
    "ProcessValidationReport": "PVR/BTL.218.00-2.3LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTL.218.00-2.3LaE/18/01-01",
    "BMR": "BTL.249.02-2.3LaE, Edition No. 02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceutical Ltd.",
    "Batchsize": "230 000 Tablets",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.08.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lacosamid Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205405.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LACO-004(tableting) \nMPV-LACO-001 (common granules)",
    "ProcessValidationReport": "PVR/BTL.219.00-3.1LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTL.219.00-3.1LaE/17/01-01",
    "BMR": "BTL.295.00-3.1LaE, Edition No. 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceutical Ltd.",
    "Batchsize": "310 000 Tablets",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.08.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lacosamid Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205406.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LACO-005(tableting) \nMPV-LACO-001 (common granules)",
    "ProcessValidationReport": "PVR/BTL.220.00-2.325LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTL.220.00-2.325LaE/17/01-01",
    "BMR": "BTL.296.00-2.325LaE, Edition No. 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceutical Ltd.",
    "Batchsize": "232 500 Tablets",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.08.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lacosamid Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205403.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LACO-002 (tableting) \nMPV-LACO-001 (common granules)",
    "ProcessValidationReport": "PVR/BTL.217.00-4.6LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTL.217.00-4.6LaE/17/01-01",
    "BMR": "BTL.247.02-4.6LaE, Edition No. 02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceutical Ltd.",
    "Batchsize": "460 000 Tablets",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.08.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lactulose Heumann Sirup",
    "Dosageform": "SIR",
    "MA_No": "3004100.00.00",
    "CMOSite": "Fresenius Kabi Austria GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-FK-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamivudin/Zidovudin Heumann 150 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88313.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LZD-001",
    "ProcessValidationReport": "PVR1403-02",
    "ProcessValidationProtocol": "PVP1403-00",
    "BMR": "LZD-T-001-02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "112,5 Kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamivudin/Zidovudin Heumann 150 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88313.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LZD-002",
    "ProcessValidationReport": "PVR1404-02",
    "ProcessValidationProtocol": "PVP1404-00",
    "BMR": "LZD-T-002-02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "150.000 Tabs",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamivudin/Zidovudin Heumann 150 mg/300 mg Filmtabletten",
    "Dosageform": "Blend",
    "MA_No": "88313.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LZD-005",
    "ProcessValidationReport": "PVR-FD-1594-01",
    "ProcessValidationProtocol": "PVP-FD-1594-00",
    "BMR": "MPR No. LZD-T-001-05 (1st + 2nd batch)\nMPR No. LZD-T-001-06 (3rd batch)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "112,500 kg",
    "Process": "Roll compaction\nblending\nlubrication",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "18.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamivudin/Zidovudin Heumann 150 mg/300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88313.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LZD-003",
    "ProcessValidationReport": "PVR-FD-1594-00",
    "ProcessValidationProtocol": "PVP-FD-1594-00",
    "BMR": "LZD-T-001-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamivudin/Zidovudin Heumann 150 mg/300 mg Filmtabletten",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "",
    "Country": "",
    "Reference": "",
    "MPVReviewNo": "MPV-LZD-004",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00713",
    "MPVReviewNo": "MPV-LAM-029",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.12.2023",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n27.03.25 Protokoll erhalten , Bericht steht noch aus Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-001",
    "ProcessValidationReport": "PV/BTL.106.05-354kgE/16",
    "ProcessValidationProtocol": "PV/BTL.106.05-354kgE/16",
    "BMR": "BTL.106.06-354kgE/06 (1.3)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2020",
    "comments": "Granules used for all strengths! Revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-002",
    "ProcessValidationReport": "VR/BTL.109.07-10.14LaE/17",
    "ProcessValidationProtocol": "PV/BTL.109.07-10.14LaE/17",
    "BMR": "BTL.109.08-10.14LaE/08 (1.1)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "1 014 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2020",
    "comments": "revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-004",
    "ProcessValidationReport": "VR/BTL.241.00-354kgE/19/01-01",
    "ProcessValidationProtocol": "PVR/BTL.241.00-354kgE/19/01-01",
    "BMR": "BTL.241.01-354kgE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.05.2020",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-005",
    "ProcessValidationReport": "PRV/BTL.244.00-10.14 LaE /19/01-01",
    "ProcessValidationProtocol": "PVR/BTL.244.00-10.14 LaE /19/01-01",
    "BMR": "BTL.244.01-10.14 LaE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 014 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-011",
    "ProcessValidationReport": "PVR/BTL.260.00-10.41LaE /20/01-01",
    "ProcessValidationProtocol": "PRV/BTL.260.00-10.41LaE /20/01-01",
    "BMR": "BTL.260.01-10.41LaE Edition: 01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 041 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.02.2021",
    "comments": "Validation for compression stage using TPL API with batch size 354 Kg. Process validation review of granules stage can be considered as per PV review no: MPV-LAM-004. Current validation includes validation of compression stage due to change of batch size."
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-020",
    "ProcessValidationReport": "PRVR/BTL.264.01-10.41LaE",
    "ProcessValidationProtocol": "PRVP/BTL.264.01-10.41LaE",
    "BMR": "BTL.264.01-10.41LaE",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "1,041,00 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01819",
    "MPVReviewNo": "MPV-LAM-025",
    "ProcessValidationReport": "PRVR/BTL.322.00-10.41LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.322.00-10.41LaE/24/01",
    "BMR": "BTL.322.00-10.41LaE\nBTL.322.01-10.41LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S SMS Pharmaceuticals Ltd.",
    "Batchsize": "1,041,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "20.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-001",
    "ProcessValidationReport": "PV/BTL.106.05-354kgE/16",
    "ProcessValidationProtocol": "PV/BTL.106.05-354kgE/16",
    "BMR": "BTL.106.06-354kgE/06 (1.3)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2020",
    "comments": "Granules used for all strengths! revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-003",
    "ProcessValidationReport": "VR/BTL.110.06-5LaE/17",
    "ProcessValidationProtocol": "PV/BTL.110.06-5LaE/17",
    "BMR": "BTL.110.07-5LaE (1.1)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "500 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.02.2020",
    "comments": "validated compression machines F/COM-02/06/14/18"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-004",
    "ProcessValidationReport": "VR/BTL.241.00-354kgE/19/01-01",
    "ProcessValidationProtocol": "PVR/BTL.241.00-354kgE/19/01-01",
    "BMR": "BTL.241.01-354kgE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.05.2020",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-015",
    "ProcessValidationReport": "PVR/BTL.261.00-5.20LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BTL.261.00-5.20LaE/20/01-01",
    "BMR": "BTL.261.01-5.20LaE, Edition No. 01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "520 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.04.2022",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00713",
    "MPVReviewNo": "MPV-LAM-030",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "01.12.2023",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n27.03.25 Protokoll erhalten , Bericht steht noch aus Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-010",
    "ProcessValidationReport": "PVR/BTL.245.00-5LaE /20/01-01",
    "ProcessValidationProtocol": "PRV/BTL.245.00-5LaE /19/01-01",
    "BMR": "BTL.245.02-5LaE Edition: 2",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500000 Tab",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2021",
    "comments": "Validation for compression stage using TPL API with batch size 354 Kg."
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-021",
    "ProcessValidationReport": "PRVR/BTL.265.01-5.20LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.265.01-5.20LaE/23/01",
    "BMR": "BTL.265.01-5.20LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "520,000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "NA",
    "MPVReviewNo": "MPV-LAM-023",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "20.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00183",
    "MPVReviewNo": "MPV-LAM-023",
    "ProcessValidationReport": "PRV/BTL.404.07-2.75E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTL.404,07-2,75E/21/01-01",
    "BMR": "BTL.404.07-2.75E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "275,000 tablets",
    "Process": "compression",
    "OOX": "NA",
    "Receipt_Date": "01.08.2024",
    "Due_Date": "31.07.2024",
    "Completed": "14.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 200mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01819",
    "MPVReviewNo": "MPV-LAM-024",
    "ProcessValidationReport": "PRVR/BTL.323.00-5.20LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.323.00-5.20LaE/24/01",
    "BMR": "BTL.323.00-5.20LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "SMS Pharmaceuticals Ltd.",
    "Batchsize": "520 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "22.07.2024",
    "Due_Date": "07.02.2025",
    "Completed": "27.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-001",
    "ProcessValidationReport": "PV/BTL.106.05-354kgE/16",
    "ProcessValidationProtocol": "PV/BTL.106.05-354kgE/16",
    "BMR": "BTL.106.06-354kgE/06 (1.3)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2020",
    "comments": "Granules used for all strengths! Revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-004",
    "ProcessValidationReport": "VR/BTL.241.00-354kgE/19/01-01",
    "ProcessValidationProtocol": "PVR/BTL.241.00-354kgE/19/01-01",
    "BMR": "BTL.241.01-354kgE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.05.2020",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-008",
    "ProcessValidationReport": "VR/BTL.107.06-5.47 LaE /17",
    "ProcessValidationProtocol": "PV/BTL.107.06-5.47 LaE /16",
    "BMR": "VR/BTL.107.08-5.47LaE /16 Edition: 8",
    "Reason_for_validation": "API",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "547000 Tab",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.10.2020",
    "comments": "Granules used for all strengths!"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-009",
    "ProcessValidationReport": "PVR/BTL.242.00-5.47058LaE /20/01-01",
    "ProcessValidationProtocol": "PRV/BTL.242.00-5.47058LaE /19/01-01",
    "BMR": "BTL.242.02-5.47058LaE Edition: 2",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "547000 Tab",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.10.2020",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-013",
    "ProcessValidationReport": "PVR/BTL.266.00-20.58823LaE/21/01-01",
    "ProcessValidationProtocol": "RV/BTL.266.00-20.58823LaE/21/01-01",
    "BMR": "BTL.266.01-20.58823LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2 058 823 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-017",
    "ProcessValidationReport": "PVR/BTL.266.02-22LaE/21/01-02",
    "ProcessValidationProtocol": "PRV/BTL.266.02-22LaE/21/01-01",
    "BMR": "BTL.266.04-22LaE Ed. 04",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2 200 000 Tablets",
    "Process": "misc",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.05.2022",
    "comments": "tr"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-018",
    "ProcessValidationReport": "PRVR/BTL.270.03-221LAE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.270.03-221LAE/23/01",
    "BMR": "BTL.270.03-22LaE",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "2,200,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01189\nCR-00762",
    "MPVReviewNo": "MPV-LAM-022",
    "ProcessValidationReport": "PRVR/BTL.266.07-22LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.266.07-22LaE/23/01",
    "BMR": "BTL.266.07-22LaE",
    "Reason_for_validation": "revised granulation parameters",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2,200,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "07.03.2024",
    "Due_Date": "25.07.2025",
    "Completed": "15.04.2024",
    "comments": "26.07.24 MaWa: revalidation due to CAPA C/OTH/2022/0003"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01819",
    "MPVReviewNo": "MPV-LAM-026",
    "ProcessValidationReport": "PRVR/BTL.320.00-22LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.320.00-22LaE/24/01",
    "BMR": "BTL.320.00-22LaE \nBTL.320.01-22LaE ( post validation)",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S SMS Pharmaceuticals Ltd.",
    "Batchsize": "2200000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "08.10.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-001",
    "ProcessValidationReport": "PV/BTL.106.05-354kgE/16",
    "ProcessValidationProtocol": "PV/BTL.106.05-354kgE/16",
    "BMR": "BTL.106.06-354kgE/06 (1.3)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2020",
    "comments": "Granules used for all strengths! Revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-004",
    "ProcessValidationReport": "VR/BTL.241.00-354kgE/19/01-01",
    "ProcessValidationProtocol": "PVR/BTL.241.00-354kgE/19/01-01",
    "BMR": "BTL.241.01-354kgE/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.05.2020",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-006",
    "ProcessValidationReport": "VR/BTL.108.06-5LaE/16",
    "ProcessValidationProtocol": "PV/BTL.108.06-5LaE/16",
    "BMR": "VR/BTL.108.08-5LaE/16 Edition:8",
    "Reason_for_validation": "",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": "Granules used for all strengths! Revalidation as granules where manufactured with a sprinkler used for binder addition"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-006",
    "ProcessValidationReport": "VR/BTL.108.06-5 LaE/16",
    "ProcessValidationProtocol": "PV/BTL.108.06-5 LaE/16",
    "BMR": "VR/BTL.108.08-5LaE/16 Edition: 8",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "500 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-007",
    "ProcessValidationReport": "PVR/BTL.267.00-20.58823LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTL.267.00-20.58823LaE/20/01-01",
    "BMR": "BTL.267.00-20.58823LaE Ed.01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "354 kg granules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.08.2021",
    "comments": "Granules used for all strengths! Revalidation performed with API from TPL Dahej but also valid for API from TPL Vizag"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-007",
    "ProcessValidationReport": "PVR/BTL.243.00-5 LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTL.243.00-5 LaE/19/01-01",
    "BMR": "VR/BTL.243.01-5LaE/19 Edition: 01",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500 000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-012",
    "ProcessValidationReport": "PVR/BTL.267.00-20.58823LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTL.267.00-20.58823LaE/20/01-01",
    "BMR": "BTL.267.01-20.58823LaE Ed.01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2 058 823 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.08.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-014",
    "ProcessValidationReport": "PVR/BTL.267.02-20.82352LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTL.267.02-20.82352LaE/21/01-01",
    "BMR": "BTL.267.04-20.82352LaE Ed. 04",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2 082 352 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.03.22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LAM-019",
    "ProcessValidationReport": "PRVR/BTL.271.01-20.82352LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.271.01-20.82352LaE/23/01",
    "BMR": "BTL.271.01-20.82352LaE",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "2,082,352 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lamotrigin Heumann 50 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "57031.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01819",
    "MPVReviewNo": "MPV-LAM-027",
    "ProcessValidationReport": "PRVR/BTL.321.00-20.82352LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.321.00-20.82352LaE/",
    "BMR": "BTL.321.00-20.82352LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "SMS Pharmaceuticals Ltd.",
    "Batchsize": "2 082 352 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "27.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflon 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77328.00.00",
    "CMOSite": "Pharmathen S.A. / Pharmathen International S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "not marketed, 30.01.2024 MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflon 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77328.00.00",
    "CMOSite": "Pharmathen S.A. / Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflon 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77329.00.00",
    "CMOSite": "Pharmathen S.A. / Pharmathen International S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "not marketed, 30.01.2024 MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95663.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEF-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPRQA0012201206.1000-INT (Version 001)",
    "ProcessValidationProtocol": "QPRQA0012201206.1000 (Version 001)",
    "BMR": "TDRMN0012201206.1000 (Version 001)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "1.000.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95663.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEF-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-LEF/10/CPL/ Version 002 / 17-07-2018",
    "ProcessValidationProtocol": "QPR-QC-001-LEF/10/CPL/ Version 1 / 20-02-2017",
    "BMR": "TDR-PR-022-01206 / Version 2 / 02-07-2019",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "600.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.04.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95663.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95664.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEF-001\nPVD.Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-LEF/20/CPL/600k (Version 001)",
    "ProcessValidationProtocol": "QPR-QC-001- LEF/20/CPL/600k (Version 001)",
    "BMR": "TDR-PR-022-01207 / 600K / Version 001 / 02-05-2019",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "600.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.01.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020\nBased on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95664.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEF-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "QPRQA0012201207.100 / Version 001 / 31-10-2019",
    "BMR": "TDRMN0012201207 / Version 001 / 31-10-2019",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.03.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Leflunomid Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95664.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  10 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204048.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-003",
    "ProcessValidationReport": "LP638-PVR01- EU/TW/KR, Revision No. 01",
    "ProcessValidationProtocol": "LP639-PVP01-EU/TW/KR, Revision No. 01",
    "BMR": "LP639-M04-Global-112K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "28 000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  15 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204049.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-004",
    "ProcessValidationReport": "LP642-PVR01- EU/TW/KR, Revision No. 01",
    "ProcessValidationProtocol": "LP640-PVP01-EU/TW/KR, Revision No. 00",
    "BMR": "LP640-M01-Global-46.66K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "46 666 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  2,5 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204037.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-001",
    "ProcessValidationReport": "LP637-PVR01-US/EU/TW/KR, Revision No. 01",
    "ProcessValidationProtocol": "LP637-PVP01-US/EU/TW/KR, Revision No. 01",
    "BMR": "LP637-M01-US/EU/TW/KR-30K(V)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "30 000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  20mg Kapslen",
    "Dosageform": "CAP",
    "MA_No": "2204050.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-007",
    "ProcessValidationReport": "LP641-PVR01-EU/TW/KR, Revision No 01",
    "ProcessValidationProtocol": "LP641-PVP01-EU/TW/KR, Revision No. 03",
    "BMR": "LP641-M01-Global-35K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "35,000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  25 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204051.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-005",
    "ProcessValidationReport": "LP642-PVR01- EU/TW/KR, Revision No. 01\nLP642-PVR01- EU/TW/KR, Revision No. 01 – Addendum 02",
    "ProcessValidationProtocol": "LP642-PVP01-EU/TW/KR, Revision No. 00",
    "BMR": "LP642-M01-Global-28K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "28 000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  5 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204046.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-002",
    "ProcessValidationReport": "LP638-PVR01- EU/TW/KR, Revision No. 01",
    "ProcessValidationProtocol": "LP638-PVP01-EU/TW/KR, Revision No. 01",
    "BMR": "LP638-M01-Global-56K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "56 000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lenalidomid  7,5 mg  Kapseln",
    "Dosageform": "CAP",
    "MA_No": "2204047.00.00",
    "CMOSite": "Lotus Pharmaceutical Co., Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LENA-006",
    "ProcessValidationReport": "LP643-PVR01-EU/TW/KR, Revision No. 01",
    "ProcessValidationProtocol": "LP643-PVP01-EU/TW/KR, Revision No. 02",
    "BMR": "LP643-M01-Global-20K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Limited",
    "Batchsize": "20,000 capsules",
    "Process": "Blending and Encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.06.2022",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Lercanidipin HCL 10mg",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.Dahej",
    "Country": "Non-EU",
    "Reference": "CR-02223",
    "MPVReviewNo": "MPV-LER-009",
    "ProcessValidationReport": "PRVR/BTL.117.01-19E/25/01",
    "ProcessValidationProtocol": "PRVP/BTL.117.01-19E/24/01",
    "BMR": "BTL.303.00-36LaE",
    "Reason_for_validation": "batch size\nequipment\ncommercial launch",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 900 000 film coated tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "11.11.2024",
    "Due_Date": "27.04.2025",
    "Completed": "18.03.25",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder Dfo \n17.03.25 PVP PVR erhalten Dfo"
  },
  {
    "Status": "Open",
    "Productname": "Lercanidipin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00150",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.08.2023",
    "Due_Date": "31.08.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Lercanidipin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01108\nCR-00266",
    "MPVReviewNo": "MPV-LER-008",
    "ProcessValidationReport": "PRVR/BTL.303.00-36LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.303.00-36LaE/23/01",
    "BMR": "BTL.303.00-36LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "36 00 000 film coated tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "06.03.2024",
    "Due_Date": "29.08.2025",
    "Completed": "18.03.2025",
    "comments": "24.02.25: Report in CR-01108; Protokoll anfragen \n18.03.25: Nach PVP angefragt Dfo\n18.03.25 PVP erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02518\nCR-02302",
    "MPVReviewNo": "MPV-LER-010",
    "ProcessValidationReport": "PRVR/BTL.303.01-36LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.330.01-36LaE/24/02",
    "BMR": "BTL.303.01-36LaE",
    "Reason_for_validation": "batch size\nequipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "36 00 000 film coated tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.03.2025",
    "comments": "PPQR attached to CR-02302\n20.03.25: PVR da, nach PVP angefragt\n24.03.25 PVP erhalten Dfo\n25.03.25 an BPr zur Freigabe geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LER-001",
    "ProcessValidationReport": "PVR/BTL.237.00-12LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTL.237.00-12LaE/19/01-01",
    "BMR": "BTL.237.02-12LaE ed 03",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,200,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74293.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LER-003",
    "ProcessValidationReport": "PVR/BTL.155.09-12LaE/17/01-01",
    "ProcessValidationProtocol": "PRV/BTL.155.09-12LaE/17/01-01",
    "BMR": "BTL.155.16-12LaE Ed. 17",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": 1200000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.09.2021",
    "comments": "The objective of this Process Revalidation was to summarize the activities completed to confirm that the manufacturing of Lercanidipine Hydrochloride Tablets 10 mg is capable of consistently delivering product that meets the requirements of the quality target product file, CPPs and CQAs and Finished Product Specification."
  },
  {
    "Status": "Open",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00150",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.08.2023",
    "Due_Date": "31.08.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01692",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.07.2024",
    "Due_Date": "03.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01190\nCR-01681\nCR-00149",
    "MPVReviewNo": "MPV-LER-007",
    "ProcessValidationReport": "PRVR/BTL.302.00-17LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTL.302.00-17LaE/23/01",
    "BMR": "BTL.302.00-17LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.Baddi",
    "Batchsize": "17 00 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "16.05.2024",
    "Due_Date": "27.12.2024",
    "Completed": "12.02.2025",
    "comments": "14.06.24: PVR attached to CR, Reason_for_validation is CCF/C/2023/0242 (=CR-00149)\n20.06.24: Editorial change of PPQR in CR-01681; peristaltic pump parameters\n11.07.24: CR-01681 - Request updated validation report PRVR/BTL.302.00-17LaE/23/01; updated report needs to be considered for process validation review in CR-01190"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LER-002",
    "ProcessValidationReport": "VR/BTL.140.00-12LaE/15",
    "ProcessValidationProtocol": "PV/BTL.140.00-12LaE/15",
    "BMR": "BTL.140.05-12LaE ed 05",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,200,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LER-004",
    "ProcessValidationReport": "VR/BTL.78.07-12LaE/17",
    "ProcessValidationProtocol": "PV/BTL.78.07-12LaE/16",
    "BMR": "BTL.231.02-12LaE, Edition No. 02",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": 1200000,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.12.2021",
    "comments": "The objective of this Process Revalidation was to collect sufficient data to generate documented evidence, which provides a high degree of assurance that a specific process produced product, meeting its predetermined specifications and quality attributes, when manufactured as per Batch Manufacturing Record No. BTL.78.07-12LaE"
  },
  {
    "Status": "Open",
    "Productname": "Lercanidipin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "74294.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.Dahej",
    "Country": "Non-EU",
    "Reference": "CR-02768",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.03.2025",
    "Due_Date": "26.06.2026",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Letrozol Heumann 2,5 Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "73223.00.00",
    "CMOSite": "Haupt Pharma Münster GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-HPM-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Letrozol Heumann 2,5 Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "73223.00.00",
    "CMOSite": "Haupt Pharma Münster GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-HPM-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 100 mg/ml Lösung zum Einnehmen",
    "Dosageform": "LSE",
    "MA_No": "88654.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-013",
    "ProcessValidationReport": "PVR-FB-0193-00",
    "ProcessValidationProtocol": "PVP-FB-0193-00",
    "BMR": "BMR/3002527-01-07\n(only Manufacturing vessel PDE-971)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1000 L / 1150.000 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 100 mg/ml Lösung zum Einnehmen",
    "Dosageform": "LSE",
    "MA_No": "88654.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-021",
    "ProcessValidationReport": "PVR-FB-1434-00",
    "ProcessValidationProtocol": "PVP-FB-1434-00",
    "BMR": "BMR/3002527-02-00\nBMR/3002527-02-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I\nHetero Labs Limited - Unit IX",
    "Batchsize": "2000 L / 2300 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-001",
    "ProcessValidationReport": "PVRF622-00",
    "ProcessValidationProtocol": "PVPF622-00",
    "BMR": "BMR/3001142-06-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-001",
    "ProcessValidationReport": "PVRF622-00",
    "ProcessValidationProtocol": "PVPF622-00",
    "BMR": "BMR/3001142-06-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-002",
    "ProcessValidationReport": "PVRF688-00",
    "ProcessValidationProtocol": "PVPF688-00",
    "BMR": "BMR/3001142-07-02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation for new production area in Module II of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-003",
    "ProcessValidationReport": "PVRF-636-00",
    "ProcessValidationProtocol": "PVPF-636-00",
    "BMR": "BMR/3001143-08-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "975.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX; PVRF704-00 is also attached, but was only evaluated because of coater PDE-412."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-003",
    "ProcessValidationReport": "PVRF-636-00",
    "ProcessValidationProtocol": "PVPF-636-00",
    "BMR": "BMR/3001143-08-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "975.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX; PVRF704-00 is also attached, but was only evaluated because of coater PDE-412."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83765.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86888.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-011",
    "ProcessValidationReport": "PVR/BTL.104.09-2.25LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTL.104.09-2.25LaE/18/01-01",
    "BMR": "BMR/BTL.104.09-2.25LaE-09",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "225.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.04.2020",
    "comments": "The check also includes the BMR BTL.104.10-2.25LaE/10 version, as the change history was already included"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86888.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-017",
    "ProcessValidationReport": "PVR/BTL.56.02-6E/21/01-01",
    "ProcessValidationProtocol": "PV/BTL.56.02-6E/20/01-01",
    "BMR": "BTL.56.03-6E Edition No. 03",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86888.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CC-22-1588",
    "MPVReviewNo": "MPV-LEVE-023",
    "ProcessValidationReport": "PPQR/BTL.89.02-9E/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.89.02-9E/23/02",
    "BMR": "BTL.89.01-9E\nBTL.89.02-9E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "900,000 tablets",
    "Process": "entire process",
    "OOX": "OOS Batch 4PB3L001",
    "Receipt_Date": "03.07.2024",
    "Due_Date": "NA",
    "Completed": "19.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 100mg/ml Konzentrat zur Herstellung einer Inj.-/Inf.-Lösung",
    "Dosageform": "IFK",
    "MA_No": 7012800,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 100mg/ml Konzentrat zur Herstellung einer Inj.-/Inf.-Lösung",
    "Dosageform": "IFK",
    "MA_No": 7012800,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 100mg/ml Konzentrat zur Herstellung einer Inj.-/Inf.-Lösung",
    "Dosageform": "IFK",
    "MA_No": 7012800,
    "CMOSite": "MEFAR ILAC SANAYII A.S",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "Open",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01127",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "02.02.2024",
    "Due_Date": "25.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-007",
    "ProcessValidationReport": "PVRF014-00",
    "ProcessValidationProtocol": "PVPB014-00",
    "BMR": "BMR/3001137-05-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-007",
    "ProcessValidationReport": "PVRF014-00",
    "ProcessValidationProtocol": "PVPB014-00",
    "BMR": "BMR/3001137-05-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86885.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-008",
    "ProcessValidationReport": "PVR/BTL.224.00-8LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTL.224.00-8LaE/18/01-01",
    "BMR": "BTL.224.01-8LaE Ed.1",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "800000 tabs",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-012",
    "ProcessValidationReport": "PVRF639-00, PVRG1183-00",
    "ProcessValidationProtocol": "PVPF639-00, PVPG1183-00",
    "BMR": "BMR/3001137-05-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83762.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-012",
    "ProcessValidationReport": "PVRF639-00, PVRG1183-00",
    "ProcessValidationProtocol": "PVPF639-00, PVPG1183-00",
    "BMR": "BMR/3001137-05-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86885.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-014",
    "ProcessValidationReport": "PVR/BTL.53.01-5E/21/01-01",
    "ProcessValidationProtocol": "PV/BTL.53.01-5E/18/01-01",
    "BMR": "BTL.53.01-5E, Edition No.: 1.1",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "500 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01700",
    "MPVReviewNo": "MPV-LEVE-025",
    "ProcessValidationReport": "PRVR/BTL.324.01-5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.324.01-5LaE/24/02",
    "BMR": "BTL.324.01-5LaE",
    "Reason_for_validation": "equipment, API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd. Baddi",
    "Batchsize": "500000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "11.07.2024",
    "Due_Date": "28.11.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00425\nCR-01691",
    "MPVReviewNo": "MPV-LEVE-024",
    "ProcessValidationReport": "PRVR/BTL.306.00-5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.306.00-5LaE/24/01",
    "BMR": "BTL.306.00-5LaE",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "500000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.12.2023",
    "Due_Date": "29.11.2024",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01467",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "02.02.2024",
    "Due_Date": "25.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00291",
    "MPVReviewNo": "MPV-LEVE-026",
    "ProcessValidationReport": "PPQR/BTL.350.04-3.5E/23/01",
    "ProcessValidationProtocol": "PPQP/BTL.350.04-3.5E/23/01",
    "BMR": "BTL.350.04-3.5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd. Indrad",
    "Batchsize": "350000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "09.10.2023",
    "Due_Date": "29.11.2024",
    "Completed": "12.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83763.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83763.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83763.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-005",
    "ProcessValidationReport": "PVRB012-00, PVRF741-00",
    "ProcessValidationProtocol": "PVPB012-00, PVPF741-00",
    "BMR": "BMR/3001139-07-07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "PPVRB012-00 is only for API Hetero Unit I, PVRF741-00 is verification protocol for API Hetero Unit IX with one validation batch, VRF829-00 is also attached, but was only evaluated because of coater PDE-633."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83763.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-005",
    "ProcessValidationReport": "PVRB012-00, PVRF741-00",
    "ProcessValidationProtocol": "PVPB012-00, PVPF741-00",
    "BMR": "BMR/3001139-07-07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "PPVRB012-00 is only for API Hetero Unit I, PVRF741-00 is verification protocol for API Hetero Unit IX with one validation batch, VRF829-00 is also attached, but was only evaluated because of coater PDE-633."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-009",
    "ProcessValidationReport": "VR/MFC/4006551/01\nPVR/BTL.102.08-5LaE/18/01-01",
    "ProcessValidationProtocol": "PV/MFC/4006551/00\nV/BTL.102.08-5LaE/18/01-01",
    "BMR": "BTL-102.10-5LaE/10",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "500.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-015",
    "ProcessValidationReport": "PVR/BTL.54.01-12E/21/01-01",
    "ProcessValidationProtocol": "PV/BTL.54.01-12E/18/01-01",
    "BMR": "BTL.54.02-12E, Edition No. 02.",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "1 200 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.02.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-018",
    "ProcessValidationReport": "PRVR/BTL.102.15-5LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTL.102.15-5LaE/22/01",
    "BMR": "BTL.102.16-5LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "500.000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30/01/2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86886.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-Leve-019",
    "ProcessValidationReport": "PPQR/BTL.350.04-3.5E/23/01",
    "ProcessValidationProtocol": "PPQP/BTL.350.04-3.5E/23/01",
    "BMR": "BTL.350.04-3.5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "350,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CR-00009",
    "MPVReviewNo": "MPV-LEVE-027",
    "ProcessValidationReport": "PRVR/BTL.94.02-18E/24/01",
    "ProcessValidationProtocol": "PPQP/BTL.94.01-18.0E/23/01",
    "BMR": "BTL.94.01-18.0E",
    "Reason_for_validation": "batch size, equipment",
    "API_Manufacturer": "Dr. Reddy´s Laboratories Ltd",
    "Batchsize": "18 00 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "16.10.2023",
    "Due_Date": "13.12.2024",
    "Completed": "12.02.2025",
    "comments": "angefragt am 23.10.24 Dfo                                                                                                           06.11.2024 Dfo: Reminder  , \n19.11.2024 Protokoll im Ordner gespeichert   und nach Bericht angefragt\n27.11.24 erneut angefragt nach Bericht DFo\n29.11.24 : erneut nach Bericht angefragt , da Antwort unklar war ( Siehe mail von Patel) DFo\n02.12.24  Validierungsbericht erhalten ( siehe mail Pankaj Patil) Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-001",
    "ProcessValidationReport": "PVRF622-00",
    "ProcessValidationProtocol": "PVPF622-00",
    "BMR": "BMR/3001142-06-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-001",
    "ProcessValidationReport": "PVRF622-00",
    "ProcessValidationProtocol": "PVPF622-00",
    "BMR": "BMR/3001142-06-06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation only with API from Unit I, justifiable for API from Unit IX"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-002",
    "ProcessValidationReport": "PVRF688-00",
    "ProcessValidationProtocol": "PVPF688-00",
    "BMR": "BMR/3001142-07-02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1092 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.03.2020",
    "comments": "Validation for new production area in Module II of Block B."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-004",
    "ProcessValidationReport": "PVRB008-00, PVRF732-00",
    "ProcessValidationProtocol": "PVPB008-00, PVPF732-00",
    "BMR": "BMR/3001142-05-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "728 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "PVRB008-00 is only for API Hetero Unit I, PVRF732-00 is verification protocol for API Hetero Unit IX with one validation batch."
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-006",
    "ProcessValidationReport": "PVRF628-00",
    "ProcessValidationProtocol": "PVPF628-00",
    "BMR": "BMR/3001141-07-04",
    "Reason_for_validation": "",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-006",
    "ProcessValidationReport": "PVRF628-00",
    "ProcessValidationProtocol": "PVPF628-00",
    "BMR": "BMR/3001141-07-04",
    "Reason_for_validation": "",
    "API_Manufacturer": "Hetero Labs Limited - Unit I",
    "Batchsize": "1.300.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86887.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-010",
    "ProcessValidationReport": "VR/MFC4006552/01",
    "ProcessValidationProtocol": "PV/MFC4006552/00",
    "BMR": "BTL.103.07-4LaE/07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "400 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86887.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-013",
    "ProcessValidationReport": "PVR/BTL.103.08-4LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BTL.103.08-4LaE/19/01-01",
    "BMR": "BTL.103.08-4LaE/08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "400 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.06.2020",
    "comments": "*Dating error by Luis on sugnature (06June 2020 was sent on 05 June 2020)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetiracetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "83764.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-016",
    "ProcessValidationReport": "PVR/BTL.55.02-1.7E/21/01-01",
    "ProcessValidationProtocol": "PV/BTL.55.02-1.7E/19/01-01",
    "BMR": "BTL.55.02-1.7E Edition No. 02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "170 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.04.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetriacetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86887.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01156",
    "MPVReviewNo": "MPV-LEVE-022",
    "ProcessValidationReport": "PRVR/BTL.353.05-2.3E/22/01",
    "ProcessValidationProtocol": "PRV/BTL.353.05-2.3E/22/01-01",
    "BMR": "BTL.353.05-2.3E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Dr.Reddy`s laboratories Limited",
    "Batchsize": "230000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.02.2024",
    "Due_Date": "27.09.2024",
    "Completed": "",
    "comments": "31.01.2025 nach Protokoll angefragt Dfo\n10.02.25 erneut nach Protokoll angefragt Dfo\n10.02.25 Protokoll erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetriacetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86887.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEVE-020",
    "ProcessValidationReport": "PRVP/BTL.103.14-4LaE/23/01",
    "ProcessValidationProtocol": "PPVP/BTL.103.14-4LaE/22/01",
    "BMR": "BTL.103.14-4LaE\nBTL.103.15-4LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr. Reddy's Laboratories LTD",
    "Batchsize": "400,000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.12.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Levetriacetam Heumann 750mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "86887.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CR-00012",
    "MPVReviewNo": "MPV-LEVE-028",
    "ProcessValidationReport": "PRVR/BTL.95.01-12E/24/01",
    "ProcessValidationProtocol": "PRVP/BTL.95.01-12E/23/01",
    "BMR": "BTL.95.01-12E",
    "Reason_for_validation": "batch size\nequipment",
    "API_Manufacturer": "Dr.Reddy`s laboratories Limited",
    "Batchsize": "1 200 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.08.2024",
    "Due_Date": "23.01.2025",
    "Completed": "13.03.2025",
    "comments": "Protokoll im Ordner gespeichert, nach Bericht angefragt am 19.11.2024 Dfo\n27.11.24 erneut nach Bericht angefragt Dfo\n29.11.24 erneut nach Bericht angefragt, da Antwort unklar war , (siehe Mail vo Patel) Dfo\n02.12.24 Validierungsbericht erhalten ( siehe Mail Pankaj Patil) DFo\n23.01.25: An BPr geschickt DFo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levofloxacin Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79075.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEV-002",
    "ProcessValidationReport": "VR/MFC/4001780/01, VR/MFC/4001780/02",
    "ProcessValidationProtocol": "PV/MFC/4001780/00, PV/MFC/4001780/01",
    "BMR": "BTL.285.01-1.2 LaE Ed 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Cadila Healthcare Ltd",
    "Batchsize": "120.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.05.2021",
    "comments": "Last batch expired"
  },
  {
    "Status": "TBD",
    "Productname": "Levofloxacin Heumann 250 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79075.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00343",
    "MPVReviewNo": "MPV-LEV-003",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "PRVP/BTL.305.00-1.2LaE/23/01",
    "BMR": "BTL.305.00-1.2LaE",
    "Reason_for_validation": "",
    "API_Manufacturer": "Zydus Lifesciences Limited",
    "Batchsize": "120 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.10.2023",
    "Due_Date": "13.12.2024",
    "Completed": "",
    "comments": "No batch intiated, kommt eventuell 2025, Due_Date in Trackwise stimmt nicht DFo 25.10.24 levofloxacin 250mg (4001780)-No batch initiated.(siehe Mail Vishal)\n10.12.24 erneut angefragt Dfo\n10.12.2024 Protokoll erhalten  \nAs per the change control CCF/C/2023/0377 only validation protocol available & NO batch executed.( Antwort VIshal)\n02.01.25 : erneut angefragt Dfo \n22.01.25 erneut angefragt DFo\n04.03.25: Nach Bericht und Protokoll angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Levofloxacin Heumann 500 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79076.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LEV-001",
    "ProcessValidationReport": "PRV/BTL.86.08-2LaE/18/01-01",
    "ProcessValidationProtocol": "PVR/BTL.86.08-2LaE/19/01-01",
    "BMR": "BTL.86.09-2LaE Edition 09",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Cadila Healthcare Limited Dabhasa",
    "Batchsize": "200.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Lisinopril 10 Heumann",
    "Dosageform": "TAB",
    "MA_No": "47576.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LIS-001",
    "ProcessValidationReport": "VR/MFC/4003833/01",
    "ProcessValidationProtocol": "PV/MFC/4003833/00",
    "BMR": "BTL.59.03-13LaE, Edition 3",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Azelis Deutschland pharma GmBh",
    "Batchsize": "1300000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.02.2021",
    "comments": "Reason_for_validation: New validation for site for the said batch size.               Not yet relesed"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lisinopril 2,5 Heumann",
    "Dosageform": "TAB",
    "MA_No": "47576.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LIS-002",
    "ProcessValidationReport": "VR/MFC/4003831/01",
    "ProcessValidationProtocol": "PV/MFC/4003831/00",
    "BMR": "BTL.54.06-3.5LaE, Edition 6",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Azelis Deutschland pharma GmBh",
    "Batchsize": "350000 tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.03.2021",
    "comments": "Awaiting release product on market"
  },
  {
    "Status": "QP Approval",
    "Productname": "Lisinopril 20 Heumann",
    "Dosageform": "TAB",
    "MA_No": "47576.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LIS-003",
    "ProcessValidationReport": "PRVR/BTL.289.00-7.5LaE/22/01",
    "ProcessValidationProtocol": "PRV/BTL.289.00-7.5LaE/21/01-01",
    "BMR": "BTL.289.02-7.5LaE Ed. 02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Zhejiang Huahai Pharma",
    "Batchsize": "750 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.10.2023",
    "comments": "Not marketed"
  },
  {
    "Status": "QP Approval",
    "Productname": "Loperamid 2 Heumann",
    "Dosageform": "TAB",
    "MA_No": "14306.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOP-001",
    "ProcessValidationReport": "VR/MFC/4006292/01",
    "ProcessValidationProtocol": "PV/MFC/4006292/00",
    "BMR": "BTL.105.08-17.5LaE/08",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Lake Chemicals Private Ltd.",
    "Batchsize": "1 750 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Loperamid akut Heumann",
    "Dosageform": "TAB",
    "MA_No": "14306.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOP-001",
    "ProcessValidationReport": "VR/MFC/4006292/01",
    "ProcessValidationProtocol": "PV/MFC/4006292/00",
    "BMR": "BTL.105.08-17.5LaE/08",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Lake Chemicals Private Ltd.",
    "Batchsize": "1 750 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.04.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Loratadin 10 Heumann",
    "Dosageform": "TAB",
    "MA_No": "46778.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOR-001",
    "ProcessValidationReport": "VR/MFC/4006538/01",
    "ProcessValidationProtocol": "PV/MFC/4006538/00",
    "BMR": "BTL.111.03-5LaE, Edition 3",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Morepen Laboratories LTD Masulkhana",
    "Batchsize": "500 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.01.2021",
    "comments": "All current product expired, awaiting release."
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 100 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "72741.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOSHCT-002",
    "ProcessValidationReport": "PVR/BTL.291.01-4E/12",
    "ProcessValidationProtocol": "PV/BTL.291.01-4E/11",
    "BMR": "BTL.291.06-4E, Edition No. 06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Losartan Potassium: Hetero Labs Ltd. (Unit-I)\nHydrochlorothiazid: Unichem Laboratories Ltd",
    "Batchsize": "400,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2022",
    "comments": "All current product expired, from this source"
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 100 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95893.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 100 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "72084.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOSHCT-001",
    "ProcessValidationReport": "PRVR/BTL.541.01-4E/19/01-01",
    "ProcessValidationProtocol": "PRV/BTL.541.01-4E/19/01-01",
    "BMR": "BTL.541.05-4E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Losartan: Cadila Healthcare Ltd.\nHCT: Unichem Laboratories Ltd.",
    "Batchsize": "400,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06. Jul 22",
    "comments": "All current product expired, from this source"
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 100 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "72084.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOSHCT-001",
    "ProcessValidationReport": "PRVR/BTL.541.01-4E/19/01-01",
    "ProcessValidationProtocol": "PRV/BTL.541.01-4E/19/01-01",
    "BMR": "BTL.559.01-4E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Losartan: Cadila Healthcare Ltd.\nHCT: Unichem Laboratories Ltd.",
    "Batchsize": "400,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06. Jul 22",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 100 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "72084.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-LOSHCT-003",
    "ProcessValidationReport": "PRVR/BTL.541.06-4E/22/01",
    "ProcessValidationProtocol": "PRV/BTL.541.06-4E/22/01-01",
    "BMR": "BTL.541.06-4E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Losartan: Cadila Healthcare Ltd.\nHCT: Unichem Laboratories Ltd.",
    "Batchsize": "400,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan comp. Heumann 50 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "95892.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96070.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Losartan Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96070.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "",
    "Reference": "CR-02494",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "17.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96068.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Losartan Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96069.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-06",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Losartan Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96069.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CR-02494",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "17.02.25",
    "Due_Date": "22.08.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Memantin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87894.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00687\nCR-02089",
    "MPVReviewNo": "MPV-MEM-013",
    "ProcessValidationReport": "PRVP/BTM.158.02-4LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTM.158.02-4LaE/23/01",
    "BMR": "BTM.158.02-4LaE/24/01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd. Baddi",
    "Batchsize": "250000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "18.01.2024",
    "Due_Date": "28.02.2025",
    "Completed": "12.03.2025",
    "comments": "12.03.25 an BPr geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87894.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-001",
    "ProcessValidationReport": "PVR/BTM205.01-9E/16\n(PPQR: PRV/BTM.228.01-9E/18/01-01, for alternative compression & coating equip.)",
    "ProcessValidationProtocol": "PV/BTM205.01-9E/16\n(PPQP: PRV/BTM.228.01-9E/18/01-01, for alternative compression & coating equip.)",
    "BMR": "BTM.205.04-9E/04.2 (1.2)",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "900.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.02.2020",
    "comments": "In addition, the process qualification report (PPQR: PRV/BTM.228.01-9E/18/01-01) due to the newly installed machines was also considered. \nA milling step, which was not taken into account during validation, is connected upstream. Milling of API will help to break soft lumps of API to achieve better blend uniformity. API has particle size D (v, 0.90) of 100 micron where milling is done through 0.5 mm (500 micron) screen using comminuting mill."
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87894.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-007",
    "ProcessValidationReport": "PRVR/BTM.232.01-9E/20/01-01 (re-validation for minor change of formula)",
    "ProcessValidationProtocol": "PRV/BTM.232.01-9E/18/01-01",
    "BMR": "BTM.232.04-9E Ed 4",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "900.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.12.2020",
    "comments": "Validation report is initiated for change in formula (increase magnesium stearate quantity)Entire process (excluding pulverization process – As pulverization process includes only lump breakage with sieve – no impact)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87894.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-010",
    "ProcessValidationReport": "VR/BTM.114.00-4.0LaE/19",
    "ProcessValidationProtocol": "PV/BTM.114.00-4.0LaE/16",
    "BMR": "BTM.114.02-4.0LaE Ed. 02",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "400 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.11.2021",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Memantin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "",
    "Country": "",
    "Reference": "CR-01701",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Tianish Laboratories Private Limited (Unit-8)\nformerly known as Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "23.07.2023",
    "Due_Date": "20.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 10 mg/ml Lösung zum Einnehmen",
    "Dosageform": "LSE",
    "MA_No": "88150.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-005",
    "ProcessValidationReport": "PVR-121",
    "ProcessValidationProtocol": "PVP-129",
    "BMR": "CM252/2, PWCM265/3",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Procos SPA",
    "Batchsize": "700 L",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96415.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-004",
    "ProcessValidationReport": "PVR/BTM.212.01-1.2E/17",
    "ProcessValidationProtocol": "PV/BTM.212.01-1.2E/17",
    "BMR": "BTM.212.02-1.2E, Edition 2.1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "120.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96415.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-012",
    "ProcessValidationReport": "PVR/BTM.142.00-2.5LaE/20/01-01",
    "ProcessValidationProtocol": "PV/BTM.142.00-2.5LaE/17/01-01",
    "BMR": "BTM.142.00-2.5LaE Ed. 00",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Mylan Laboratories Limited.",
    "Batchsize": "250 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.11.21",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Memantin Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96415.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01947",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Tianish Laboratories Private Limited (Unit-8)\nformerly known as Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "18.02.2025",
    "Due_Date": "20.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00687\nCR-02089",
    "MPVReviewNo": "MPV-MEM-015",
    "ProcessValidationReport": "PRVR/BTM.160.02-2.5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTM.160.02-2.5LaE/23/01",
    "BMR": "BTM.160.00-2.5LaE\nBTM.160.02-2.5LaE",
    "Reason_for_validation": "API\ncontinuation of validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "400000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "18.01.2024",
    "Due_Date": "28.02.2025",
    "Completed": "12.03.2025",
    "comments": "12.03.25 an BPr geschickt Dfo"
  },
  {
    "Status": "Documents requested",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01701",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Tianish Laboratories Private Limited (Unit-8)\nformerly known as Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "23.07.2023",
    "Due_Date": "20.11.2025",
    "Completed": "",
    "comments": "20.03.25: PVP und PVR angefragt Dfo\n21.03.25: no batch executed against the change control.\nBoth validation protocol & validation report pending Dfo (Mail Vishal)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-002",
    "ProcessValidationReport": "PVR/BTM.208.01-5E/16\n(PPQR: PRVR/BTM.229.01-5E/18/01-01, for alternative compression & coating equip.)",
    "ProcessValidationProtocol": "PV/BTM.208.01-5E/16\n(PPQP: PRV/BTM.229.01-5E/18/01-01, for alternative compresson & coating equip.)",
    "BMR": "BTM.208.03-5E/03.2",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "500.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.02.2020",
    "comments": "In addition, the process qualification report (PPQR: PRVR/BTM.229.01-5E/18/01-01) due to the newly installed machines was also considered. \nA milling step, which was not taken into account during validation, is connected upstream. Milling of API will help to break soft lumps of API to achieve better blend uniformity. API has particle size D (v, 0.90) of 100 micron where milling is done through 0.5 mm (500 micron) screen using comminuting mill."
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-006",
    "ProcessValidationReport": "PRVR/BTM.231.01-5E/20/01-01 (re-validation for minor change of formula)",
    "ProcessValidationProtocol": "PRV/BTM.231.01-5E/18/01-01",
    "BMR": "BTM.231.04-5E Ed 4",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "500.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.12.2020",
    "comments": "Validation report is initiated for change in formula (increase magnesium stearate quantity) Entire process (excluding pulverization process – As pulverization process includes only lump breakage with sieve – no impact)"
  },
  {
    "Status": "Documents requested",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01631",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.03.2025",
    "Due_Date": "17.04.2025",
    "Completed": "",
    "comments": "20.03.25: PVP und PVR angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-008",
    "ProcessValidationReport": "VR/BTM.115.00-2.5LaE/19",
    "ProcessValidationProtocol": "PV/BTM.115.00-2.5LaE/16",
    "BMR": "BTM.115.02-2.5LaE, Ed. 02",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "250 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.11.2021",
    "comments": "Product was transferred from Torrent Pharmaceuticals Limited, Indrad to Torrent Pharmaceuticals Limited, Baddi (India) as per CCF/BDF/16/0050.\n(Annex 3)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "87895.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-009",
    "ProcessValidationReport": "VR/BTM.113.00-15KgE/19",
    "ProcessValidationProtocol": "PV/BTM.113.00-15KgE/16",
    "BMR": "BTM.113.03-15KgE, Ed. 03",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "15 000 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.11.2021",
    "comments": "Memantine Hydrochloride, Pulverized:    Product was transferred from Torrent Pharmaceutical Limited Indrad to Torrent Pharmaceutical Limited Baddi (India), as per CCF/BDF/16/0050 (Annex 3).\n•\tType of Validation: Prospective Validation"
  },
  {
    "Status": "QP Approval",
    "Productname": "Memantin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96414.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MEM-003",
    "ProcessValidationReport": "PVR/BTM.219.01-1.6E/18 and its addendum",
    "ProcessValidationProtocol": "PV/BTM.219.01-1.6E/17 and its addendum",
    "BMR": "BTM.219.02-1.6E, Edition 2.2",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Mylan Laboratories Ltd. Unit-8",
    "Batchsize": "160.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.11.2020",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Memantin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00687\nCR-02089",
    "MPVReviewNo": "MPV-MEM-017",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "PRVP/BTM.157.01-4LaE/23/01",
    "BMR": "BTM.157.01-4LaE",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "400000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "18.01.2024",
    "Due_Date": "28.02.2025",
    "Completed": "",
    "comments": "13.12.24 Antwort von Vishal :This is for your information that batch already under work in progress.\nWe will update once activity closed.\n21.01.25 erneut angefragt wann Charge produziert wird und nach Bericht Dfo ( Vishal)\n10.02.25 Reminder geschickt an Vishal DFo\n14.03.25 Reminder geschickt DFo\n26.03.25 Reminder Dfo\n27.03.25 Protokoll erhalten , Process under validation , Bericht steht noch aus DFo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 1000mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012749,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 1000mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012749,
    "CMOSite": "SAVIOR LIFETEC CORPORATION",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 1000mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012749,
    "CMOSite": "DEMO S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 1000mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012749,
    "CMOSite": "ANFARM HELLAS S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 500mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012748,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 500mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012748,
    "CMOSite": "SAVIOR LIFETEC CORPORATION",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 500mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012748,
    "CMOSite": "DEMO S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Meropenem Heumann 500mg Pulver z. Herstellung einer Inj.-/Inf.-Lsg.",
    "Dosageform": "PII",
    "MA_No": 7012748,
    "CMOSite": "ANFARM HELLAS S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Metamizol Heumann 500 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "91883.00.00",
    "CMOSite": "Sofarimex Industria Química e Farmacêutica, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-SOFARIMEX-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metformin Heumann 1000mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205058.00.00",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-METF-003",
    "ProcessValidationReport": "GGP/PVR/TT/MFG/158",
    "ProcessValidationProtocol": "GGP/PVR/TT/MFG/158-00",
    "BMR": "GIT/BMR/PR/649/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Granules Limited India, Gagillapur",
    "Batchsize": "6,766,917 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metformin Heumann 500mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205056.00.00",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-METF-001",
    "ProcessValidationReport": "GGP/PVR(TT/MFG/159",
    "ProcessValidationProtocol": "GGP/PVR(TT/MFG/159-00",
    "BMR": "GIT/BMR/PR/647/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Granules Limited India, Gagillapur",
    "Batchsize": "13,533,809 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metformin Heumann 850mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205057.00.00",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-METF-002",
    "ProcessValidationReport": "GGP/PVR/TT/MFG/160",
    "ProcessValidationProtocol": "GGP/PVR/TT/MFG/160-00",
    "BMR": "GIT/BMR/PR/648/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Granules Limited India, Gagillapur",
    "Batchsize": "7,961,079 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metformin Hydrochloride 500mg, 850mg, 1000mg Film Coated Tablets BP Common Blend",
    "Dosageform": "Blend",
    "MA_No": "2205056.00.00\n2205057.00.00\n2205058.00.00",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-METF-004",
    "ProcessValidationReport": "GGP/PVP/TT/MFG/151/01",
    "ProcessValidationProtocol": "GGP/PVP/TT/MFG/151-00",
    "BMR": "GGP/BPR/FM/090",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Granules Limited india, Jeedimetla",
    "Batchsize": "7200kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metformin Hydrochloride 500mg, 850mg, 1000mg Film Coated Tablets BP Common Blend",
    "Dosageform": "Blend",
    "MA_No": "2205056.00.00\n2205057.00.00\n2205058.00.00",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV_METF-005",
    "ProcessValidationReport": "GGP/PVR/TT/MFG/205",
    "ProcessValidationProtocol": "GGP/PVP/TT/MFG/205-00",
    "BMR": "GGP/BPR/FM/090, Rev. 02",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Granules India, Bonthapally",
    "Batchsize": "7200.00 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.05.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprolol 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "11781.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MET-003",
    "ProcessValidationReport": "VR/MFC/4004105/01",
    "ProcessValidationProtocol": "PV/MFC/4004105/00",
    "BMR": "BTM.84.03-5.25LaE Edition:03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "525000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2021",
    "comments": "Expired 31.12.2020     but PV done after:  This validation for batch size of 5.25 L tablets. The validation was performed as the product is transferred to Baddi plant from Indrad plant of TPL."
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprolol 200 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "11781.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MET-001",
    "ProcessValidationReport": "VR/MFC/4005692/01",
    "ProcessValidationProtocol": "PV/MFC/4005692/00",
    "BMR": "BTM.75.06-3LaE; edition 06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "300000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Metoprolol 200 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "11781.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01752",
    "MPVReviewNo": "MPV-MET-005",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo\n26.03.25 Reminder Dfo\n27.03.25 Protocol cum Report erhalten !!"
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprolol 200 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "11781.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01273",
    "MPVReviewNo": "MPV-MET-004",
    "ProcessValidationReport": "PVR/BTM.75.08-3LaE/21/01-02",
    "ProcessValidationProtocol": "PRV/BTM.75.08-3LaE/21/01-02",
    "BMR": "BTM.75.11-3LaE, Edition No. 11",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "CTX Lifesciences PVT. LTD.",
    "Batchsize": "300000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "30.08.2024",
    "Due_Date": "28.11.2024",
    "Completed": "",
    "comments": "30.08.24: MPV completed on 07.03.2022; Addendum to be prepared due to correction of ampere load as per CR.     Anhang erhalten am 23.10.24 Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprolol 50 Heumann",
    "Dosageform": "TAB",
    "MA_No": "11781.01.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MET-002",
    "ProcessValidationReport": "VR/BTM.116.00-3.0LaE/17",
    "ProcessValidationProtocol": "PV/BTM.116.00-3.0LaE/16",
    "BMR": "BTM.116.01-3.0LaE Edition:01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "300000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.01.2021",
    "comments": "Expired 31.12.2020   but PV done after: This validation for batch size of 3.0 L tablets. The validation was performed as the product is transferred to Baddi plant from Indrad plant of TPL."
  },
  {
    "Status": "Documents requested",
    "Productname": "Metoprolol succinat 190mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "CR-02184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "25.06.2024",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "07.03.2025: Nach Protokoll und Bericht angefragt Dfo\n17.03.25: Reminder Dfo\n26.03.25 Reminder Dfo"
  },
  {
    "Status": "Documents requested",
    "Productname": "Metoprolol succinat 23,75mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "CR-02184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "25.06.2024",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "07.03.25: Nach Protokoll und Bericht angefragt Dfo\n17.03.25: Reminder Dfo"
  },
  {
    "Status": "Documents requested",
    "Productname": "Metoprolol succinat 47,5mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "CR-02184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "25.06.2024",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "07.03.25: Nach Protokoll und Bericht angefragt Dfo\n17.03.25: Reminder Dfo"
  },
  {
    "Status": "Documents requested",
    "Productname": "Metoprolol succinat 95mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Granules Limited India, Gagillapur",
    "Country": "Non-EU",
    "Reference": "CR-02184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "25.06.2024",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "07.03.25: Nach Protokoll und Bericht angefragt Dfo\n17.03.25: Reminder Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprololsuccinat Heumann 190 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "76467.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprololsuccinat Heumann 23,75 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "76464.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprololsuccinat Heumann 47,5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "76465.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metoprololsuccinat Heumann 95 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "76466.00.00",
    "CMOSite": "Acino",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Acino-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metronidazol 400 Heumann",
    "Dosageform": "TAB",
    "MA_No": "36918.00.00",
    "CMOSite": "Advance Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-01618",
    "MPVReviewNo": "MPV-METRO-001",
    "ProcessValidationReport": "VB-00853",
    "ProcessValidationProtocol": "VP-00410",
    "BMR": "HA-00737\nHA-00738\nHA-00739",
    "Reason_for_validation": "",
    "API_Manufacturer": "Unichem Laboratories Limted Wuhan Wuyao Pharmaceutical Cp.Ltd",
    "Batchsize": "800 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.07.2024",
    "Due_Date": "16.01.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Metronidazol 400 Heumann",
    "Dosageform": "TAB",
    "MA_No": "36918.00.00",
    "CMOSite": "Advance Pharma GmbH",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Advance-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.01.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Mirtazapin Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MIR-001",
    "ProcessValidationReport": "VR/MFC/4004396/01 – initial validation\nVR/BTM.55.06-24LaE/16 – Re-validation\nPVR/BTM.55.11-24LaE/18/01-01 – Process performance qualification + new equip",
    "ProcessValidationProtocol": "PV/MFC/4004396/02 – initial validation\nPV/BTM.55.06-24LaE/15 – Re-validation\nPRV/BTM.55.11-24LaE/18/01-01 – Process performance qualification + new equip",
    "BMR": "BTM.55.13-24LaE/13.1",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": "2.400.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.03.2020",
    "comments": "3 Validation combined. Initial validation, Re-validation, New equipment"
  },
  {
    "Status": "Completed",
    "Productname": "Mirtazapin Heumann 15 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02775",
    "MPVReviewNo": "MPV-MIR-005",
    "ProcessValidationReport": "PRVR/BTM.55m18-24LaE/25/01",
    "ProcessValidationProtocol": "PRVP/BTM.55,18-24LaE/24/01",
    "BMR": "BTM.55.18-24LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Neuland Laboratories LTD",
    "Batchsize": "24 00 000",
    "Process": "film coated tablets",
    "OOX": "NA",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "03.06.2025",
    "Completed": "11.03.2025",
    "comments": "07.03.25: PVR vorhanden, PVP muss angefragt werden MaWa\n07.03.25 : PVP angefragt dfo\n10.03.25 PVP erhalten dfo\n11.03.25 an BPr geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Mirtazapin Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MIR-002",
    "ProcessValidationReport": "VR/MFC/4004397/01 - initial validation\nVR/BTM.56.09-9LaE/17  - Re-validation\nPVR/BTM.56.11-9LaE/18/01-01  - Change hardness\nVR/BTM.77.04-9LaE/15  - Re-validation + equip",
    "ProcessValidationProtocol": "PV/MFC/4004397/00 - initial validation\nPV/BTM.56.09-9LaE/16 - Re-validation\nPRV/BTM.56.11-9LaE/17/01-01 - Change hardness\nPV/BTM.77.04-9LaE/15 - Re-validation + equip",
    "BMR": "BTM.56.13-9LaE/13",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": 900,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.04.2020",
    "comments": "VR/BTM.77.04-9LaE/15 - Validation done with BMR for Megagine API, changes were applied to BMR for Neuland API as well\nVR/BTM.56.06-9LaE/16 - validation for new coater equipment was not considered in review, since same equipment was used in more current validations"
  },
  {
    "Status": "QP Approval",
    "Productname": "Mirtazapin Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MIR-004",
    "ProcessValidationReport": "PRVR/BTM.167.00-12LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTM.167.00-12LaE/23/01",
    "BMR": "BTM.167.00-12LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": "1,200,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.11.2023",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Mirtazapin Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02736",
    "MPVReviewNo": "MPV-MIR-006",
    "ProcessValidationReport": "PRVR/BTM.56.20-9LaE/25/01",
    "ProcessValidationProtocol": "PRVP/BTM.56.20-9LaE/24/01",
    "BMR": "BTM.56.20-9LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Neuland Laboratories LTD",
    "Batchsize": "9 00 000 film coated tablets",
    "Process": "film coating",
    "OOX": "NA",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "25.05.2025",
    "Completed": "11.03.2025",
    "comments": "07.03.25 Nach PVP und PVR angefragt Dfo\n10.03.25 PVP und PVR erhalten dfo\n11.03.25 an BPr geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Mirtazapin Heumann 45 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "60281.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MIR-003",
    "ProcessValidationReport": "PV/MFC/4005658/00 - initial validation\nPV/BTM.72.08-8LaE/16 - Change water\nPRV/BTM.72.11-8LaE/18/01-01 - Change equipment",
    "ProcessValidationProtocol": "VR/MFC/4005658/00 - initial validation\nVR/BTM.72.08-8LaE/16 - Change water\nPVR/BTM.72.11-8LaE/18/01-01 - Change equipment",
    "BMR": "BTM.72.12-8LaE/12",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": 800,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Modafinil Heumann 100 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2202898.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MODA-001\nPVD-CHA-001",
    "ProcessValidationReport": "PVR-124",
    "ProcessValidationProtocol": "PVP-030 (for batches no. 20203F and 20204F) \nPVP-174 (for batch no. 23044A)",
    "BMR": "Manufacturing Work Order (MWO): CM258/5",
    "Reason_for_validation": "compression",
    "API_Manufacturer": "Perrigo",
    "Batchsize": "280,000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.12.2020\n14.07.2020",
    "comments": "The process validation for Modafinil 100mg tablets was due to validate the manufacturing process for the compression on the Fette Tablet Press using Modafinil Powder PhEur API Code: RM0877 (manufactured by Chemagis)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Modafinil Heumann 200 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "2202899.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MODA-002\nPVD-CHA-001",
    "ProcessValidationReport": "PVR-125",
    "ProcessValidationProtocol": "PVP-031 (for batches no. 20205F and 20206F)\nPVP-171 (for batch no. 23045A)",
    "BMR": "Manufacturing Work Order (MWO): CM259/3",
    "Reason_for_validation": "compression",
    "API_Manufacturer": "Perrigo",
    "Batchsize": "140,000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.12.2020\n14.07.2020",
    "comments": "The process validation for Modafinil 200mg tablets was due to validate the manufacturing process for the compression on the Fette Tablet Press using Modafinil Powder PhEur API Code: RM0877 (manufactured by Chemagis) using manufacturing work order No.: CMRD019 and CM259."
  },
  {
    "Status": "QP Approval",
    "Productname": "Molsidomin 2 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7856.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOL-002",
    "ProcessValidationReport": "PVR/BTM.184.01-12E/17 & PVR/BTM.184.02-12E/17 (combined report)",
    "ProcessValidationProtocol": "PV/BTM.184.01-12E/14 & PV/BTM.184.02-12E/16",
    "BMR": "BTM.184.03-12E, Edition: 03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Ipochem",
    "Batchsize": "1200000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.05.2020",
    "comments": "Entire manufacturing process with input as milled API    - New API  Ipochem Sp.z o.o"
  },
  {
    "Status": "QP Approval",
    "Productname": "Molsidomin 4 Heumann",
    "Dosageform": "TAB",
    "MA_No": "7856.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOL-001",
    "ProcessValidationReport": "PVR/BTM.183.01-6.75E/17 & PVR/BTM.183.02-6.75E/17 (combined report)",
    "ProcessValidationProtocol": "PV/BTM.183.01-6.75E/17 & PV/BTM.183.02-6.75E/17",
    "BMR": "BTM.183.03-6.75E, Edition: 03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Ipochem",
    "Batchsize": "675000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Molsidomin 8 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "48484.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOL-003",
    "ProcessValidationReport": "VR/MFC/4007685/01",
    "ProcessValidationProtocol": "PV/MFC/4007685/00",
    "BMR": "BTM.97.05-2.4LaE; edition 05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Ipochem",
    "Batchsize": "240000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 10 mg tabletten",
    "Dosageform": "TAB",
    "MA_No": "78570.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-003",
    "ProcessValidationReport": "PVR/BTM.132.00-10.0LaE/20/01-01",
    "ProcessValidationProtocol": "PV/BTM.132.00-10.0LaE/16",
    "BMR": "BTM.132.00-10.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops IV",
    "Batchsize": "1.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 10 mg tabletten",
    "Dosageform": "TAB",
    "MA_No": "78570.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-004",
    "ProcessValidationReport": "PVR/BTM.211.01-6E/17 \nPVR/BTM.43.02-6E/12",
    "ProcessValidationProtocol": "PV/BTM.211.01-6E-16 \nPV/BTM.43.02-6E/11",
    "BMR": "BTM.185.04-6E Edition 04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "600,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 10 mg tabletten",
    "Dosageform": "TAB",
    "MA_No": "78570.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-008",
    "ProcessValidationReport": "PVR/BTM.185.05-6E/22/01-01",
    "ProcessValidationProtocol": "PV/BTM.185.05-6E/22/01-01",
    "BMR": "BTM.185.05-6E, Edition No. 05",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.07.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 10 mg tabletten",
    "Dosageform": "TAB",
    "MA_No": "78570.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01384",
    "MPVReviewNo": "MPV-MONT-011",
    "ProcessValidationReport": "PPQR/BTM.242.01-10E/24/01",
    "ProcessValidationProtocol": "PPQP/BTM.242.01-10E/24/01",
    "BMR": "BTM.242.01-10E, Edition 01\nBTM.242.01-10E, Edition 02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "05.07.2024",
    "Due_Date": "29.11.2024",
    "Completed": "28.08.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 4 mg Granulat",
    "Dosageform": "GRA",
    "MA_No": "2203038.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-007",
    "ProcessValidationReport": "PVR/BTM.240.01-100E/22/01-02",
    "ProcessValidationProtocol": "PV/BTM.240.01-100E/21/01-01",
    "BMR": "BTM.240.01-100E Edition No. 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Laurus Labs Limited (Unit-I)",
    "Batchsize": "450000 Tab (SFG: 4010890)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.02.22",
    "comments": "Product under launch"
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 4 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78571.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-001",
    "ProcessValidationReport": "PVR/BTM.130.00-4.0LaE/20/01-01",
    "ProcessValidationProtocol": "PV/BTM.130.00-4.0LaE/16",
    "BMR": "BTM.130.00-4.0LaE Ed. 01",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "400 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 4 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78571.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-005",
    "ProcessValidationReport": "PVR/BTM.33.03-2E/12",
    "ProcessValidationProtocol": "PV/BTM.33.03-2E/09",
    "BMR": "BTM.198.03-2LaE Ed. 03",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "200,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.02.2021",
    "comments": "New validation for site for specific strength and batch size."
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 4 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78571.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-009",
    "ProcessValidationReport": "PPQR/BTM.188.04-4E/23/01",
    "ProcessValidationProtocol": "PPQP/BTM.188.04-4E/22/01",
    "BMR": "BTM.188.05-4E Ed. 05",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Dr. Reddy’s Laboratories (Unit V)",
    "Batchsize": "400 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 5 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78572.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-002",
    "ProcessValidationReport": "PVR/BTM.131.00-6.0LaE/20/01-01",
    "ProcessValidationProtocol": "PV/BTM.131.00-6.0LaE/16",
    "BMR": "BTM.131.00-6.0LaE Ed. 01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "600,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 5 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78572.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-006",
    "ProcessValidationReport": "PV/BTM.34.03-1.5E/09",
    "ProcessValidationProtocol": "PV/BTM.34.03-1.5E/09",
    "BMR": "BTM.189.03-1.5E Ed. 03",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "150,000 Tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.02.2021",
    "comments": "New validation for site for specific strength and Batchsize"
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 5 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78572.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MONT-010",
    "ProcessValidationReport": "PVR/BTM.192.06-1.5E/22/01-01",
    "ProcessValidationProtocol": "PV/BTM.192.06-1.5E/22/01-01",
    "BMR": "BTM.192.06-1.5E\nBTM.189.04-1.5E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Dr. Reddy’s Laboratories",
    "Batchsize": "150,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Montelukast Heumann 5 mg Kautabletten",
    "Dosageform": "TAB",
    "MA_No": "78572.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01987",
    "MPVReviewNo": "MPV-MONT-012",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "25.10.2024",
    "Due_Date": "25.10.2025",
    "Completed": "14.02.2025",
    "comments": "06.02.25 MaWa: batches delivered; PVR requested"
  },
  {
    "Status": "QP Approval",
    "Productname": "Morphin  10 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "40108.00.00",
    "CMOSite": "Temmler Pharma GmbH & Co. KG",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-PS-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2020",
    "comments": "PS pharma released product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Morphin  30 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "40108.01.00",
    "CMOSite": "Temmler Pharma GmbH & Co. KG",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-PS-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2020",
    "comments": "PS pharma released product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Morphin  60 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "40108.02.00",
    "CMOSite": "Temmler Pharma GmbH & Co. KG",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-PS-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2020",
    "comments": "PS pharma released product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Morphin 100 retard Heumann",
    "Dosageform": "RET",
    "MA_No": "40108.03.00",
    "CMOSite": "Temmler Pharma GmbH & Co. KG",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-PS-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2020",
    "comments": "PS pharma released product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Morphin Heumann 200 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "74409.00.00",
    "CMOSite": "Temmler Pharma GmbH & Co. KG",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-PS-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.10.2020",
    "comments": "PS pharma released product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxifloxacin Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200881.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOXI-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPR10QC12200730-RE / Version 3 (17-03-2015)",
    "ProcessValidationProtocol": "QPR10QC12200730 / Version 3 (17-02-2015)",
    "BMR": "TDR09MN12200730 / Version 5 / 23-04-2015",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops II",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxifloxacin Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200881.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,2 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-004",
    "ProcessValidationReport": "PVR/BTM.117.02-30LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BTM.117.02-30LaE/20/01-01",
    "BMR": "BTM.117.02-30LaE ed 2",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,2 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-003",
    "ProcessValidationReport": "VR/BTM.118.00-30LaE/16",
    "ProcessValidationProtocol": "PV/BTM.118.00-30LaE/16",
    "BMR": "BTM.118.02-30LaE/02 (1.1)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Farmak, a.s.",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,3 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-008",
    "ProcessValidationReport": "PRVRBTM.119.10-30LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTM.119.10-30LaE/23/01",
    "BMR": "BTM.119.10-30LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Farmak, a.s.",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.08.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,3 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-002",
    "ProcessValidationReport": "VR/BTM.119.00-30LaE/16",
    "ProcessValidationProtocol": "PV/BTM.119.00-30LaE/16",
    "BMR": "BTM.119.03-30LaE/03 (1.1)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Farmak, a.s.",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,3 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-006",
    "ProcessValidationReport": "PVR/BTM.121.03-30LaE/20/01-01,  (Re-validation to manufacture with increase batch size i.e. 3000000 Tablets )",
    "ProcessValidationProtocol": "PRV/BTM.121.03-30LaE/20/01-01\nPRV/BTM.121.03-30LaE/20/01-02",
    "BMR": "BTM.121.05-30LaE",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.02.21",
    "comments": "Reason: Validation report is initiated for increase in batch size in Process Area-B"
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,4 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-001",
    "ProcessValidationReport": "VR/BTM.120.00-30LaE/16",
    "ProcessValidationProtocol": "PV/BTM.120.00-30LaE/16",
    "BMR": "BTM.120.02-30LaE/02(1.1)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Farmak, a.s.",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Moxonidin Heumann 0,4 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "57414.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-MOX-005",
    "ProcessValidationReport": "PVR/BTM.122.02-30LaE/20/01-01",
    "ProcessValidationProtocol": "PRV/BTM.122.02-30LaE/20/01-01",
    "BMR": "BTM.122.02-30LaE ed 2",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Neuland Laboratories LTD Unit I",
    "Batchsize": "3 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-001",
    "ProcessValidationReport": "PVR-200",
    "ProcessValidationProtocol": "PVP-264",
    "BMR": "MWO CM273",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "61,2 kg (300.000 tablets)",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-001",
    "ProcessValidationReport": "PVR-201",
    "ProcessValidationProtocol": "PVP-274",
    "BMR": "CM290",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "61,2 kg (300.000 tablets)",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": "Confirmation by CMO, that MPV-NARA-001 and 002 are also valid for BMR CM290."
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-002",
    "ProcessValidationReport": "PVR-201",
    "ProcessValidationProtocol": "PVP-274",
    "BMR": "FCCM273",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "61,2 kg (300.000 tablets)",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-002",
    "ProcessValidationReport": "PVR-201",
    "ProcessValidationProtocol": "PVP-274",
    "BMR": "CM290",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "61,2 kg (300.000 tablets)",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": "Confirmation by CMO, that MPV-NARA-001 and 002 are also valid for BMR CM290."
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-003",
    "ProcessValidationReport": "VR01.CM226-2.5mg",
    "ProcessValidationProtocol": "CM226-2.5mg",
    "BMR": "CM281",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "22,44 kg (110.000 tablets)",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Naratriptan Heumann bei Migräne",
    "Dosageform": "FTA",
    "MA_No": "87335.00.00",
    "CMOSite": "Chanelle Medical",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NARA-004",
    "ProcessValidationReport": "VR01.FCCM226-2.5mg",
    "ProcessValidationProtocol": "FCCM226-2.5mg",
    "BMR": "FCCM281",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr. Reddy's Laboratories Ltd., Chemical Tech Ops VI",
    "Batchsize": "22,44 kg (110.000 tablets)",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Nasenspray Heumann",
    "Dosageform": "NAS",
    "MA_No": "26328.00.00",
    "CMOSite": "Lichtenheldt GmbH",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-LIC-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Nebivolol 10mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00191",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.09.2023",
    "Due_Date": "30.11.2025",
    "Completed": "",
    "comments": "Produktlaunch Oktober 2025\n25.10.24: TPL Baddi oder Indrad? Bei CH und FP angefragt; MAH = TPL Malta; CH: Launch in Klärung (pricing)\n22.01.25 angefragt nach Protokoll und Bericht Dfo"
  },
  {
    "Status": "Open",
    "Productname": "Nebivolol 2,5mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00191",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.09.2023",
    "Due_Date": "30.11.2025",
    "Completed": "",
    "comments": "Produktlaunch Oktober 2025\n25.10.24: TPL Baddi oder Indrad? Bei CH und FP angefragt; MAH = TPL-b Malta; CH: Launch in Klärung (pricing)\n22.01.25 angefragt nach Protokoll und Bericht Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Nebivolol Heumann 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "67523.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NEB-001",
    "ProcessValidationReport": "PV/BTN.26.01-13E/08",
    "ProcessValidationProtocol": "PV/BTN.26.01-13E/08",
    "BMR": "BTN.46.06-13E, Edition: 06.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1.300.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Nevirapin Heumann 400 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "95659.00.00",
    "CMOSite": "Hetero Labs Limited - Unit III",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-NEV-001",
    "ProcessValidationReport": "PVRG1071-00",
    "ProcessValidationProtocol": "PVPG1071-00",
    "BMR": "BMR/3005657-01-01 (Blend)\nBMR/3005658-01-01 (Bulk Tablets)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited - Unit IX",
    "Batchsize": "150000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.05.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Nikofrenon Pflaster 7mg/24h\nNikofrenon Pflaster 14mg/24h\nNikofrenon Pflaster 21mg/24h",
    "Dosageform": "Mass",
    "MA_No": "",
    "CMOSite": "LTS Lohmann Therapie-Systeme AG",
    "Country": "EU",
    "Reference": "CR-02670",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.03.2025",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Nikofrenon Pflaster 7mg/24h\nNikofrenon Pflaster 14mg/24h\nNikofrenon Pflaster 21mg/24h",
    "Dosageform": "Patches",
    "MA_No": "",
    "CMOSite": "LTS Lohmann Therapie-Systeme AG",
    "Country": "EU",
    "Reference": "CR-01576",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.03.2025",
    "Due_Date": "30.08.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Olanzapin 5mg",
    "Dosageform": "TAB",
    "MA_No": "77511.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00453\nCR-01508",
    "MPVReviewNo": "MPV-OLA-016",
    "ProcessValidationReport": "PPQR/BTO.203.08-3.5E/23/01",
    "ProcessValidationProtocol": "PPQP/BTO.203.08-3.5E/23/02",
    "BMR": "BTO.203.08-3.5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "TEVA Pharmaceutical And Chemical",
    "Batchsize": "350 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "03.11.2023",
    "Due_Date": "27.12.2024",
    "Completed": "14.03.2025",
    "comments": "24.10.24 MaWa: Report Nummern in CR-01508; CR-01508 muss transfer of recommendations into BMR geprüft werden, Validierungsprotokoll angefragt 18.11.2024 Dfo\n29.11.24 erneunt nach Protokoll angefragt Dfo \n10.12.24 erneut nach Protokoll angefragt Dfo \n16.12.24 Berichte wurden geschickt, erneut nach Protokoll angefragt\n17.12.24 Protokoll erhalten Dfo \n04.03.25 an BPr geschickt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77513.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01114",
    "MPVReviewNo": "MPV-OLA-015",
    "ProcessValidationReport": "PRVR/BTO.26.19-15.5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.26.19-15.5LaE/24/01",
    "BMR": "BTO.26.19-15.5LaE",
    "Reason_for_validation": "composition",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,550,000 tablets",
    "Process": "entire process",
    "OOX": "OOS\nBatch CW42L003",
    "Receipt_Date": "06.03.2024",
    "Due_Date": "30.11.2025",
    "Completed": "25.10.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77513.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-001",
    "ProcessValidationReport": "VR/MFC/4006911/01",
    "ProcessValidationProtocol": "PV/MFC/4006911/00",
    "BMR": "BTO.26.08-15.5LaE/08",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 550 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77513.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-001",
    "ProcessValidationReport": "PVR/BTO.26.06-15.5LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTO.26.06-15.5LaE/17/01-01",
    "BMR": "BTO.26.08-15.5LaE/08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 550 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.03.2020",
    "comments": "Re-validation was performed due to new roller compacter and compressio machine. Still, prior manufacturing steps were considered in the validation. Therefore valid for entire process"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77513.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01983",
    "MPVReviewNo": "MPV-OLA-015",
    "ProcessValidationReport": "PRVR/BTO.26.19-15.5LaE/24/01",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "10.10.2024",
    "Due_Date": "11.05.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Olanzapin Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77513.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00453",
    "MPVReviewNo": "MPV-OLA-017",
    "ProcessValidationReport": "PPQR/BTO.206.08-3.5E/24/01",
    "ProcessValidationProtocol": "PPQP/BTO.206.08-3.5E/23/01",
    "BMR": "BTO.206.08-3.5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "TEVA Pharmaceutical And Chemical",
    "Batchsize": "350 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "03.11.2023",
    "Due_Date": "27.12.2024",
    "Completed": "",
    "comments": "Validierungsprotokoll angefragt 18.11.2024 Dfo\n29.11.24 erneut nach Protokoll angefragt Dfo \n10.12.24 erneut nach Protokoll angefragt\n16.12.24 Bericht wurde geschickt, erneut nach Protokoll angefragt Dfo\n17.12.24 Protokoll erhalten dfo \n24.02.24: OOX Bericht in Review referenziert; OOX Bericht angelegt MaWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 15 mg Orodispersible Tablets",
    "Dosageform": "",
    "MA_No": "77514.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-009",
    "ProcessValidationReport": "PRVP/BTO.27.16-6.3LaE/22/01\nADD/PRVR/BTO.27.16-6.3LaE/22/01/01",
    "ProcessValidationProtocol": "PRVR/BTO.27.16-6.3LaE/22/01",
    "BMR": "BTO.27.18-6.3LaE/18",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "630 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.03.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 15 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77514.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01699",
    "MPVReviewNo": "MPV-OLA-014",
    "ProcessValidationReport": "PRVR/BTO.27.19-6.3LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.27.19-6.3LaE/24/01",
    "BMR": "BTO.27.19-6.3LaE",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "630 000Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.07.2024",
    "Due_Date": "25.09.2025",
    "Completed": "25.09.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 15 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77514.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-002",
    "ProcessValidationReport": "VR/MFC/4006912/01",
    "ProcessValidationProtocol": "PV/MFC/4006912/00",
    "BMR": "BTO.27.10-6.3LaE/10",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "630 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 2,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77510.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-005",
    "ProcessValidationReport": "VR/MFC/4006908/01",
    "ProcessValidationProtocol": "PV/MFC/4006908/00",
    "BMR": "BTO.23.09-7LaE/09",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "700 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 2,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77510.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-005",
    "ProcessValidationReport": "PVR.BTO.23.08-7LaE/18/01-01",
    "ProcessValidationProtocol": "PRV.BTO.23.08-7LaE/18/01-01",
    "BMR": "BTO.23.09-7LaE/10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "700 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 2,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77510.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-010",
    "ProcessValidationReport": "PRVR/BTO.73.00-7LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.73.00-7LaE/23/01",
    "BMR": "BTO.73.00-7LaE",
    "Reason_for_validation": "Composition + Equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "700,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 20 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77515.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-006",
    "ProcessValidationReport": "PVR/BTO.28.06-9.4LaE/18/01-01 – Revalidation due to change of compaction machine and compression machine\nVR/MFC/4006913/01 – Original validation at Baddi",
    "ProcessValidationProtocol": "PRV/BTO.28.06-9.4LaE/18/01-01- Revalidation due to change of compaction machine and compression machine\nPV/MFC/4006913/00 – Original validation at Baddi",
    "BMR": "BTO.28.10-9.4LaE ed 10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "940,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.10.2020",
    "comments": "CC-22-0895: addendum prepared to correct recommended roller gap"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 20 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77515.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01114\nCR-01451",
    "MPVReviewNo": "MPV-OLA-012",
    "ProcessValidationReport": "PRVR/BTO.28.15-9.4LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.28.15-9.4LaE/24/01",
    "BMR": "BTO.28.15-9.4LaE",
    "Reason_for_validation": "composition",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "940,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "06.03.2024",
    "Due_Date": "30.11.2025",
    "Completed": "22.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77511.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-011",
    "ProcessValidationReport": "PRVR/BTO.74.00.17.5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.74.00.17.5LaE/24/01",
    "BMR": "BTO.74.00-17.5LaE",
    "Reason_for_validation": "Composition + Equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,750,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77511.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-004",
    "ProcessValidationReport": "VR/MFC/4006909/01",
    "ProcessValidationProtocol": "PV/MFC/4006909/00",
    "BMR": "BTO.24.06-17.5LaE/06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 750 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.03.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77511.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-007",
    "ProcessValidationReport": "PVR/BTO.24.09-17.5LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTO.24.09-17.5LaE/20/01-01",
    "BMR": "BTO.24.09-17.5LaE Ed. 09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 750 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.05.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 7,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77512.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-003",
    "ProcessValidationReport": "VR/MFC/4006910/01",
    "ProcessValidationProtocol": "PV/MFC/4006910/00",
    "BMR": "BTO.25.06-5LaE/06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.03.2020",
    "comments": "Compression machine Ids F/COM-03 and -012 were not validated but are given in BMR. No validation required due to equivalency of machines"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 7,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77512.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLA-008",
    "ProcessValidationReport": "PRVR/BTO.72.00-5LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTO.72.00-5LaE/22/01",
    "BMR": "BTO.72.00-5LaE Ed. 00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.10.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 7,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77512.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01114",
    "MPVReviewNo": "MPV-OLA-013",
    "ProcessValidationReport": "PRVR/BTO.72.03-5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.72.03-5LaE/24/01",
    "BMR": "BTO.72.03-5LaE",
    "Reason_for_validation": "composition",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500,000 tablets",
    "Process": "entire process",
    "OOX": "OOS\nBatch CW66L002",
    "Receipt_Date": "06.03.2024",
    "Due_Date": "30.11.2025",
    "Completed": "24.10.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olanzapin Heumann 7,5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "77512.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01821                                    CR-01114",
    "MPVReviewNo": "MPV-OLA-013",
    "ProcessValidationReport": "PRVR/BTO.72.03-5LaE/24/01",
    "ProcessValidationProtocol": "PRVP/BTO.72.03-5LaE/24/01",
    "BMR": "BTO.72.03-5LaE",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "500000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "22.08.2024",
    "Due_Date": "20.02.2025",
    "Completed": "",
    "comments": "CR-01821 BMR Update gehört zu CR-01114 Dfo 18.11.2024"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94973.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM-001",
    "ProcessValidationReport": "PVR/BTO.108.02-1.6E/17",
    "ProcessValidationProtocol": "PV/BTO.108.02-1.6E/17",
    "BMR": "BTO.108.03-1.6E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Glenmark Life sciences Limited",
    "Batchsize": "160000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": "Last released 28/06/2019, Expires Jan 2023"
  },
  {
    "Status": "Open",
    "Productname": "Olmesartan Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94973.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01089",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.05.2024",
    "Due_Date": "26.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94974.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM-003",
    "ProcessValidationReport": "PVR/BTO.99.03-12E/16",
    "ProcessValidationProtocol": "PV/BTO.99.03-12E/16",
    "BMR": "BTO.292.02-12E, Edition No. 2.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Glenmark Pharmaceuticals Ltd.",
    "Batchsize": "1 200 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.07.2021",
    "comments": "Awaiting release product on market"
  },
  {
    "Status": "Open",
    "Productname": "Olmesartan Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94974.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01089",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.05.2024",
    "Due_Date": "26.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94975.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM-002",
    "ProcessValidationReport": "PVR/BTO.252.01-1.4E/14",
    "ProcessValidationProtocol": "PV/BTO.252.01-1.4E/14",
    "BMR": "BTO.286.01-1.4E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD",
    "Batchsize": "140000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": "Last released 24/04/2019, expires Okt 22"
  },
  {
    "Status": "Open",
    "Productname": "Olmesartan Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94975.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01089",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.05.2024",
    "Due_Date": "26.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Olmesartan Hydrochloothiazid 20/25 mg",
    "Dosageform": "FTA",
    "MA_No": "94970.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.-Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01090",
    "MPVReviewNo": "MPV-OLM_HCT-001",
    "ProcessValidationReport": "PVR/BTO.284.02-1.5E/17",
    "ProcessValidationProtocol": "PV/BTO.284.02-1.5E/17",
    "BMR": "BTO.284.02-1.5E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dr. Glenmark Life Sciences Limited & Unichem Laboratories Lmited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "05.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "13.02.25",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Olmesartan Hydrochloothiazid 40/25mg",
    "Dosageform": "FTA",
    "MA_No": "94972.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.-Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01090",
    "MPVReviewNo": "MPV-OLM_HCT-003",
    "ProcessValidationReport": "PVR/BTO.143.02-1.3E/17",
    "ProcessValidationProtocol": "PV/BTO.143.02-1.3E/17",
    "BMR": "BTO.143.02-1.3E",
    "Reason_for_validation": "commercial launch",
    "API_Manufacturer": "Glenmark",
    "Batchsize": "130 000 Tablets",
    "Process": "entire process",
    "OOX": "OOS Batch BFC3D001",
    "Receipt_Date": "05.09.2024",
    "Due_Date": "27.12.2024",
    "Completed": "12.02.25",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin Heumann 20 mg/5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203762.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLOLM-001",
    "ProcessValidationReport": "MPL/N2/PPQR/23/016/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/016/00",
    "BMR": "MPL/BMR/AK8/1/07\nMPL/BMR/AK8/1/08",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Amlodipin Besilat: Hetero Drugs Limited\nOlmesartan Medoxomil: Macleods Pharmaceuticals Limited",
    "Batchsize": "250,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.06.24",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Olmesartan/Amlodipin Heumann 20 mg/5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203762.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02108",
    "MPVReviewNo": "MPV-AMLOLM-006",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "26.09.2024",
    "Due_Date": "27.12.24",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin Heumann 40 mg/10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203763.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-AMLOLM-002",
    "ProcessValidationReport": "MPL/N2/PPQR/23/022/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/022/00-A1",
    "BMR": "MPL/BMR/AL1/1/08",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Amlodipin Besilat: Hetero Drugs Limited\nOlmesartan Medoxomil: Macleods Pharmaceuticals Limited",
    "Batchsize": "375,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.06.24",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Olmesartan/Amlodipin Heumann 40 mg/10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203763.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02108",
    "MPVReviewNo": "MPV-AMLOLM-005",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "26.09.2024",
    "Due_Date": "27.12.24",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin Heumann 40 mg/5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203764.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01650",
    "MPVReviewNo": "MPV-AMLOLM-003",
    "ProcessValidationReport": "MPL/N2/PPQR/23/023/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/023/00-A1",
    "BMR": "MPL/BMR/AK/2/00",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Amlodipin Besilat: Hetero Drugs Limited\nOlmesartan Medoxomil: Macleods Pharmaceuticals Limited",
    "Batchsize": "250,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.06.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin Heumann 40 mg/5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203764.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-02108",
    "MPVReviewNo": "MPV-AMLOLM-004",
    "ProcessValidationReport": "MPL/N2/PPQR/23/095/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/23/095/00",
    "BMR": "MPL/BMR/AK9/1/08",
    "Reason_for_validation": "increase in Batchsize",
    "API_Manufacturer": "Amlodipin Besilat: Hetero Drugs Limited\nOlmesartan Medoxomil: Macleods Pharmaceuticals Limited",
    "Batchsize": "600,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "26.09.2024",
    "Due_Date": "27.12.24",
    "Completed": "12.12.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin/HCT Heumann 20 mg/5 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205817.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPVOLM/AML/HCT-006",
    "ProcessValidationReport": "F1/VR/000319 1.0",
    "ProcessValidationProtocol": "F1/VP/000226 1.0",
    "BMR": "ALPBMR3913-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Olmesartan: Alembic Pharmaceuticals Limited\nAmlodipine: Hetero Drugs Limited\nHydrochlorothiazide: Alembic Pharmaceuticals Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin/HCT Heumann 40 mg/10 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205819.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPVOLM/AML/HCT-008",
    "ProcessValidationReport": "F1/VR/000316 1.0",
    "ProcessValidationProtocol": "F1/VP/000229 1.0",
    "BMR": "ALPBMR3917-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Olmesartan: Alembic Pharmaceuticals Limited\nAmlodipine: Hetero Drugs Limited\nHydrochlorothiazide: Alembic Pharmaceuticals Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin/HCT Heumann 40 mg/10 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205821.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPVOLM/AML/HCT-010",
    "ProcessValidationReport": "F1/VR/000322 1.0",
    "ProcessValidationProtocol": "F1/VP/000230 1.0",
    "BMR": "ALPBMR3914-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Olmesartan: Alembic Pharmaceuticals Limited\nAmlodipine: Hetero Drugs Limited\nHydrochlorothiazide: Alembic Pharmaceuticals Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin/HCT Heumann 40 mg/5 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205818.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPVOLM/AML/HCT-007",
    "ProcessValidationReport": "F1/VR/000315 1.0",
    "ProcessValidationProtocol": "F1/VP/000228 1.0",
    "BMR": "ALPBMR3915-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Olmesartan: Alembic Pharmaceuticals Limited\nAmlodipine: Hetero Drugs Limited\nHydrochlorothiazide: Alembic Pharmaceuticals Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Amlodipin/HCT Heumann 40 mg/5 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205820.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPVOLM/AML/HCT-009",
    "ProcessValidationReport": "F1/VR/000320 1.0",
    "ProcessValidationProtocol": "F1/VP/000227 1.0",
    "BMR": "ALPBMR3916-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Olmesartan: Alembic Pharmaceuticals Limited\nAmlodipine: Hetero Drugs Limited\nHydrochlorothiazide: Alembic Pharmaceuticals Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.03.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Hydrochlorothiazid Heumann 20 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94969.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM/HCT-004",
    "ProcessValidationReport": "PRV/BTO.145.04-13E/21/01-01",
    "ProcessValidationProtocol": "PV/BTO.145.04-13E/21/01-01",
    "BMR": "BTO.145.04-13E Edition No. 04",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD / Unichem Laboratories LTD",
    "Batchsize": 130,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.02.2022",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Olmesartan/Hydrochlorothiazid Heumann 20 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94970.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM/HCT-001",
    "ProcessValidationReport": "PVR/BTO.248.02-1.5E/17",
    "ProcessValidationProtocol": "PV/BTO.284.02-1.5/17",
    "BMR": "BTO.284.03-1,5E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Glenmark Life sciences Limited & Unichem Laboratories Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.03.2025",
    "comments": "No Stock on market, batch awaiting release\n04.03.25 an BPr geschickt dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Olmesartan/Hydrochlorothiazid Heumann 40 mg/12,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94971.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM/HCT-002",
    "ProcessValidationReport": "PR/BTO.142.02-1.3E/17",
    "ProcessValidationProtocol": "PV/BTO.142.02-1.3E/17",
    "BMR": "BTO.142.003-1.3E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Glenmark Pharmaceuticals LTD / Unichem Laboratories LTD",
    "Batchsize": 130,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.05.2021",
    "comments": "No Stock on market, batch awaiting release"
  },
  {
    "Status": "Completed",
    "Productname": "Olmesartan/Hydrochlorothiazid Heumann 40 mg/25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94972.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OLM/HCT-003",
    "ProcessValidationReport": "PVR/BTO.143.02-1.3E/17",
    "ProcessValidationProtocol": "PV/BTO.143.02-1.3E/17",
    "BMR": "BTO.143.03-1.3E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Glenmark Life sciences Limited & Unichem Laboratories Limited",
    "Batchsize": "130 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.03.2025",
    "comments": "No Stock on market, batch awaiting release\n04.03.25 an BPr geschickt dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 10 mg magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "72547.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CC-22-0546\nCC-22-0547",
    "MPVReviewNo": "MPV-OMEP-001",
    "ProcessValidationReport": "VAL 1116 ED.01\nVAL 1135 ED.01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "New composition of finished product",
    "API_Manufacturer": "N/A",
    "Batchsize": "24.533.805 capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "25.03.24",
    "comments": "In addition to performed review a EU-QP Statement on process validation shall be requested from CMO, confirming that process validation of Omeprazol gastro-resistant hard capsules 10mg, 20mg and 40mg premium formula has been conducted according GMP Annex 15"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 10 mg magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "72547.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 20 mg bei Sodbrennen magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "41997.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CC-22-0546\nCC-22-0547",
    "MPVReviewNo": "MPV-OMEP-001",
    "ProcessValidationReport": "VAL 1116 ED.01\nVAL 1124 ED.01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "New composition of finished product",
    "API_Manufacturer": "N/A",
    "Batchsize": "12.266.902 capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "25.03.24",
    "comments": "In addition to performed review a EU-QP Statement on process validation shall be requested from CMO, confirming that process validation of Omeprazol gastro-resistant hard capsules 10mg, 20mg and 40mg premium formula has been conducted according GMP Annex 15"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 20 mg bei Sodbrennen magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "41997.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 20 mg magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "61381.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 40 mg magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "72549.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CC-22-0546\nCC-22-0547",
    "MPVReviewNo": "MPV-OMEP-001",
    "ProcessValidationReport": "VAL 1116 ED.01\nVAL 1125 ED.01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "New composition of finished product",
    "API_Manufacturer": "N/A",
    "Batchsize": "6.133.451 capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "25.03.24",
    "comments": "In addition to performed review a EU-QP Statement on process validation shall be requested from CMO, confirming that process validation of Omeprazol gastro-resistant hard capsules 10mg, 20mg and 40mg premium formula has been conducted according GMP Annex 15"
  },
  {
    "Status": "QP Approval",
    "Productname": "Omeprazol Heumann 40 mg magensaftresistente Hartkapseln",
    "Dosageform": "KMR",
    "MA_No": "72549.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Opipramol Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "65400.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OPI-002",
    "ProcessValidationReport": "PVR/BTO.30.05-5LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTO.30.05-5LaE/19/01-01",
    "BMR": "BTO.30.06-5LaE Edition:06",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Polpharma S.A.",
    "Batchsize": "500,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.02.2021",
    "comments": "Last released 24/06/2016, Expires May 21"
  },
  {
    "Status": "QP Approval",
    "Productname": "Opipramol Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "65399.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-OPI-001",
    "ProcessValidationReport": "PVR/BTO.29.04-10LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTO.29.04-10LaE/19/01-01",
    "BMR": "BTO.29.05-10LaE ED:05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Polpharma S.A.",
    "Batchsize": "1000000 Tabs",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Oxycodon/Naloxon 10mg/5mg",
    "Dosageform": "TAB",
    "MA_No": "2204719.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02470",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "01.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Oxycodon/Naloxon 20mg/10mg",
    "Dosageform": "TAB",
    "MA_No": "2204720.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02470",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "01.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Oxycodon/Naloxon 30mg/15mg",
    "Dosageform": "TAB",
    "MA_No": "2204721.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02470",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "01.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Oxycodon/Naloxon 40mg/20mg",
    "Dosageform": "TAB",
    "MA_No": "2204722.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02470",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "01.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Oxycodon/Naloxon 5mg/2,5mg",
    "Dosageform": "TAB",
    "MA_No": "2204718.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02470",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.01.2025",
    "Due_Date": "01.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodon/Naloxon Heuamnn 5mg/2,5mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2204718.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodon/Naloxon Heumann 10mg/5mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2204719.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodon/Naloxon Heumann 20mg/10mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2204720.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodon/Naloxon Heumann 30mg/15mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2204721.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodon/Naloxon Heumann 40mg/20mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2204722.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 10 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92108.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BAL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 10 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91465.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 20 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92109.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BAL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 20 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91467.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 30 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91468.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 40 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91469.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 5 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92107.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BAL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 5 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91464.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BalkanpharmaDup-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 60 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91470.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BAL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Oxycodonhydrochlorid Heumann 80 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "91471.00.00",
    "CMOSite": "Balkanpharma - Dupnitsa AD",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-BAL-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Panthenol Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "6225756.00.00",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-CPM-002",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.07.2020",
    "comments": "PVD-CPM-01 covers only product Diclofenac Heumann Gel, Panthenol CRE and Aciclovir CRE are not covered."
  },
  {
    "Status": "QP Approval",
    "Productname": "Panthenol Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "6225756.00.00",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-CPM-05",
    "ProcessValidationReport": "NA",
    "ProcessValidationProtocol": "NA",
    "BMR": "NA",
    "Reason_for_validation": "NA",
    "API_Manufacturer": "NA",
    "Batchsize": "NA",
    "Process": "NA",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "24.02.2025",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Panthenol Heumann Creme",
    "Dosageform": "CRE",
    "MA_No": "6225756.00.01",
    "CMOSite": "C.P.M. Contractpharma GmbH",
    "Country": "EU",
    "Reference": "CR-02476",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "NA",
    "Due_Date": "06.02.2024",
    "Completed": "",
    "comments": "07.01.25 MaWa: Reminder\n03.03.25 MaWa: new QP statement provided and reviewed, PVD-CPM-005 on 24.02.25. Execution of Process Verification to be discussed"
  },
  {
    "Status": "Open",
    "Productname": "Pantoprazol 20mg",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.-Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01995",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "05.11.2024",
    "Due_Date": "18.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Pantoprazol 40mg",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd.-Baddi",
    "Country": "Non-EU",
    "Reference": "CR-01995",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "05.11.2024",
    "Due_Date": "18.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg bei Sodbrennen magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "75264.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-006",
    "ProcessValidationReport": "PVR/BTP.51.14-15LaE/21/01-02",
    "ProcessValidationProtocol": "PRV/BTP.51.14-15LaE/21/01-01",
    "BMR": "BTP.51.15-15LaE Ed. 15",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs PVT. Limited",
    "Batchsize": "1 500 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.04.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "75264.00.00/64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PAN-005",
    "ProcessValidationReport": "PVR/BTP.51.06-15LaE/17/01-01 – Change of Autocoater – F/TCM-09\nVR/BTP.51.02-15LaE/15  - – Change of Autocoater – F/TCM-07 and TCM-08\nVR/MFC/4006087/01 – Original validation with autocoater TCM 03",
    "ProcessValidationProtocol": "PRV/BTP.51.06-15LaE/17/01-01 – Change of Autocoater – F/TCM-09\nPV/BTP.51.02-15LaE/15  - – Change of Autocoater – F/TCM-07 and TCM-08\nPV/MFC/4006087/01 – Original validation with autocoater TCM 03",
    "BMR": "BTP.51.09-15LaE. Edition 09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs PVT. Limited Unit-II",
    "Batchsize": "1.500.000",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2020",
    "comments": "Apart from original validation. Subsequent two validation performed for change of autocoater."
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-002",
    "ProcessValidationReport": "VR/BTP.91.00-30LaE/17",
    "ProcessValidationProtocol": "",
    "BMR": "BTP.91.04-30LaE/04",
    "Reason_for_validation": "",
    "API_Manufacturer": "Nosch Labs PVT. Limited Unit-II",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-003",
    "ProcessValidationReport": "PVR/BTP.18.01-30E/19/01-01",
    "ProcessValidationProtocol": "PV/BTP.18.01-30E/18/01-01 & 02",
    "BMR": "BTP.18.03-30E Ed. 03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Nosch Labs PVT. Limited Unit-II",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-006",
    "ProcessValidationReport": "PVR/BTP.51.14-15LaE/21/01-02",
    "ProcessValidationProtocol": "PRV/BTP.51.14-15LaE/21/01-01",
    "BMR": "BTP.51.15-15LaE Ed. 15",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs PVT. Limited",
    "Batchsize": "1 500 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.04.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Advance Pharma GmbH",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Advance-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.01.2022",
    "comments": "Obsolete as per CC-23-0164"
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 20 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-010",
    "ProcessValidationReport": "PRVR/BTP.91.09-30LaE/23/02",
    "ProcessValidationProtocol": "PRVP/BTP.91.09-30LaE/22/01",
    "BMR": "BTP.91.10.-30LaE\nBTP.140.00-30LaE/00",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs PVT. Limited",
    "Batchsize": "3.000.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.05.2023",
    "comments": "17.06.24 MaWa: refer to annexure 2 of CR-00565: manufacturing formula, composition, manufacturing process, equipment and process parameters in BTP.140.00-30LaE/00 are similar to BTP.91.10-30LaE)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64962.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-001",
    "ProcessValidationReport": "VR/BTP.85.00-14LaE/16",
    "ProcessValidationProtocol": "",
    "BMR": "BTP.85.05-14LaE/05",
    "Reason_for_validation": "",
    "API_Manufacturer": "Nosch Labs PVT. Limited Unit-II",
    "Batchsize": "1.400.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64962.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-004",
    "ProcessValidationReport": "PV/BTP.19.01-15E/19/01-01",
    "ProcessValidationProtocol": "PV/BTP.19.01-15E/18/01-02",
    "BMR": "BTP.19.02-15E/03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Nosch Labs PVT. Limited Unit-II",
    "Batchsize": "1.500.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64962.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-008",
    "ProcessValidationReport": "PRVR/BTP.85.13-15LaE/22/01",
    "ProcessValidationProtocol": "PRV/BTP.85.13-15LaE/22/01-01",
    "BMR": "BTP.85.15-15LaE Ed. 15",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs Private Limited",
    "Batchsize": "1.500.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64962.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PANTO-009",
    "ProcessValidationReport": "PRVR/BTP.85.15-15LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTP.85.15-15LaE/22/01",
    "BMR": "BTP.85.15-15LaE Ed. 15",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Nosch Labs Private Limited",
    "Batchsize": "1.500.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.09.2022",
    "comments": "17.06.24 MaWa: refer to TPL Baddi reply on 17.06.24 - Process validation BTP.85.15-15LaE is applicable for BTP.141.00-15LaE/00"
  },
  {
    "Status": "QP Approval",
    "Productname": "Pantoprazol Heumann 40 mg magensaftresistente Tabletten",
    "Dosageform": "TMR",
    "MA_No": "64962.00.00",
    "CMOSite": "Advance Pharma GmbH",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Advance-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.01.2022",
    "comments": "Obsolete as per CC-23-0164"
  },
  {
    "Status": "Invalid",
    "Productname": "Paracetamol Tablets 500mg",
    "Dosageform": "FTA",
    "MA_No": "3599.99.98",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PARA-001",
    "ProcessValidationReport": "F/PPQR/HPB/M/001-00",
    "ProcessValidationProtocol": "F/PPQP/HPB/01/2015-00",
    "BMR": "ATH/HPB/M/001-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Farmson Pharmaceutical Gujarat (Unit I)",
    "Batchsize": "4.800.000 Tablets",
    "Process": "Granulation and Compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2022",
    "comments": "27.02.24 MaWa: According to audit findings (07.12.23) process validation and PVR are not applicable for Heumann product"
  },
  {
    "Status": "QP Approval",
    "Productname": "Paracetamol Tablets 500mg",
    "Dosageform": "FTA",
    "MA_No": "3599.99.98",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "NA",
    "MPVReviewNo": "MPV-PARA-002",
    "ProcessValidationReport": "PPQR/ATH/ILW/2024/00\nF/PPQR/HPB/01/2015-00",
    "ProcessValidationProtocol": "PPQP/ATH/ILQ/2024/00\nF/PPQP/HPB/01/2015-00",
    "BMR": "ATH/JAP/M//001-00\nATH/ILW/M/002-02\nATH/HPB/M/001-00",
    "Reason_for_validation": "batch size\nEquipment",
    "API_Manufacturer": "Farmson Pharmaceutical Gujarat (Unit I)\nSri Krishna Pharmaceuticals Limited, India",
    "Batchsize": "4,800,000 tablets",
    "Process": "ILW: Compression\nHPB: Granulation Compression Coating",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "NA",
    "Completed": "20.03.2024",
    "comments": "PV found to be acceptable in combination with DEV-01165"
  },
  {
    "Status": "QP Approval",
    "Productname": "Paracetamol Tablets 500mg",
    "Dosageform": "FTA",
    "MA_No": "3599.99.98",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "DEV-01165",
    "MPVReviewNo": "MPV-PARA-003",
    "ProcessValidationReport": "GNR/MIS-111/00/24",
    "ProcessValidationProtocol": "GNP/MIS-111/00/24",
    "BMR": "JAP4001",
    "Reason_for_validation": "",
    "API_Manufacturer": "IPCA Laboratories Limited -Athal",
    "Batchsize": "4.800.000",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "21.03.2024",
    "Due_Date": "31.10.2024",
    "Completed": "06.02.2025",
    "comments": "26.06.24: Pending PO list --> expected delivery date: 31.10.24\n15.07.24: Export Production Order (EPO) is now available and verification activity shall be performed within next couple of days and same shall be completed as per given timeline.\n05.09.24: Reminder (AT)"
  },
  {
    "Status": "Open",
    "Productname": "Paracetamol Tablets 500mg",
    "Dosageform": "FTA",
    "MA_No": "3599.99.98",
    "CMOSite": "IPCA Laboratories Limited - Athal",
    "Country": "Non-EU",
    "Reference": "CR-02317",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "API",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "20.03.2025",
    "Due_Date": "16.10.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Posaconazole 100 mg Gastro-resistant Tablets",
    "Dosageform": "GRT",
    "MA_No": "2202579.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-POSA-001",
    "ProcessValidationReport": "PVR.Aİ.1890.001/00",
    "ProcessValidationProtocol": "PVP.Aİ.1890.001/00",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "99.000 kg / 110 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.10.2020",
    "comments": "Batch record number not referenced in documentation"
  },
  {
    "Status": "Documents requested",
    "Productname": "Posaconazole 100 mg Gastro-resistant Tablets",
    "Dosageform": "GRT",
    "MA_No": "2202579.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "",
    "Reference": "CR-01727\nCR-01527",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "27.08.2024",
    "Due_Date": "30.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVP und PVR angefragt Dfo\n27.03.25: Antwort von Ipek: The PVP and PVR have been requested by our Production Science & Technology team and will be shared with you once we receive their revert."
  },
  {
    "Status": "TBD",
    "Productname": "Posaconazole 100 mg Gastro-resistant Tablets",
    "Dosageform": "GRT",
    "MA_No": "2202579.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "CR-00862",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "08.12.2023",
    "Due_Date": "30.08.2024",
    "Completed": "",
    "comments": "12.08.24: documents requested; Reply: The first series of validation studies has been completed. We plan to start the 2nd and 3rd series this month.\n10.12.24 auf TBD gesetzt Dfo + Mwa (  Vorangegangene Validierung lt. Historie)"
  },
  {
    "Status": "TBD",
    "Productname": "Posaconazole 100 mg Gastro-resistant Tablets",
    "Dosageform": "GRT",
    "MA_No": "2202579.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "CR-01527",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "04.07.2024",
    "Due_Date": "28.10.2024",
    "Completed": "",
    "comments": "10.12.24 auf TBD gesetzt Dfo + Mwa ( vorangegangene Validierung lt. Historie)"
  },
  {
    "Status": "TBD",
    "Productname": "Posaconazole 100 mg Gastro-resistant Tablets",
    "Dosageform": "GRT",
    "MA_No": "2202579.00.00",
    "CMOSite": "Abdi Ibrahim Ilac San A.S.",
    "Country": "Non-EU",
    "Reference": "CR-01491",
    "MPVReviewNo": "MPV-POSA-003",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "23.05.2024",
    "Due_Date": "30.10.2024",
    "Completed": "",
    "comments": "04.03.25 MaWa Neue Validierung geplant lt CMO, da probleme in API grad bei Validierung in MPV-POSA-003 aufgetreten. In Klärung, was mit Validierungschargen passiert ist"
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Common Blend for Prasugrel Heumann 5mg FTA / 10mg FTA",
    "Dosageform": "blend",
    "MA_No": "7008123.00.00\n7008124.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRAS-001",
    "ProcessValidationReport": "F1/VR/000597",
    "ProcessValidationProtocol": "ALP7F/PVP/3007-00",
    "BMR": "F1/VNR/00225-2.0.",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceuticals Limited (API Unit III)",
    "Batchsize": "39,586 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7008124.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRAS-003",
    "ProcessValidationReport": "F1/VR/000628 1.0",
    "ProcessValidationProtocol": "ALP/F/PVP/3009-00",
    "BMR": "F1/BMR/00322-2.0\nALPBMR3278-05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceuticals Limited",
    "Batchsize": "170,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7008124.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRAS-004",
    "ProcessValidationReport": "F1/VR/000626 1.0",
    "ProcessValidationProtocol": "ALP/F/PVP/3143-00",
    "BMR": "F1/BMR/00323-2.0\nALPBMR3284-05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceuticals Limited",
    "Batchsize": "217,500 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99799.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7008123.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRAS-002",
    "ProcessValidationReport": "F1/VR/000625 1.0",
    "ProcessValidationProtocol": "ALP/F/PVP/30088-00",
    "BMR": "F1/BMR/00511  & 1.0\nALPBMR3277-04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Pharmaceuticals Limited",
    "Batchsize": "95,010 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Prasugrel Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99798.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Pravastatin Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "62051.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRA-003",
    "ProcessValidationReport": "VR/MFC/4004430/01",
    "ProcessValidationProtocol": "PV/MFC/4004430/00",
    "BMR": "BTP.34.11-5LaE, Edition 11",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "500 000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pravastatin Heumann 20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "62051.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRA-002",
    "ProcessValidationReport": "VR/MFC/4004431/01",
    "ProcessValidationProtocol": "PV/MFC/4004431/00",
    "BMR": "BTP.35.09-12.5LaE, Edition 9",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "1 250 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pravastatin Heumann 40 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "62051.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRA-001",
    "ProcessValidationReport": "VR/MFC/4004432/01",
    "ProcessValidationProtocol": "PV/MFC/4004432/00",
    "BMR": "BTP.36.08-6.25LaE, Edition 8",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "625 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92779.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-008",
    "ProcessValidationReport": "PVR/BCP.97.00-10.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.97.00-10.0LaE/18/01-01",
    "BMR": "BCP.97.00-10.0LaE; edition 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "1.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 100 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92779.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-015",
    "ProcessValidationReport": "PVR/CP.06.02-3E/15 & PVR/CP.49.01-3E/17/01-01",
    "ProcessValidationProtocol": "PV/CP.06.02-3E/15 & PV/CP.49.01-3E/17/01-01",
    "BMR": "CP.06.07-3E/edition 07",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": 300,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 150 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92780.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-009",
    "ProcessValidationReport": "PVR/BCP.98.00-15.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.98.00-15.0LaE/18/01-01",
    "BMR": "BCP.98.00-15.0LaE; edition 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "1500000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 150 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92780.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-016",
    "ProcessValidationReport": "PVR/CP.21.02-6E/15   – Original complete validation for the manufacturing process with capsule filing machine AF – 40\nPRVR/CP.54.01-6E/18/01-01– validation of capsule filing stage with capsule filing machine AF-90 T",
    "ProcessValidationProtocol": "PV/CP.21.02-6E/15 & PRV/CP.54.01-6E/18/01-01",
    "BMR": "CP.21.09-6E; edition 09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "600000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 200 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92781.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-003",
    "ProcessValidationReport": "PVR/CP.07.02-2E/15 & PRVR/CP.53.01-2E/18/01-01",
    "ProcessValidationProtocol": "PV/CP.07.02-2E/15 & PRV/CP.53.01-2E/18/01-01",
    "BMR": "CP.07.06-2E/edition 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": 200,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 200 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92781.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-010",
    "ProcessValidationReport": "PVR/BCP.105.00-2.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.105.00-2.0LaE/18/01-01",
    "BMR": "BCP.105.00-2.0LaE; edition 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "200000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 225 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92782.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-002",
    "ProcessValidationReport": "PV/CP.08.02-2E/15 & PRV/CP.52.01-2E/18/01-01",
    "ProcessValidationProtocol": "PV/CP.08.02-2E/15 & PRV/CP.52.01-2E/18/01-01",
    "BMR": "CP.08.06-2E/edition 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": 200,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 225 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92782.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-011",
    "ProcessValidationReport": "PVR/BCP.106.00-2.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.106.00-2.0LaE/18/01-01",
    "BMR": "BCP.106.00-2.0LaE; edition 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "200000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 25 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92776.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-004",
    "ProcessValidationReport": "PVR/ CP.05.03-4E/15 & PVR/CP.51.01-4E/17/01-01",
    "ProcessValidationProtocol": "PV/CP.05.03-4E/15 & PV/CP.51.01-4E/17/01-01",
    "BMR": "CP.05.08-4E; edition 08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "400000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 25 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92776.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-005",
    "ProcessValidationReport": "PVR/BCP.103.00-20.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.103.00-20.0LaE/18/01-01",
    "BMR": "BCP.103.01-20.0LaE; edition 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "2000000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 300 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92783.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-001",
    "ProcessValidationReport": "PVR/CP.09.04-1.875E/15, SFG Code: 4006676",
    "ProcessValidationProtocol": "PV/CP.09.04-1.875E/15",
    "BMR": "CP.09.07-1.875E/07.2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": 187.5,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 300 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92783.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-012",
    "ProcessValidationReport": "PVR/BCP.107.01-3.75LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.107.01-3.75LaE/19/01-01 – Change of capsule machine (based on deviation)\nPV/BCP.107.00-3.75LaE/18/01-01",
    "BMR": "BCP.107.01-3.75LaE; edition 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "375000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 50 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92777.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-006",
    "ProcessValidationReport": "PVR/BCP.104.00-20.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.104.00-20.0LaE/18/01-01",
    "BMR": "BCP.104.01-20.0LaE; edition 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "2000000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 50 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92777.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-013",
    "ProcessValidationReport": "PVR/ CP.15.02-7E/15 – Original complete validation for the manufacturing process with capsule filing machine AF – 40\nPVR/CP.50.01-7E/17/01-01– validation of capsule filing stage with capsule filing machine AF-90 T",
    "ProcessValidationProtocol": "PV/CP.15.02-7E/15 & PV/CP.50.01-7E/17/01-01",
    "BMR": "CP.15.07-7E; edition 07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "700000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 75  mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92778.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-007",
    "ProcessValidationReport": "PVR/BCP.96.00-30.0LaE/19/01-01",
    "ProcessValidationProtocol": "PV/BCP.96.00-30.0LaE/18/01-01",
    "BMR": "BCP.96.01-30.0LaE; edition 01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "3000000 Capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Pregabin 75  mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "92778.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRE-014",
    "ProcessValidationReport": "PVR/CP.17.02-8E/15 & PVR/CP.48.01-8E/17/01-01",
    "ProcessValidationProtocol": "PV/CP.17.02-8E/15 & PV/CP.48.01-8E/17/01-01",
    "BMR": "CP.17.08-8E; edition 08.3",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "800000 Capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Propafenon 150 Heumann",
    "Dosageform": "FTA",
    "MA_No": "11108.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRO-001",
    "ProcessValidationReport": "PVR/BTP.47.04-6LaE/18/01-01 & VR/MFC/4001510/01",
    "ProcessValidationProtocol": "PRV/BTP.47.04-6LaE/17/01-01 & PV/MFC/4001510/00",
    "BMR": "BTP.47.06-6LaE; edition 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Procos SPA",
    "Batchsize": "600000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.08.2020",
    "comments": "PVR/BTP.47.04-6LaE/18/01-01 : Revalidation of coating state for change of Auto coater F/TCM-09\nVR/MFC/4001510/01 : Original process validation with auto coater F/TCM-03"
  },
  {
    "Status": "QP Approval",
    "Productname": "Propafenon 150 Heumann",
    "Dosageform": "FTA",
    "MA_No": "11108.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRO-003",
    "ProcessValidationReport": "PRVR/BTP.136.00-3LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTP.136.00-3LaE/23/01",
    "BMR": "BTP.136.00-3LaE/23/01\nBTP.136.01-31LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Procos SPA",
    "Batchsize": "300,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Propafenon 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "11108.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRO-002",
    "ProcessValidationReport": "VR/MFC/4001511/01",
    "ProcessValidationProtocol": "PV/MFC/4001511/00",
    "BMR": "BTP.48.05-6.2LaE; Edition 05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Procos SPA",
    "Batchsize": "620 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Propafenon 300 Heumann",
    "Dosageform": "TAB",
    "MA_No": "11108.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-PRO-004",
    "ProcessValidationReport": "PRVR/BTP.137.00-1.5LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTP.137.00-1.5LaE/23/01",
    "BMR": "BTP.137.00-1.5LaE\nBTP.137.01-1.5LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Procos SPA",
    "Batchsize": "150,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.09.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79952.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-014",
    "ProcessValidationReport": "PVR/BTQ.172.02-5E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.172.01-5E/20/01-01 and PV/BTQ.172.02-5E/20/01-02",
    "BMR": "BTQ.172.03-5E",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.04.21",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79952.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-017",
    "ProcessValidationReport": "PVR/BTQ.172.02-5E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.172.01-5E/20/01-01 and  PV/BTQ.172.02-5E/20/01-02",
    "BMR": "BTQ.178.01-5E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "500 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.10.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79952.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-024",
    "ProcessValidationReport": "PPQR/BTQ.187.01-10E/23/01",
    "ProcessValidationProtocol": "PPQP/BTQ.187.01-10E/23/01",
    "BMR": "BTQ.187.01-10E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "1,000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79953.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-011",
    "ProcessValidationReport": "PVR/BTQ.175.01-3.5E/20/01-01",
    "ProcessValidationProtocol": "PV/BTQ.175.01-3.5E/20/01-01",
    "BMR": "BTQ.175.01-3.5E Ed 01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "350,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.12.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79953.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00145",
    "MPVReviewNo": "MPV-QUE-025",
    "ProcessValidationReport": "PPQR/BTQ.192.01-7E/24/01",
    "ProcessValidationProtocol": "PPQP/BTQ.192.01-7E/24/01",
    "BMR": "BTQ.192.01-7E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "700,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.08.2024",
    "Due_Date": "11.11.2024",
    "Completed": "11.09.24",
    "comments": "documents on sharepoint"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 150 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79953.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01125",
    "MPVReviewNo": "MPV-QUE-025",
    "ProcessValidationReport": "PPQR/BTQ.192.01-7E/24/01",
    "ProcessValidationProtocol": "PPQP/BTQ.192.01-7E/24/01",
    "BMR": "BTQ.192.01-7E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "700,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.08.2024",
    "Due_Date": "28.03.2025",
    "Completed": "11.09.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79954.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-012",
    "ProcessValidationReport": "PVR/BTQ.174.02-2.5E/20/01-01",
    "ProcessValidationProtocol": "PV/BTQ.174.02-2.5E/20/01-01 and PV/BTQ.174.01-2.5E/20/01-01",
    "BMR": "BTQ.174.03-2.5E ed 03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "250,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 200 mg Filmtabletten",
    "Dosageform": "TAB",
    "MA_No": "79954.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-021",
    "ProcessValidationReport": "PVR/BTQ.174.02-2.5E/20/01-01",
    "ProcessValidationProtocol": "PV/BTQ.174.01-2.5E/20/01-01 & PV/BTQ.174.02-2.5E/20/01-02",
    "BMR": "BTQ.180.01-2.5E Edition No. 01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "250 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.07.2022",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Quetiapin Heumann 200 mg Filmtabletten",
    "Dosageform": "TAB",
    "MA_No": "79954.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01512",
    "MPVReviewNo": "MPV-QUE-027",
    "ProcessValidationReport": "PPQR/BTQ.194.01-5.5E/24/01",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": "13.02.2025: PVP muss angefordert werden"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79950.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-010",
    "ProcessValidationReport": "PRVR/BTQ.173.01-2.5E/20/01-01",
    "ProcessValidationProtocol": "PRV/ BTQ.173.01-2.5E/20/01-01",
    "BMR": "BTQ.173.01-2.5E ed 02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "250,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79950.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-018",
    "ProcessValidationReport": "PVR/BTQ.176.01-20E/21/01-01",
    "ProcessValidationProtocol": "PV/BTQ.176.01-20E/20/01-01",
    "BMR": "BTQ.176.01-20E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "2000000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.12.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79950.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-019",
    "ProcessValidationReport": "PRVR/BTQ.173.01-2.5E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.173.01-2.5E/20/01-01",
    "BMR": "BTQ.179.01-2.5E, Edition No. 01",
    "Reason_for_validation": "API",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "250 0 00 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.03.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79950.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-022",
    "ProcessValidationReport": "PPQR/BTQ.182.01-20E/23/01",
    "ProcessValidationProtocol": "PPQP/BTQ.182.01-20E/23/01",
    "BMR": "BTQ.182.01-20E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "2,000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79955.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-013",
    "ProcessValidationReport": "PRVR/BTQ.171.01-1.25E/20/01-01",
    "ProcessValidationProtocol": "PRV/ BTQ.171.01-1.25E/20/01-01",
    "BMR": "BTQ.171.02-1.25E ed 02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "125,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79955.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-016",
    "ProcessValidationReport": "PRV/BTQ.171.01-1.25E/20/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.171.01-1.25E/20/01-01",
    "BMR": "BTQ.177.01-1.25E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "CTX Life Sciences Pvt. Ltd.",
    "Batchsize": "125 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.10.2021",
    "comments": ""
  },
  {
    "Status": "Invalid",
    "Productname": "Quetiapin Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79955.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00409",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "26.10.2023",
    "Due_Date": "28.06.2024",
    "Completed": "12.08.2024",
    "comments": "11.06.24: Quetiapine fumarate tablets 300 mg [4014547] No BMR/PPQ/PPQ report was prepared and relevant change control is closed as all action was not implemented."
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79955.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00145",
    "MPVReviewNo": "MPV-QUE-026",
    "ProcessValidationReport": "PPQR/BTQ.191.01-3.5E/24/01",
    "ProcessValidationProtocol": "PPQP/BTQ.191.01-3.5E/24/01",
    "BMR": "BTQ.191.01-3.5E",
    "Reason_for_validation": "API\nBatchsize",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "350,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "15.08.2024",
    "Due_Date": "11.11.2024",
    "Completed": "11.09.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 300 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79955.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01125",
    "MPVReviewNo": "MPV-QUE-026",
    "ProcessValidationReport": "PPQR/BTQ.191.01-3.5E/24/01",
    "ProcessValidationProtocol": "PPQP/BTQ.191.01-3.5E/24/01",
    "BMR": "BTQ.191.01-3.5E",
    "Reason_for_validation": "API\nBatchsize",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "350,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.08.2024",
    "Due_Date": "28.03.2025",
    "Completed": "11.09.24",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79956.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-015",
    "ProcessValidationReport": "PRVR/BTQ.168.01-1.25E/19/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.168.01-1.25E/18/01-01",
    "BMR": "BTQ-167.02-1.25E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "125,000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.04.21",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Quetiapin Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79956.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "",
    "Reference": "CR-01125",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "30.08.2024",
    "Due_Date": "28.03.2025",
    "Completed": "",
    "comments": "25.10.24 MaWa: neuer Change CCF/B/2023/0571; Dokumente angefragt (auch für 150mg und 300mg, da von Change betroffen)                                                                  06.11.2024 Dfo:Reminder zu Quetiapin 400mg                                                                   07.11.24DFo:Till date remaining two PPQ batches are not manufactured. So PPQ report will be concluded after execution of remaining two batches. (siehe Mail von Ruta Modh )\n10.12.24 nach aktuellen status angefragt DFo"
  },
  {
    "Status": "TBD",
    "Productname": "Quetiapin Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79956.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "",
    "Reference": "CR-00145\nCR-01125",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.08.2024",
    "Due_Date": "11.11.2024",
    "Completed": "",
    "comments": "25.10.24 MaWa: neuer Change CCF/B/2023/0571; Dokumente angefragt (auch für 150mg und 300mg, da von Change betroffen)                                                                  06.11.2024 Dfo:Reminder zu Quetiapin 400mg                                                                   07.11.24DFo:Till date remaining two PPQ batches are not manufactured. So PPQ report will be concluded after execution of remaining two batches. (siehe Mail von Ruta Modh )\n10.12.24 nach aktuellen Status angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79951.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-009",
    "ProcessValidationReport": "PVR/BTQ.166.01-10E/17/01-01",
    "ProcessValidationProtocol": "PV/BTQ.166.01-10E/17/01-01",
    "BMR": "BTQ.166.02-10E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,000,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79951.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-020",
    "ProcessValidationReport": "PRVR/BTQ.166.05-10E/22/01-01",
    "ProcessValidationProtocol": "PRV/BTQ.166.05-10E/21/01-01",
    "BMR": "BTQ.166.05-10E, Edition No. 05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1,000,000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.06.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "79951.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-023",
    "ProcessValidationReport": "PPQR/BTQ.186.01-20E/23/01",
    "ProcessValidationProtocol": "PPQP/BTQ.186.01-20E/23/01",
    "BMR": "BTQ.186.01-20E",
    "Reason_for_validation": "API",
    "API_Manufacturer": "M/S Nosh Labs Private Limited",
    "Batchsize": "2,000,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 150 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200856.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "1. QRC-QA-001-QUE/GRA/150/2007300/400, Version: 001\n2. QRC-QA-001-QUE/150/560K/TC, Version: 001 (Compression – Coating)\n3. REP-QA-001-QUE/150/560K/TAB6 (alternative Tabletting Machine)",
    "ProcessValidationProtocol": "1. QPR-QC-001-QUE/ GRA/150/2007300/400, Version: 001\n2. QPR-QC-001-QUE/150/560K/TC, Version: 001\n3. QPR-QC-001-QUE/150/560K/TAB6, Version: 001",
    "BMR": "TDR-PR-022-00700 / 560K / Version 6 / 21-06-2019",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "560.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2020\n11.02.2020",
    "comments": "Covers compression machines no. PHI3-TAB-003, PHI3-TAB-005 and PHI3-TAB-006; PHI3-TAB-004 not validated but also covered (same principles as PHI3-TAB-005); Reason_for_validation: new batch size + new granulation machine + new tabletting machine; TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 150 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200856.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-QUE/150/200/300/400/GRA4, Version: 001 (10-09-2018)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/150/200/300/400/GRA4, Version 001 (25-05-2018)",
    "BMR": "TDR-PR-022-00700 / 560K",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "220.600,8 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 150 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200856.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 200 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200857.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "1. QRC-QA-001-QUE/GRA/150/2007300/400, Version: 001\n2. QRC-QA-001-QUE/200/420K/TC, Version: 001 (Compression – Coating)",
    "ProcessValidationProtocol": "1. QPR-QC-001-QUE/ GRA/150/2007300/400, Version: 001\n2. QPC-QA-001-QUE/200/420K/TC, Version: 001",
    "BMR": "TDR-PR-022-00701 / 420K / Version 5 / 27-09-2018",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "420.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2020\n11.02.2020",
    "comments": "Covers compression machine no. PHI3-TAB-003 and PHI3-TAB-004; Reason_for_validation: new batch size + new granulation machine,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 200 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200857.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-QUE/150/200/300/400/GRA4, Version: 001 (10-09-2018)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/150/200/300/400/GRA4, Version 001 (25-05-2018)",
    "BMR": "TDR-PR-022-00701 / 420K",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "220.600,8 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 200 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200857.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-006\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-QUE/200/TAB6, Version 001 (08-03-2016)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/200/TAB6, Version 001 (23-12-2015)",
    "BMR": "TDR-PR-022-00701/420K, Version 005 (27-09-2018)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "420.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.02.2020\n11.02.2020",
    "comments": "Covers compression machine no. PHI3-TAB-006, Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 200 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200857.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 300 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200858.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "1. QRC-QA-001-QUE/GRA/150/2007300/400, Version: 001\n2. QRC-QA-001-QUE/300/ Version: 001 (Compression – Coating)",
    "ProcessValidationProtocol": "1. QPR-QC-001-QUE/ GRA/150/2007300/400, Version: 001\n2. QPC-QA-001-QUE/300, Version: 002",
    "BMR": "TDR-PR-022-01042 / GRA2 / Version 5 / 26-09-2018",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "280.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Covers compression machine no. PHI3-TAB-003 and PHI3-TAB-004; Reason_for_validation: new batch size + new granulation machine,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 300 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200858.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-QUE/150/200/300/400/GRA4, Version: 001 (10-09-2018)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/150/200/300/400/GRA4, Version 001 (25-05-2018)",
    "BMR": "TDR-PR-022-01042 / GRA2",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "220.600,8 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 300 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200858.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-007\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPC-QA-001-QUE/300/TAB6, Version 001 (22-12-2015)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/300/TAB6, Version 001 (25-11-2015)",
    "BMR": "TDR-PR-022-01042\nTDR-PR-022-01042 / GRA2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "280.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Covers compression machine no. PHI3-TAB-006, Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 300 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200858.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 400 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200859.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "1. QRC-QA-001-QUE/GRA/150/2007300/400, Version: 001\n2. QRC-QA-001-QUE/400, Version: 001 (Compression – Coating)",
    "ProcessValidationProtocol": "1. QPR-QC-001-QUE/ GRA/150/2007300/400, Version: 001\n2. QPC-QA-001-QUE/400, Version: 002",
    "BMR": "TDR-PR-022-00702 / GRA2 / Version 6 / 25-09-2018",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "210.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Covers compression machines no. PHI3-TAB-005; PHI3-TAB-003 and PHI3-TAB-004 not validated but also covered (same principles as PHI3-TAB-005); Reason_for_validation: new batch size + new granulation machine + new tabletting machine; TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 400 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200859.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-005\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-QUE/150/200/300/400/GRA4, Version: 001 (10-09-2018)",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/150/200/300/400/GRA4, Version 001 (25-05-2018)",
    "BMR": "TDR-PR-022-00702 / GRA2",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "220.600,8 g",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 400 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200859.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-QUE-008\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-QUE/400/TAB6, Version: 001, 29.03.2016",
    "ProcessValidationProtocol": "QPR-QC-001-QUE/400/TAB6, Version: 001, 25.11.2015",
    "BMR": "TDR-PR-022-00702 / GRA2",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Moehs Cantabra S.L.",
    "Batchsize": "210.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.02.2020\n11.02.2020",
    "comments": "Covers compression machine no. PHI3-TAB-006, Reason_for_validation: new granulation line,TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 400 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200859.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 50 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200855.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Quetiapin Heumann retard 50 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "2200855.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rasagilin Heumann 1 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "95570.00.00",
    "CMOSite": "Iberfar - Indústria Farmacêutica S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RAS-001",
    "ProcessValidationReport": "RVP 498",
    "ProcessValidationProtocol": "PVP 498",
    "BMR": "MPC/RAS/001-01",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "N/A",
    "Batchsize": "1000000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28. Mai 20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risedronat Heumann 35 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "88133.00.00",
    "CMOSite": "Zaklad Farmaceutyczny \nAdamed Pharma SA",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Adamed-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risperidon Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "64997.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIS-001",
    "ProcessValidationReport": "VR/MFC/4001698/01",
    "ProcessValidationProtocol": "PV/MFC/4001698/00",
    "BMR": "BTR.51.06-8LaE, Edition: 06",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 800,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26. Mai 20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risperidon Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "64998.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIS-002",
    "ProcessValidationReport": "VR/MFC/4000849/01",
    "ProcessValidationProtocol": "PV/MFC/4000849/00",
    "BMR": "BTR.47.09-12LAE 04",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1.200.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risperidon Heumann 2 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "64999.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIS-003",
    "ProcessValidationReport": "VR/BTR.83.00-6.0LaE/17",
    "ProcessValidationProtocol": "PV/BTR.83.00-6.0LaE/16",
    "BMR": "BTR.83.04-6.0LaE, Edition: 04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 600,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risperidon Heumann 3 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "65000.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIS-004",
    "ProcessValidationReport": "VR/BTR.84.00-4.0LaE/17",
    "ProcessValidationProtocol": "PV/BTR.84.00-4.0LaE/16",
    "BMR": "BTR.84.04-4.0LaE, Edition: 04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 400,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Risperidon Heumann 4 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "65001.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIS-005",
    "ProcessValidationReport": "VR/BTR.85.00-3.0LaE/17",
    "ProcessValidationProtocol": "PV/BTR.85.00-3.0LaE/16",
    "BMR": "BTR.85.04-3.0LaE, Edition: 04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 300,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29. Mai 20",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Rivaroxaban 10mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01231\nCR-01867",
    "MPVReviewNo": "MPV-RIVX-01",
    "ProcessValidationReport": "PPQR/BTR.347.03-2E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.347.03-2E/23/01",
    "BMR": "BTR.347.03-2E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Indrad",
    "Batchsize": "200 000 Tabets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.02.2024",
    "Due_Date": "01.01.2026",
    "Completed": "",
    "comments": "Validation documents in CR-01867 (including Granules)\n09.12.24 Laut Launchmeeting :TPL Indrad Jan 2026"
  },
  {
    "Status": "Open",
    "Productname": "Rivaroxaban 15mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01231\nCR-01867",
    "MPVReviewNo": "MPV-RIVX-02",
    "ProcessValidationReport": "PPQR/BTR.348.03-17.5E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.348.03-17.5E/23/01",
    "BMR": "BTR.348.03-17.5E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Indrad",
    "Batchsize": "266 666 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.02.2024",
    "Due_Date": "01.01.2026",
    "Completed": "",
    "comments": "Validation documents in CR-01867 (including Granules)\n09.12.24 Laut Launchmeeting :TPL Indrad Jan 2026"
  },
  {
    "Status": "Open",
    "Productname": "Rivaroxaban 20mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01231\nCR-01867",
    "MPVReviewNo": "MPV-RIVX-03",
    "ProcessValidationReport": "PPQR/BTR.349.03-2E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.349.03-2E/23/01",
    "BMR": "BTR.349.03-2E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent Pharmaceuticals Indrad",
    "Batchsize": "200 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "07.02.2024",
    "Due_Date": "01.01.2026",
    "Completed": "",
    "comments": "Validation documents in CR-01867 (including Granules)\n09.12.24 Laut Launchmeeting :TPL Indrad Jan 2026"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 1,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76254.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-003",
    "ProcessValidationReport": "PVR/CR.07.03-5E/20",
    "ProcessValidationProtocol": "PV/CR.07.03-5E/12",
    "BMR": "CR.07.07-5E/07.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 1,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76254.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-004",
    "ProcessValidationReport": "PRVR/CR..34.01-5E/19/01-01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "CR.07.07-5E/07.1",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "26.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 1,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76254.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIVS-001",
    "ProcessValidationReport": "PPQR/BCR.100.00-5.0LaE/22/01",
    "ProcessValidationProtocol": "PV/BCR.100.00-5.0LaE/22/01-01",
    "BMR": "BCR.100.00-5.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 13,3 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "93709.00.00",
    "CMOSite": "SK Chemicals Co., Ltd., Cheongju plant",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-011",
    "ProcessValidationReport": "CVR-PV(R)-RVP15-20.12",
    "ProcessValidationProtocol": "CVP-PV(R)-RVP15.20.07",
    "BMR": "MF-5064,5065,5066-BR-P",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Shodhana Laboratories Ltd.",
    "Batchsize": "375m²",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.05.2024",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Rivastigmin Heumann 13,3 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "",
    "CMOSite": "AdhexPharma",
    "Country": "EU",
    "Reference": "CR-02324",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.2025",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "15.01.25: CR in assessment\n07.03.25: Nach Protokoll und Bericht angefragt DFO"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 3 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76255.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-001",
    "ProcessValidationReport": "PVR/CR.08.03-5E/13 & PVR/CR.08.03-5E/20",
    "ProcessValidationProtocol": "PV/CR.08.03-5E/12",
    "BMR": "CR.08.09-5E/09.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 3 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76255.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-002",
    "ProcessValidationReport": "PRVR/CR.33.01-5E/19/01-01",
    "ProcessValidationProtocol": "PRV/CR.33.01-5E/18/01-01",
    "BMR": "CR.08.09-5E/09.1",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "05.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 3 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76255.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIVS-002",
    "ProcessValidationReport": "PPQR/BCR.101.00-5.0LaE/22/01",
    "ProcessValidationProtocol": "PV/BCR.101.00-5.0LaE/22/01-01",
    "BMR": "BCR.101.00-5.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 4,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76256.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-005",
    "ProcessValidationReport": "PVR/CR.09.03-5E/20",
    "ProcessValidationProtocol": "PV/CR.09.03-5E/12",
    "BMR": "CR.09.08-5E/08.1",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 4,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76256.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-006",
    "ProcessValidationReport": "PRVR/CR.36.01-5E/18/01-01",
    "ProcessValidationProtocol": "N/A",
    "BMR": "CR.09.08-5E/08.1",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 4,5 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76256.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIVS-003",
    "ProcessValidationReport": "PPQR/BCR.102.00-5.0LaE/22/01",
    "ProcessValidationProtocol": "PV/BCR.102.00-5.0LaE/22/01-01",
    "BMR": "BCR.102.00-5.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 4,6 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "85682.00.00",
    "CMOSite": "SK Chemicals Co., Ltd., Cheongju plant",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-009",
    "ProcessValidationReport": "CVR-PV(R)-RVP5-20.11",
    "ProcessValidationProtocol": "CVR-PV(R)-RVP5-20.07",
    "BMR": "MF-5064,5065,5066-BR-P",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Shodhana Laboratories Ltd.",
    "Batchsize": "375m²",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.05.2024",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Rivastigmin Heumann 4,6 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "",
    "CMOSite": "AdhexPharma",
    "Country": "EU",
    "Reference": "CR-02324",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.2025",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "15.01.25: CR in assessment\n07.03.25: Nach Protokoll und Bericht angefragt DFO"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 6 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76257.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-007",
    "ProcessValidationReport": "PVR/CR.10.03-5E/13 – Batch size 2013\nPRV/CR.35.01-5E/19/01-01 _ Capsule filling",
    "ProcessValidationProtocol": "PRV/CR.35.01-5E/18/01-01",
    "BMR": "CR.35.01-5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.07.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 6 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76257.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-008",
    "ProcessValidationReport": "PVR/CR.10.03-5E/13 & PRVR/ CR.35.01-5E/19/01-01",
    "ProcessValidationProtocol": "PV/'CR.10.03-5E12 (full validation), \nPRV/CR.35.01-5E/18/01-01 (Partial validation)",
    "BMR": "CR.10.09-5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.05.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 6 mg, Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "76257.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIVS-004",
    "ProcessValidationReport": "PPQR/BCR.103.00-5.0LaE/22/01",
    "ProcessValidationProtocol": "PV/BCR.103.00-5.0LaE/22/01-01",
    "BMR": "BCR.103.00-5.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": 500,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rivastigmin Heumann 9,5 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "85683.00.00",
    "CMOSite": "SK Chemicals Co., Ltd., Cheongju plant",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIV-010",
    "ProcessValidationReport": "CVR-PV(R)-RVP10-20.12",
    "ProcessValidationProtocol": "CVP-PV(R)-RVP10-20.07",
    "BMR": "MF-5064,5065,5066-BR-P",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Shodhana Laboratories Ltd.",
    "Batchsize": "375m²",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.05.2024",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Rivastigmin Heumann 9,5 mg / 24 Stunden transdermales Pflaster",
    "Dosageform": "PFL",
    "MA_No": "",
    "CMOSite": "AdhexPharma",
    "Country": "EU",
    "Reference": "CR-02324",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.01.2025",
    "Due_Date": "01.06.2025",
    "Completed": "",
    "comments": "15.01.25: CR in assessment\n07.03.25: Nach Protokoll und Bericht angefragt DFO"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "98854.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIZA-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPR10QC12200461.250-RE / Version 1",
    "ProcessValidationProtocol": "QPR10QC12200461.250 / Version 1",
    "BMR": "TDR09MN12200461.250/ Version 2",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops II",
    "Batchsize": "250.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 10 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "98854.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "98856.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIZA-004\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPR10QC12200459.1 / Version 1",
    "ProcessValidationProtocol": "QPR10QC12200459.1 / Version 1",
    "BMR": "TDR09MN12200459.1 / Version 4",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops II",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.08.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 10 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "98856.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "98853.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIZA-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPR10QC12200460.1-RE / Version 001",
    "ProcessValidationProtocol": "QPR10QC12200460.1 / Version 1",
    "BMR": "TDRMN1212201355 / Version 001",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops II",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.07.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 5 mg Schmelztabletten",
    "Dosageform": "SMT",
    "MA_No": "98853.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "98855.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-RIZA-003\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QPR10QC12200458.1 / Version 1",
    "ProcessValidationProtocol": "QPR10QC12200458.1 / Version 1",
    "BMR": "TDR09MN12200458.1 / Version 4",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dr Reddy's Laboratories Ltd., Chemical Tech Ops II",
    "Batchsize": "100.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.08.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rizatriptan Heumann 5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "98855.00.00",
    "CMOSite": "Pharmathen S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Heumann 250 Mikrogramm Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004658.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-002",
    "ProcessValidationReport": "PVR/BTR.94.01-2.0LaE/20/01-01",
    "ProcessValidationProtocol": "PV/BTR.94.01-2.0LaE/20/01-01",
    "BMR": "BTR.94.01-2.0LaE\nBTR.94.03-2.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Private Limited",
    "Batchsize": "200,000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.10.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Heumann 250 Mikrogramm Tabletten",
    "Dosageform": "TAB",
    "MA_No": "7004658.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-004",
    "ProcessValidationReport": "PRVR/BTR.110.00-2.0LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTR.110.00-2.0LaE/22/01",
    "BMR": "BTR.110.00-2.0LaE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "200,000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.08.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Heumann 500 Mikrogramm Filmtabletten",
    "Dosageform": "FCT",
    "MA_No": "2203311.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-001",
    "ProcessValidationReport": "PVR/BTS.97.02-109.215KgE /20/01-01 – Granules\nPVR/BTR.87.02-4.5LaE/20/01-01 – Tablets",
    "ProcessValidationProtocol": "PRV/BTS.97.02-109.215KgE /20/01-01 - Granules\nPRV/BTR.87.02-4.5LaE /20/01-01 - Tablets",
    "BMR": "BTS.97.02-109.215KgE  Edition: 2 – Granules, BTR.87.02-4.5LaE  Edition: 2- Tablet",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "109.215 Kg Granules (SFG: 4011095)   450000 Tab (SFG: 4010890)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2021",
    "comments": "Launch,    Validation for commercialization based on approval and regulatory requirement"
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Heumann 500 Mikrogramm Filmtabletten",
    "Dosageform": "FCT",
    "MA_No": "2203311.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-007",
    "ProcessValidationReport": "PRVR/BTR.111.00-4.5LaE/22/01",
    "ProcessValidationProtocol": "PRVP/BTR.111.00-4.5LaE/22/01",
    "BMR": "BTR.111.00-4.5LaE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "450.000 tablets",
    "Process": "Compression & coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.02.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Sized Granules for Roflumilast 250mcg tablets",
    "Dosageform": "GRA",
    "MA_No": "7004658.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-003",
    "ProcessValidationReport": "PVR/BTS.114.00-24.270kgE/20/01-02",
    "ProcessValidationProtocol": "PV/BTS.114.00-24.270kgE/20/01-01",
    "BMR": "BTS.114.00-24.270kgE\nBTS.114.02-24.270kgE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Private Limited",
    "Batchsize": "24270kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.10.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Sized Granules for Roflumilast 250mcg tablets",
    "Dosageform": "GRA",
    "MA_No": "7004658.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-005",
    "ProcessValidationReport": "PRVR/BTS.130.00-24.270kgE",
    "ProcessValidationProtocol": "PRVP/BTS.130.00-24.270kgE",
    "BMR": "BTS.130.0024270kgE",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "24270kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.08.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roflumilast Sized Granules for Roflumilast 500mcg tablets",
    "Dosageform": "GRA",
    "MA_No": "2203311.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROF-006",
    "ProcessValidationReport": "PRVR/BTS.131.00-109.215KgE/22/01",
    "ProcessValidationProtocol": "PRVP/BTS.131.00-109.215KgE/22/01",
    "BMR": "BTS.131.00-109.215KgE",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "109215kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.02.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 0,25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69050.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROP-001",
    "ProcessValidationReport": "PVR/BTR.118.02-8E/13",
    "ProcessValidationProtocol": "PV/BTR.118.02-8E/12",
    "BMR": "BTR.118.04-8E, edition 04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 0,25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69050.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPI-006",
    "ProcessValidationReport": "PRVR/BTR.324.01-8E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTR.324.01-8E/21/01-01",
    "BMR": "BTR.118.06-8E, Edition No. 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.05.2022",
    "comments": "Validation Report was initiated for usage of compression machine ID No. TC 107 and TC 138 (Make: Fette) instead of compression machine TC 27 and TC 67 (Make: Cadmach) for batch size of 800 000 tablets for Europe Market."
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69051.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROP-002",
    "ProcessValidationReport": "PVR/BTR.120.02-8E/13",
    "ProcessValidationProtocol": "PV/BTR.120.02-8E/12",
    "BMR": "BTR.120.05-8E, edition 05",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.05.2020",
    "comments": "Validation Report was initiated for usage of compression machine ID No. TC 107 and TC 138 (Make: Fette) instead of compression machine TC 27 and TC 67 (Make: Cadmach) for batch size of 800 000 tablets for Europe Market."
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69051.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPI-005",
    "ProcessValidationReport": "PRVR/BTR.325.01-8E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTR.325.01-8E/21/01-01",
    "BMR": "BTR.120.07-8E, Edition No. 07",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.05.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 0,5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69051.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01484",
    "MPVReviewNo": "MPV-ROP-008",
    "ProcessValidationReport": "PPQR/BTR.362.01-16E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.362.01-16E/24/01",
    "BMR": "BTR.362.01-16E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceutical Ltd.",
    "Batchsize": "1 600 000 Tablets",
    "Process": "entire process",
    "OOX": "Na",
    "Receipt_Date": "18.10.2024",
    "Due_Date": "16.05.2025",
    "Completed": "06.03.2025",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n05.03.25: Bericht und Protokoll erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69052.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROP-003",
    "ProcessValidationReport": "PVR/BTR.122.02-8E/13",
    "ProcessValidationProtocol": "PV/BTR.122.02-8E/12",
    "BMR": "BTR.122.04-8E edition 04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69052.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPI-004",
    "ProcessValidationReport": "PRVR/BTR.322.01-8E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTR.322.01-8E/21/01-01",
    "BMR": "BTR.122.06-8E, Edition No. 06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.08.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 1 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69052.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01484",
    "MPVReviewNo": "MPV-ROP-009",
    "ProcessValidationReport": "PPQR/BTR.365.01-16E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.365.01-16E/24/01",
    "BMR": "BTR.365.01-16E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceutical Ltd.",
    "Batchsize": "1 600 000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "18.10.2024",
    "Due_Date": "16.05.2025",
    "Completed": "06.03.2025",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n05.03.25: Bericht und Protokoll erhalten Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 2 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69053.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROP-004",
    "ProcessValidationReport": "PVR/BTR.124.02-8E/13",
    "ProcessValidationProtocol": "PV/BTR.124.02-8E/12",
    "BMR": "BTR.124.06-8E, edition 06",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann 2 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "69053.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPI-007",
    "ProcessValidationReport": "PRVR/BTR.326.01-8E/21/01-01",
    "ProcessValidationProtocol": "PRV/BTR.326.01-8E/21/01-01",
    "BMR": "BTR.124.08-8E, Edition No. 08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "800.000 tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.05.2022",
    "comments": "Validation Report was initiated for usage of compression machine ID No. TC 107 and TC 138 (Make: Fette) instead of compression machine TC 27 and TC 67 (Make: Cadmach) for batch size of 800 000 tablets for Europe Market."
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 2 mg Retardtabletten",
    "Dosageform": "",
    "MA_No": "90641.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPR-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "QRC-QA-001-ROP/INS/GRA, Version 002",
    "ProcessValidationProtocol": "QPR-QC-001-ROP/INS/GRA, Version 001",
    "BMR": "TDR-PR-022-01052",
    "Reason_for_validation": "",
    "API_Manufacturer": "Ind Swift Laboratories Limited",
    "Batchsize": "60 kg granules",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020, common blend is used for all strengths of Ropinirol"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 2 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90641.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-00537 / Version 03",
    "Reason_for_validation": "",
    "API_Manufacturer": "Ind Swift Laboratories Limited",
    "Batchsize": "400.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 2 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90641.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01052 / Version 002 / 12-11-2018",
    "Reason_for_validation": "",
    "API_Manufacturer": "Ind Swift Laboratories Limited",
    "Batchsize": "400.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 2 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90641.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 4 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90642.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROPR-002\nPVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01054 / Version 2",
    "Reason_for_validation": "",
    "API_Manufacturer": "Ind Swift Laboratories Limited",
    "Batchsize": "200.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 4 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90642.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 8 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90643.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "TDR-PR-022-01055 / Version 4 / 17-09-2018",
    "Reason_for_validation": "",
    "API_Manufacturer": "Ind Swift Laboratories Limited",
    "Batchsize": "100.000 tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Ropinirol Heumann retard 8 mg Retardtabletten",
    "Dosageform": "RET",
    "MA_No": "90643.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-002",
    "ProcessValidationReport": "PV/BTR.158.02-7.5E/14",
    "ProcessValidationProtocol": "",
    "BMR": "BTR.158.04-7.5E Ed. No. 4.3",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd",
    "Batchsize": "750 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.09.2021",
    "comments": "Last released 07/10/2019, Expires Dez 21"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-006",
    "ProcessValidationReport": "PRVR/BTR.158.06.-7.5E/23/01",
    "ProcessValidationProtocol": "PRVP/BTR.158.06.7.5E/22/01",
    "BMR": "BTR.158.06-7.5E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd",
    "Batchsize": "750 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.07.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-011",
    "ProcessValidationReport": "PPQR/BTR.161.02-12.5E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.161.02.12.5E/24/01",
    "BMR": "BTR.161.02-12.5E\nBTR.161.03-12.5E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "1,250,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2024",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Rosuvastatin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89322.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-02630",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "21.02.2025",
    "Due_Date": "13.06.2026",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89323.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-003",
    "ProcessValidationReport": "PVR/BTR.156.02-4E/14",
    "ProcessValidationProtocol": "PV/BTR.156.02-4E/14",
    "BMR": "BTR.156.03-4E, Ed. No. 3.6",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd",
    "Batchsize": "400 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.09.2021",
    "comments": "Last released 08/11/2019, Expires Mrz 22"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89323.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-007",
    "ProcessValidationReport": "PRVP/BTR.156.05-4E/23/01",
    "ProcessValidationProtocol": "PRVP/BTR.156.05-4E/22/01",
    "BMR": "BTR.1156.05-4E",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd",
    "Batchsize": "400 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.07.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89323.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-010",
    "ProcessValidationReport": "PPQR/BTR.155.02-8E/24/01",
    "ProcessValidationProtocol": "PPQP/BTR.155.02-8E/24/01",
    "BMR": "BTR.155.02-8E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "800,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.05.2024",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Rosuvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89323.00.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-02630",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "21.02.2025",
    "Due_Date": "13.06.2026",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89324.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-004",
    "ProcessValidationReport": "PVR/BTR.251.01-1.25E/14",
    "ProcessValidationProtocol": "PV/BTR.251.01-1.25E/14",
    "BMR": "BTR.251.03-1.25E, Edition No. 03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "125 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.05.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89324.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-009",
    "ProcessValidationReport": "PPQR/BTR.157.02-8E/23/01",
    "ProcessValidationProtocol": "PPQP/BTR.157.02-8E/23/01",
    "BMR": "BTR.157.02-8E/23/01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "800,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.08.2023",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Rosuvastatin Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89324.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-01075",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "15.04.2024",
    "Due_Date": "17.01.2025",
    "Completed": "",
    "comments": "angefragt 30.10.2024 Dfo, Reminder am 13.11.2024 geschickt , Keine Antwort daher am 22.11 .24nochmals angefragt ( anderer Kontakt, Kamini Shah + Hinal Patel)\n28.11.24 warten auf Antwort von Subba Ji ( siehe Mail von Kamini) Dfo\n10.12.24 auf TBD gesetzt DFo + MWa"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-005",
    "ProcessValidationReport": "PVR/BTR.254.01-2E/14",
    "ProcessValidationProtocol": "PV/BTR.254.01-2E/14",
    "BMR": "BTR.254.04-2E, Edition No. 04",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "200 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.06.2022",
    "comments": "Product on market expired, awaiting release"
  },
  {
    "Status": "QP Approval",
    "Productname": "Rosuvastatin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "89321.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROS-008",
    "ProcessValidationReport": "PPQR/BTR.160.02-12.5E/23/01",
    "ProcessValidationProtocol": "PPQP/BTR.160.02-12.5E/23/01",
    "BMR": "BTR.160.02-12.5E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Laboratories Pvt. Ltd.",
    "Batchsize": "1,250,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "02.08.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roxithromycin 150 Heumann",
    "Dosageform": "FTA",
    "MA_No": "46361.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROX-002",
    "ProcessValidationReport": "PVR/BTR.148.02-1.7E/12",
    "ProcessValidationProtocol": "PV/ BTR.148.02-1.7E/10",
    "BMR": "BTR.148.04-1.7E ed 04.3",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "170,000 tab",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.02.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Roxithromycin 300 Heumann",
    "Dosageform": "FTA",
    "MA_No": "46361.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-ROX-001",
    "ProcessValidationReport": "PVR/BTR.149.03-2E/13",
    "ProcessValidationProtocol": "PV/ BTR.149.03-2E/13",
    "BMR": "BTR.149.06-2E ed 06.3",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "200 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.11.2020",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Roxithromycin 300 Heumann",
    "Dosageform": "FTA",
    "MA_No": "46361.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00685",
    "MPVReviewNo": "MPV-ROX-003",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "PRVP/BTR.149.07-2E/24/01",
    "BMR": "BTR.149.07-2E",
    "Reason_for_validation": "",
    "API_Manufacturer": "Torrent pharmaceutical limited Indrad",
    "Batchsize": "200 000 Tablets",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "30.11.2023",
    "Due_Date": "21.02.2025",
    "Completed": "",
    "comments": "angefragt am 14.11.2024 Dfo,\n 18.11.24 Antwort von Ruta,Ptotokoll erhalten , Bericht angefragt Dfo\n29.11.24 erneut nach Bericht angefragt Dfo\n10.12.24 erneut nach Bericht angefragt Dfo \n02.01.25 erneut angefragt dfo\n03.01.25 Antwort  von Girish:  in Bezug auf Roxithromycin 300mg [Referenzänderungskontrolle Nr. CCF/B/2024/0394] alle drei PPQ-Chargen in der Ausführung sind. Sobald dies abgeschlossen ist, wird der PPQ-Bericht veröffentlicht. Dfo\n21.01.25 nach Validierungsbericht angefragt DFo\n10.02.25 erneut nach Bericht angefragt DFo\n04.03.25: Nach Bericht und Protokoll angefragt Dfo\n05.03.25: Bericht und Protokoll erhalten Dfo\n14.03.25 nach dedicated equpiment angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Sertralin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "52630.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SER-001",
    "ProcessValidationReport": "PVR/BTS.88.03-10LaE/20/01-02 – Revalidation with New API CEP\nVR/BTS.88.00-10LaE/17 – Original validation",
    "ProcessValidationProtocol": "PRV/BTS.88.03-10LaE/19/01-01 – Revalidation with New API CEP\nPV/BTS.88.00-10LaE/17 – Original validation",
    "BMR": "BTS.88.03-10LaE (Edition No. 03)",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)",
    "Batchsize": "1 000 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sertralin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "52630.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SER-002",
    "ProcessValidationReport": "PVR/BTS.87.03-20LaE /20/01-01 – Revalidation with New API CEP\nVR/BTS.87.00-20LaE/17 – Original validation",
    "ProcessValidationProtocol": "PRV/BTS.87.03-20LaE /19/01-01 – Revalidation with New API CEP\nPV/BTS.87.00-20LaE/16 – Original validation",
    "BMR": "BTS.87.03-20LaE Ed: 03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Hetero Drugs Limited (Unit I)",
    "Batchsize": "2 000 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sevelamer 800mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7006805.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SEV-001\nPVD-Pharmathen-02",
    "ProcessValidationReport": "REP-QA-SEV/F229/250K/EU Version 002",
    "ProcessValidationProtocol": "QPR-QC-001-SEV/F229/250K/EU Version 001",
    "BMR": "TDR-PR-022-01927/250K",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Formosa",
    "Batchsize": "250,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.10.2023\n13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sevelamer 800mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "7006805.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sildenafil Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84885.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIL-002",
    "ProcessValidationReport": "PVR/BTS.151.02-4E/16 – Revalidation for compression stage\nPVR/BTS.151.01-4E/14 – Initial validation",
    "ProcessValidationProtocol": "PV/BTS.151.02-4E/16 – Revalidation for compression stage\nPV/BTS.151.01-4E/14 – Initial validation",
    "BMR": "BTS.151.03-4E, Edition: 03.5",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "400000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sildenafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "96661.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIL-001",
    "ProcessValidationReport": "PVR/BTS.183.01-10E/16",
    "ProcessValidationProtocol": "PV/BTS.183.01-10E/16",
    "BMR": "BTS.183.03-10E/03.2",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "1 000 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.01.2020",
    "comments": "Based on DE-WI-QA-08-01-A01 [DRAFT], checkpoints in list are the same to the final version, differences primarly in amount of general information."
  },
  {
    "Status": "QP Approval",
    "Productname": "Sildenafil Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "84884.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIL-003",
    "ProcessValidationReport": "PVR/BTS.150.01-3.2E/14",
    "ProcessValidationProtocol": "PV/BTS.150.01-3.2E/13",
    "BMR": "BTS.150.2-3.2E, Edition: 02.4",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "320,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Silodosin Heumann 4 mg Hartkapseln",
    "Dosageform": "CAP",
    "MA_No": "2202019.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SILO-001",
    "ProcessValidationReport": "PVR/CS.28.01-2E/20/01-01",
    "ProcessValidationProtocol": "PV/CS.28.01-2E/19/01-01",
    "BMR": "CS.28.01-2E Ed. No. 1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "200 000 capsules",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.10.2021",
    "comments": "Product under launch"
  },
  {
    "Status": "QP Approval",
    "Productname": "Silodosin Heumann 8 mg Hartkapseln",
    "Dosageform": "CAP",
    "MA_No": "2202020.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SILO-002",
    "ProcessValidationReport": "PVR/CS.29.01-2E/20/01-01",
    "ProcessValidationProtocol": "PV/CS.29.01-2E/19/01-01",
    "BMR": "CS.29.01-2E Ed. No. 1",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "200 000 capsules",
    "Process": "Entire Manufacturing Process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.10.2021",
    "comments": "Product under launch"
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "58155.02.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIM-001",
    "ProcessValidationReport": "PVR/BTS.104.00-13LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/ BTS.104.00-13LaE/18/01-01",
    "BMR": "BTS.104.04-13LaE; edition 04",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "1300000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "58155.02.01",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00673 \nCR-01047",
    "MPVReviewNo": "MPV-SIM-006",
    "ProcessValidationReport": "PRVR/BTS.134.00-13LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTS.134.00-13LaE/23/01",
    "BMR": "BTS.134.00-13LaE\nBTS.134.02-13LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "1,300,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.11.2023",
    "Due_Date": "25.04.2025",
    "Completed": "21.08.2024",
    "comments": ""
  },
  {
    "Status": "Completed",
    "Productname": "Simvastatin Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "85905.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00673\nCR-01138",
    "MPVReviewNo": "MPV-SIM-008",
    "ProcessValidationReport": "PRVR/BTS.135.00-8LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTS.135.00-8LaE/23/01",
    "BMR": "BTS.135.00-8LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "8 00 000 film coated tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.11.2023",
    "Due_Date": "25.05.2025",
    "Completed": "28.03.2025",
    "comments": "12.02.25: Protokoll erhalten; s. Mail von Vishal: No batch manufactured under this code, report will be shared once available\n14.03.25 Reminder geschickt Dfo  ( Bericht da)\n27.03.25 Bericht und Protokoll da Dfo\n28.03.25 an BPr geschickt dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 30 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "85905.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIM-004",
    "ProcessValidationReport": "PVR/BTS.105.00-8LaE/19/01-01",
    "ProcessValidationProtocol": "PRV/BTS.105.00-8LaE/18/01-01",
    "BMR": "BTS.105.05-8LaE Ed. 05",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "800.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.05.2021",
    "comments": "Not yet released"
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "58155.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIM-002",
    "ProcessValidationReport": "PVR/BTS.106.00-6.5LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTS.106.00-6.5LaE/18/01-01",
    "BMR": "BTS.106.03-6.5LaE ed 03",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "650,000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 40 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "58155.03.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00673\nCR-01138",
    "MPVReviewNo": "MPV-SIM-007",
    "ProcessValidationReport": "PRVR/BTS.136.00-6.5LaE/23/01",
    "ProcessValidationProtocol": "PRVP/BTS.136.00-6.5LaE/23/01",
    "BMR": "BTS.136.00-6.5LaE\nBTS.136.02-6.5LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "650,000 Tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "30.11.2023",
    "Due_Date": "25.05.2025",
    "Completed": "21.08.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Simvastatin Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "85906.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00673",
    "MPVReviewNo": "MPV-SIM-009",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "30.11.2023",
    "Due_Date": "25.04.2025",
    "Completed": "",
    "comments": "04.03.25: Nach Bericht und Protokoll angefragt Dfo\n14.03.25 Reminder geschickt Dfo (Protokoll da )\n27.03.25 Bericht steht noch aus Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 60 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "85906.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIM-005",
    "ProcessValidationReport": "PVR/BTS.107.00-2LaE/18/01-01",
    "ProcessValidationProtocol": "PRV/BTS.107.00-2LaE/18/01-01",
    "BMR": "BTS.107.07-2LaE, Edition No. 07",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": "200 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.08.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Simvastatin Heumann 80 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "70144.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIM-003",
    "ProcessValidationReport": "PVR/BTS.112.00-3LaE/21/01-01",
    "ProcessValidationProtocol": "PRV/BTS.112.00-3LaE/20/01-01",
    "BMR": "BTS.112.00-3LaE",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Biocon Ltd",
    "Batchsize": 300,
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.04.2021",
    "comments": "Not yet released"
  },
  {
    "Status": "Open",
    "Productname": "Sitagliptin Heumann 100 mg common blend",
    "Dosageform": "Blend",
    "MA_No": "2201353.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CR-00575",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.08.2023",
    "Due_Date": "30.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201353.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-003",
    "ProcessValidationReport": "PVR/BTS.101.00-1.5LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTS.101.00-1.5LaE/18/01-01",
    "BMR": "BTS.129.00-1.5.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceutical Limited",
    "Batchsize": "150 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201353.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-007",
    "ProcessValidationReport": "PVR-1657-01",
    "ProcessValidationProtocol": "PVP-FD-1657-00",
    "BMR": "SIT-T-021-02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "1.600.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.04.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201353.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-008",
    "ProcessValidationReport": "PVR-FD-2009-00",
    "ProcessValidationProtocol": "PVP-FD-2009-00",
    "BMR": "SIT-T-025-00",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Hetero Labs Limited",
    "Batchsize": "1.600.000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.04.2024",
    "comments": ""
  },
  {
    "Status": "Open",
    "Productname": "Sitagliptin Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201353.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CR-00575",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.08.2023",
    "Due_Date": "30.11.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205053.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-001",
    "ProcessValidationReport": "PVR/BTS.99.00-6.0LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTS.99.00-6.0LaE/18/01-01",
    "BMR": "BTS.127.00-6.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceutical Limited",
    "Batchsize": "600 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201351.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-005",
    "ProcessValidationReport": "PVR-FD-1614-00",
    "ProcessValidationProtocol": "PVP-FD-1614-00",
    "BMR": "SIT-T_012-02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "M/S Honour Lab Limited",
    "Batchsize": "160,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.04.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201351.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-009",
    "ProcessValidationReport": "PVR-FD-2031-00 (Common Blend)\nPVR-FD-2035-00 (film-coated tablets)",
    "ProcessValidationProtocol": "PVD-FD-2031-00 (Common Blend)\nPVD-FD-2035-00 (film-coated tablets)",
    "BMR": "SIT-T-026-00 (Common Blend)\nSIT-T-027-00 (film-coated tablets)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "M/S Honour Lab Limited",
    "Batchsize": "48.000 kg / 480.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2205053.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-002",
    "ProcessValidationReport": "PVR/BTS.100.00-3.0LaE/18/01-01",
    "ProcessValidationProtocol": "PV/BTS.100.00-3.0LaE/18/01-01",
    "BMR": "BTS.128.00-3.0LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceutical Limited",
    "Batchsize": "300 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "01.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2201352.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITA-006",
    "ProcessValidationReport": "PVR-FD-1654-01",
    "ProcessValidationProtocol": "PVP-FD-1654-00",
    "BMR": "SIT-T-019-03",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "M/S Honour Lab Limited",
    "Batchsize": "160,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.04.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann  50 mg/1000 mg Blend",
    "Dosageform": "Blend",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-005",
    "ProcessValidationReport": "PVR-FD-1897-00",
    "ProcessValidationProtocol": "PVR-FD-1897-00",
    "BMR": "SIM-T-003-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride",
    "Batchsize": "182.000 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Blend",
    "Dosageform": "Blend",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-003",
    "ProcessValidationReport": "PVR-FD-1668-00",
    "ProcessValidationProtocol": "PVP-FD-1668-00",
    "BMR": "SIM-T-003-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride\nHonour Lab Limited (Unit-III) – Sitagliptin Hydrochloride",
    "Batchsize": "182.000 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "In Review",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Blend",
    "Dosageform": "Blend",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CR-02399",
    "MPVReviewNo": "MPVSITMETF-008",
    "ProcessValidationReport": "PVR-FD-2683",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "24.01.2025",
    "Due_Date": "24.07.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-004",
    "ProcessValidationReport": "PVR-FD-1668-00",
    "ProcessValidationProtocol": "PVP-FD-1673-00",
    "BMR": "SIM-T-008-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride",
    "Batchsize": "140 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CC-22-1551",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.02.2024",
    "Due_Date": "NA",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Filmtabletten",
    "Dosageform": "Blend",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITMETF-011",
    "ProcessValidationReport": "PVR-FD-1693-00",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/1000 mg Filmtabletten",
    "Dosageform": "",
    "MA_No": "2203034.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SITMETF-012",
    "ProcessValidationReport": "PVR-FD-1677-00",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg  Blend",
    "Dosageform": "Blend",
    "MA_No": "2203033.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-001",
    "ProcessValidationReport": "PVR-FD-1665-00",
    "ProcessValidationProtocol": "PVP-FD-1665-00",
    "BMR": "SIM-T-001-01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride\nHonour Lab Limited (Unit-III) – Sitagliptin Hydrochloride",
    "Batchsize": "154.700 kg",
    "Process": "blend",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203033.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-002",
    "ProcessValidationReport": "PVR-FD-1669-01",
    "ProcessValidationProtocol": "PVP-FD-1669-00",
    "BMR": "SIM-T-007-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride\nHonour Lab Limited (Unit-III) – Sitagliptin Hydrochloride",
    "Batchsize": "140 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203033.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SIT/METF-006",
    "ProcessValidationReport": "PVR-FD-1899-00",
    "ProcessValidationProtocol": "PVP-FD-1899-00",
    "BMR": "SIM-T-008-00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Wanbury Limited Doctors Organic Chemicals Division – Metformin Hydrochloride",
    "Batchsize": "140 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2022",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203033.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CC-22-1551",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "16.02.2024",
    "Due_Date": "NA",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203033.00.00",
    "CMOSite": "Hetero Labs Limited - Unit V",
    "Country": "Non-EU",
    "Reference": "CR-00153",
    "MPVReviewNo": "MPV-SITMETF-007",
    "ProcessValidationReport": "PVR-FD-2025-00\nPVR-FD-2032-00",
    "ProcessValidationProtocol": "PVP-FD-2025-00\nPVP-FD-2032-00",
    "BMR": "SIM-T-015-00\nSIM-T-016-00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Honour Lab Limited (Unit-III) – Sitagliptin Hydrochloride\nWanburry Limited Doctors Organic chemicals division - Metformin",
    "Batchsize": "1,547,000 kg\n1,400,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.07.2023",
    "Due_Date": "31.07.2024",
    "Completed": "06.08.2024",
    "comments": "06.08.24:  annexes requested (sampling plan, process flow chart)"
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "Blend",
    "MA_No": "2203033.00.00",
    "CMOSite": "",
    "Country": "",
    "Reference": "",
    "MPVReviewNo": "MPV-SITMETF-009",
    "ProcessValidationReport": "PVR-FD-1778-00",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Sitagliptin/Metformin Heumann 50 mg/850 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2203033.00.00",
    "CMOSite": "",
    "Country": "",
    "Reference": "",
    "MPVReviewNo": "MPV-SITMETF-010",
    "ProcessValidationReport": "PVR-FD-1779-00",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94045.00.00",
    "CMOSite": "Nobel İlaç San. Ve Tic.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SOL-002",
    "ProcessValidationReport": "N-PVR-186/02",
    "ProcessValidationProtocol": "N-PVP-186/0120/8/2020",
    "BMR": "SÜ-NOBEL-493-Ü",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Honour Lab Limited (Unit-III) – Sitagliptin Hydrochloride",
    "Batchsize": "23,100 kg/ 150 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin Heumann 10 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94045.00.00",
    "CMOSite": "Nobel İlaç San. Ve Tic.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SOL-004",
    "ProcessValidationReport": "N-PVR-186/03",
    "ProcessValidationProtocol": "N-PVP-186/03",
    "BMR": "SÜ-NOBEL-493-Ü, Version 11",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Megafine Pharma (P) Limited",
    "Batchsize": "23,100 kg/ 150 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "21.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94044.00.00",
    "CMOSite": "Nobel İlaç San. Ve Tic.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SOL-001",
    "ProcessValidationReport": "N-PVR-185/ 03",
    "ProcessValidationProtocol": "N-PVP-185/02",
    "BMR": "SÜ-NOBEL-492-Ü",
    "Reason_for_validation": "",
    "API_Manufacturer": "Teva Pharmaceutical Works Ltd.",
    "Batchsize": "23,100 kg/ 150 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "94044.00.00",
    "CMOSite": "Nobel İlaç San. Ve Tic.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SOL-003",
    "ProcessValidationReport": "N-PVR-185/ 03",
    "ProcessValidationProtocol": "N-PVP-185/03",
    "BMR": "SÜ-NOBEL-492-Ü/2, Revision 13.",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Megafine Pharma (P) Limited",
    "Batchsize": "23,100 kg/ 150 000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin/Tamsulosin Heumann 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung",
    "Dosageform": "RET",
    "MA_No": "7007757.00.00",
    "CMOSite": "Adamed Pharma, S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Adamed-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.04.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Solifenacin/Tamsulosin Heumann 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung",
    "Dosageform": "RET",
    "MA_No": "7007757.00.00",
    "CMOSite": "Adamed Pharma, S.A.",
    "Country": "EU",
    "Reference": "CR-01809",
    "MPVReviewNo": "PVD-Adamed-03",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Zhejiang Ausun Pharmaceutical Co. Ltd",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "NA",
    "Receipt_Date": "24.09.24",
    "Due_Date": "29.11.2024",
    "Completed": "31.01.25",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Spironolacton 100 Heumann",
    "Dosageform": "TAB",
    "MA_No": "219.01.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "N/A",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Spironolacton 50 Heumann",
    "Dosageform": "TAB",
    "MA_No": "219.00.00",
    "CMOSite": "Dragenopharm Apotheker Püschl GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-AENOVA-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "N/A",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sumatriptan 100mg tablets",
    "Dosageform": "FTA",
    "MA_No": "7005582.00.00",
    "CMOSite": "Unison Pharmaceuticals Pvt. Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SUM-002",
    "ProcessValidationReport": "PVRE3/595/00",
    "ProcessValidationProtocol": "PVPE3/595/00",
    "BMR": "BMES3589",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "150,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Sumatriptan 50mg tablets",
    "Dosageform": "FTA",
    "MA_No": "7005581.00.00",
    "CMOSite": "Unison Pharmaceuticals Pvt. Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SUM-003",
    "ProcessValidationReport": "PVRE3/013/00",
    "ProcessValidationProtocol": "PVPE/013/00",
    "BMR": "BMES3020-1.5/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "150,000 tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.06.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Sumatriptan 50mg tablets",
    "Dosageform": "FTA",
    "MA_No": "7005581.00.00",
    "CMOSite": "Unison Pharmaceuticals Pvt. Ltd. Unit 3",
    "Country": "Non-EU",
    "Reference": "CR-02591",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "17.02.2025",
    "Due_Date": "05.05.2025",
    "Completed": "",
    "comments": "26.03.25: Nach PVP und PVR angefragt Dfo\n28.03.25 Antwort von Nikunj , Protokoll noch nicht erstellst Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Sumatriptan common granules for 25mg, 50mg, 100mg tablets",
    "Dosageform": "Granules",
    "MA_No": "7005581.00.00\n7005582.00.00",
    "CMOSite": "Unison Pharmaceuticals Pvt. Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-SUM-001",
    "ProcessValidationReport": "PVRE3/011",
    "ProcessValidationProtocol": "PVP/E3/011/00",
    "BMR": "BMECP3002/00\nBME/CS3051",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Pharmachem Private Limited",
    "Batchsize": "67,500 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.06.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Sumatriptan100mg",
    "Dosageform": "TAB",
    "MA_No": "7005582.00.00",
    "CMOSite": "Unison Pharmaceuticals Pvt. Ltd. Unit 3",
    "Country": "Non-EU",
    "Reference": "CR-02591",
    "MPVReviewNo": "MPV-SUM-004",
    "ProcessValidationReport": "PVRE3/595/00",
    "ProcessValidationProtocol": "PVPE3/595/00",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.02.2025",
    "Due_Date": "04.05.2025",
    "Completed": "",
    "comments": "12.02.25: PVR da\n25.03.25: Nach PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann 0,5 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "82612.00.00",
    "CMOSite": "Laboratorios Cinfa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAC-002",
    "ProcessValidationReport": "VPI012675/0714",
    "ProcessValidationProtocol": "VPI012675/1114",
    "BMR": "IL012675",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Teva Czech Industries, s.r.o. (TCI)",
    "Batchsize": 175.2,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann 1 mg Hartkapseln",
    "Dosageform": "KAP",
    "MA_No": "82613.00.00",
    "CMOSite": "Laboratorios Cinfa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAC-001",
    "ProcessValidationReport": "VPI012676/1114",
    "ProcessValidationProtocol": "VPI012676/0714",
    "BMR": "IL012676",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Teva Czech Industries, s.r.o. (TCI)",
    "Batchsize": 175.2,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 0,5mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005313.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 0,5mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005313.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 1mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005314.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 1mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005314.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 3mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005315.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 3mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005315.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 5mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005316.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tacrolimus Heumann retard 5mg Hartkapseln, retardiert",
    "Dosageform": "KAP",
    "MA_No": "7005316.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-001",
    "ProcessValidationReport": "PVR-GS-1828-01",
    "ProcessValidationProtocol": "PVP-GS-1828-01",
    "BMR": "EB200019938-MSO-02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "320 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-002",
    "ProcessValidationReport": "VR-PV-S-2013-01-121",
    "ProcessValidationProtocol": "VP-PV-S-2013-00-121",
    "BMR": "MPCR No.: 200019932GR-MSO-03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "153.600 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020",
    "comments": "Common Granules for Tadalafil Tablets 2.5/ 5/ 10/ 20mg / Intas Pharmaceuticals Ltd. Matoda"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-003",
    "ProcessValidationReport": "PVR-GS-2296-01",
    "ProcessValidationProtocol": "PVP-GS-2296-01",
    "BMR": "EB200019938-MSO-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "320 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-004",
    "ProcessValidationReport": "PVR-GS-1825-01",
    "ProcessValidationProtocol": "PVP-GS-1825-01",
    "BMR": "EB200019938-MSO-05",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "320 000 Tablets",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.10.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-008",
    "ProcessValidationReport": "PVR-GS-2296-01",
    "ProcessValidationProtocol": "PVP-GS-2296-01",
    "BMR": "EB200019938-MSO-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "320 000 Tablets",
    "Process": "compression",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 20 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200182.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-009",
    "ProcessValidationReport": "PVD-GS-0189-01",
    "ProcessValidationProtocol": "PVD-GS-0189-01",
    "BMR": "EB200019938-MSO-06",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "320 000 Tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "16.09.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200181.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-002",
    "ProcessValidationReport": "VR-PV-S-2013-01-121",
    "ProcessValidationProtocol": "VP-PV-S-2013-00-121",
    "BMR": "MPCR No.: 200019932GR-MSO-03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "153.600 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "08.10.2020",
    "comments": "Common Granules for Tadalafil Tablets 2.5/ 5/ 10/ 20mg / Intas Pharmaceuticals Ltd. Matoda"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200181.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-005",
    "ProcessValidationReport": "PVR-GS-2492-01",
    "ProcessValidationProtocol": "PVP-GS-2492-01",
    "BMR": "MPCR No.: EA200019934-MSO-02",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "1280000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.12.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200181.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAD-006",
    "ProcessValidationReport": "VR-PV-S-2013-01-123",
    "ProcessValidationProtocol": "VR-PV-S-2013-01-123",
    "BMR": "MPCR No.: 200019934-MSO-01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "MSN Organics Private Limited",
    "Batchsize": "160 000 Tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tadalafil Heumann 5 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "2200181.00.00",
    "CMOSite": "Intas Pharmaceuticals Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TADA-001",
    "ProcessValidationReport": "PVD-GS-0257-01",
    "ProcessValidationProtocol": "PVD-GS-0257-01",
    "BMR": "EA20019934-MSO-03",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Intas Pharmaceuticals Ltd.",
    "Batchsize": "1280000 tablets",
    "Process": "coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "20.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamoxifen 20 Heumann",
    "Dosageform": "TAB",
    "MA_No": "11210.01.00",
    "CMOSite": "Excella Pharma Source GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Excella-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.05.2020",
    "comments": "N/A"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamoxifen Heumann 20mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "11210.01.00",
    "CMOSite": "Haupt Pharma Münster GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-HPM-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-003",
    "ProcessValidationReport": "MPL/N2/BMR/TC5/1/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/TC5/1/01",
    "BMR": "MPL/BMR/TC5/1/07 (Main)\nMPL/BMR/TC5/1-BOM/02 (Dispensing)\nMPL/BMR/TC5/1-GP/1/03 (Granulation)\nMPL/BMR/TC5/1-GP/2/02 (Granulation)\nMPL/BMR/TC5/1-CIP/1/03 (Caps filling)\nMPL/BMR/TC5/1-CIP/2/02 (Caps filling)",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "RA Chem Pharma Limited",
    "Batchsize": "580.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.07.2020",
    "comments": "Assessed during the audit of Macleods."
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-004",
    "ProcessValidationReport": "MPL/N2/PPQR/19/019/01",
    "ProcessValidationProtocol": "MPL/N2/PPQP/19/019/01",
    "BMR": "MPL/BMR/TC5/1/08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "RA Chem Pharma Limited",
    "Batchsize": "580.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "09.09.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-005",
    "ProcessValidationReport": "MPL/N2/PPQP/19/019/02",
    "ProcessValidationProtocol": "MPL/N2/PPQP/19/019/02",
    "BMR": "MPL/BMR/TC5/1-CFP/3/00\n(Capsule filling part of BMR no. MPL/BMR/TC5/1/09).",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "RA Chem Pharma Limited",
    "Batchsize": "580 000 Capsules",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "24.09.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-006",
    "ProcessValidationReport": "MPL/N2/ PVR/20/008/00 and MPL/N2/PPQR/19/019/02",
    "ProcessValidationProtocol": "MPL/N2/PVP/20/008/00 and MPL/N2/PPQP/19/019/02",
    "BMR": "MPL/BMR/TC5/1-CP/1/01",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "RA Chem Pharma Limited",
    "Batchsize": "580 000 Capsules",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "22.09.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00062\nCR-00015",
    "MPVReviewNo": "MPV-TAMS-008",
    "ProcessValidationReport": "MPL/N2/PPQR/22/014/01",
    "ProcessValidationProtocol": "MPL/N2/PPQP/22/014/01",
    "BMR": "MPL/BMR/TC5/4/01",
    "Reason_for_validation": "Implementation of CAPA PR#163304 (using different lots for MCC)",
    "API_Manufacturer": "Cohance Lifesciences Limited (former Ra Chem Pharma)",
    "Batchsize": "580,000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln mit veränderter Wirkstofffreisetzung",
    "Dosageform": "REK",
    "MA_No": "95107.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00060",
    "MPVReviewNo": "MPV-TAMS-009",
    "ProcessValidationReport": "MPL/N2/PPQR/21/127/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/21/127/00",
    "BMR": "MPL/BMR/TC5/3/00",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "RA Chem Pharma Limited",
    "Batchsize": "1,150,000 capsules",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "19.07.2023",
    "Due_Date": "28.06.2024",
    "Completed": "13.08.2024",
    "comments": "05.08.24: Reminder - AV leves spread"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "63917.00.00",
    "CMOSite": "Gedeon Richter Ltd.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-001\nPVD-Gedeon-01",
    "ProcessValidationReport": "SCP-TMH-PVR-15-02, \nSCP-TMH-PVRS1-15-02",
    "ProcessValidationProtocol": "SCP-TMH-PVP-15-02, \nSCP-TMH-PVPS1-15-02",
    "BMR": "SCP-FP-TAMD-40-07 (uncoated pellets) \nSCP-FFC-TAMD2-40-09 (coating and encapsulation)",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Gedeon Richter Ltd. Budapest site",
    "Batchsize": "720.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "07.05.2020",
    "comments": "Acc. to TA: Heumann is responsible for Validation Evaluation; QP signature not verified, requested"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tamsulosin Heumann 0,4 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "63917.00.00",
    "CMOSite": "Gedeon Richter Ltd.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAMS-002",
    "ProcessValidationReport": "SCP-TMH2-PVR-06-01 & SCP-TMH2-PVRS1-06-01",
    "ProcessValidationProtocol": "SCP-TMH2-PVP-06-01 & SCP-TMH2-PVPS1-06-01",
    "BMR": "SCP-FP-TMH2-40-05 & SCP-FFC-TMH2-40-05",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Gedeon Richter Ltd. Budapest site",
    "Batchsize": "360.000 capsules",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Tannacetum 200mg",
    "Dosageform": "",
    "MA_No": "",
    "CMOSite": "Wiewelhove",
    "Country": "EU",
    "Reference": "CR-00582",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "06.05.2024",
    "Due_Date": "01.01.2026",
    "Completed": "",
    "comments": "23.05.24: Product Launch; High-Risk-CMO regarding GMP, Validation report and MPV necessary (BU + NSc) - also refer to SQA Meeting 23.05.24\n24.10.24 MaWa: Validierungschargen sind hergestellt (Pick up geplant in KW50); Validierungsbericht für Ende Oktober geplant - Update angefragt\n09.12.24  Laut Launchmeeting: Wievelhove bekommt die Spezifikation nicht hin und versucht die Chargen zu retten, indem sie nachtrocknen, wenn es nicht klappt oder die Typ 2 Variation abgelehnt wird, ist das Produkt tot\n15.11.25: Launch meeting - unklar ob Chargen freigabefähig sind; verschoben in \"launches by 25-26 or later"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 100mg",
    "Dosageform": "RET",
    "MA_No": "7006623.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-003\nPVD-Develco-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 100mg",
    "Dosageform": "RET",
    "MA_No": "7006623.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 100mg",
    "Dosageform": "RET",
    "MA_No": "7006623.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 150mg",
    "Dosageform": "RET",
    "MA_No": "7006624.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-004\nPVD-Develco-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 150mg",
    "Dosageform": "RET",
    "MA_No": "7006624.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 150mg",
    "Dosageform": "RET",
    "MA_No": "7006624.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 200mg",
    "Dosageform": "RET",
    "MA_No": "7006625.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-005\nPVD-Develco-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 200mg",
    "Dosageform": "RET",
    "MA_No": "7006625.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 200mg",
    "Dosageform": "RET",
    "MA_No": "7006625.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 250mg",
    "Dosageform": "RET",
    "MA_No": "7006626.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-006\nPVD-Develco-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 250mg",
    "Dosageform": "RET",
    "MA_No": "7006626.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 250mg",
    "Dosageform": "RET",
    "MA_No": "7006626.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 25mg",
    "Dosageform": "RET",
    "MA_No": "7006621.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-001\nPVD-Develco-01",
    "ProcessValidationReport": "VH-201951-01-All-B\nVH-201951-01-All-B V2.0",
    "ProcessValidationProtocol": "VH-201951-01-All-P\nVH-201951-02-All-P",
    "BMR": "20195130TTTTAB25mg",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "420000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.06.2023\n29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 25mg",
    "Dosageform": "RET",
    "MA_No": "7006621.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 25mg",
    "Dosageform": "RET",
    "MA_No": "7006621.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 50mg",
    "Dosageform": "RET",
    "MA_No": "7006622.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TAPE-002\nPVD-Develco-01",
    "ProcessValidationReport": "VH-201951-01-All-B\nVH-201951-01-All-B V2.0",
    "ProcessValidationProtocol": "VH-201951-01-All-B\nVH-201951-01-All-B V2.0",
    "BMR": "20195131TTTTAB50mg",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Symed Labs Ltd.\nRA Chem Pharma Limited",
    "Batchsize": "340000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.06.2023\n29.06.2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tapentadol Heumann Retardtabletten 50mg",
    "Dosageform": "RET",
    "MA_No": "7006622.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Develco-02",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.05.2024",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Tapentadol Heumann Retardtabletten 50mg",
    "Dosageform": "RET",
    "MA_No": "7006622.00.00",
    "CMOSite": "Develco Pharma GmbH",
    "Country": "EU",
    "Reference": "CR-02011",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "12.12.2024",
    "Due_Date": "22.05.2025",
    "Completed": "",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan / Hydrochlorothiazid Heumann 40 mg / 12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "88245.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CR-01541",
    "MPVReviewNo": "PVD-Liconsa-07",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "12.09.2024",
    "Due_Date": "29.11.2024",
    "Completed": "24.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan / Hydrochlorothiazid Heumann 80 mg / 12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "88246.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan / Hydrochlorothiazid Heumann 80 mg / 12,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "88246.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CR-01541",
    "MPVReviewNo": "PVD-Liconsa-07",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "12.09.2024",
    "Due_Date": "29.11.2024",
    "Completed": "24.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan / Hydrochlorothiazid Heumann 80 mg / 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "88247.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan / Hydrochlorothiazid Heumann 80 mg / 25 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "88247.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "CR-01541",
    "MPVReviewNo": "PVD-Liconsa-07",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "12.09.2024",
    "Due_Date": "29.11.2024",
    "Completed": "24.02.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77739.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 20 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "85600.00.00",
    "CMOSite": "Torrent Pharmacueticals Ltd. Indrad",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEL-004",
    "ProcessValidationReport": "PPQR/BTT.291.04-27E/23/01",
    "ProcessValidationProtocol": "PPQP/BTT.291.04-27E/22/01",
    "BMR": "BTT.291.05-27E\nBTT.291.06-27E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd.",
    "Batchsize": "2,700,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "04.12.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 40 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77740.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 40 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "85601.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEL-002",
    "ProcessValidationReport": "VR/BTT.135.00-10LaE/16",
    "ProcessValidationProtocol": "PV/BTT.135.00-10LaE/15",
    "BMR": "BTT.179.00-10LaE, Edition: 00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Tianish Laboratories Private Limited\n(formerly: Mylan laboratories, Unit 3 and Unit 7)",
    "Batchsize": "1000000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.12.2020",
    "comments": "New product at Baddi site."
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 40 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "85601.00.00",
    "CMOSite": "Torrent Pharmacueticals Ltd. Indrad",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEL-003",
    "ProcessValidationReport": "PVR/BTT.294.02-12.5E/22/01-01",
    "ProcessValidationProtocol": "PV/BTT.294.02-12.5E/22/01-01",
    "BMR": "BTT.294.02-1.3E/02",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd.",
    "Batchsize": "1,250,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "27.10.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 80 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "77741.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 80 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "85602.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEL-001",
    "ProcessValidationReport": "VR/BTT.136.00-5LaE/16",
    "ProcessValidationProtocol": "PV/BTT.136.00-5LaE/15",
    "BMR": "BTT.136.02-5LaE, Ed.02/          BTT.180.00-5LaE, Ed.00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Tianish Laboratories Private Limited\n(formerly: Mylan laboratories, Unit 3 and Unit 7)",
    "Batchsize": "500000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.08.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Telmisartan Heumann 80 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "85602.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-00336",
    "MPVReviewNo": "MPV-TEL-005",
    "ProcessValidationReport": "PPQR/BTT.659.01-6.75E/23/01",
    "ProcessValidationProtocol": "PPQP/BTT.359.01-6.75E/22/01",
    "BMR": "BTT.359.01-6.75E",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Pharmaceuticals Ltd.",
    "Batchsize": "675,000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "10.10.2023",
    "Due_Date": "31.05.2024",
    "Completed": "02.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tenofovir Heumann 245 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99194.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEN-001",
    "ProcessValidationReport": "MPL/PNR/RPV1/TC2/02-A",
    "ProcessValidationProtocol": "MPL/PNR/PPV1/TC2/01",
    "BMR": "MPL/PNR/BMR/TC2/01",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "120000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "23.06.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tenofovir Heumann 245 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "99194.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TEN-002",
    "ProcessValidationReport": "MPL/PNR/RPQ-TC2-00",
    "ProcessValidationProtocol": "MPL/PNR/PPQ-TC2-00",
    "BMR": "MPL/PNR/BMR/TC2/01",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "750000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.12.2020",
    "comments": "Validation report is iniciated for increase in batch size."
  },
  {
    "Status": "QP Approval",
    "Productname": "Terbinafin Heumann 250 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "66778.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Teriflunomid Film-Caoted Tablets 14mg",
    "Dosageform": "FTA",
    "MA_No": "7011813.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "CR-000003",
    "MPVReviewNo": "MPV-TERI-001",
    "ProcessValidationReport": "PPQR/BTT.206.00-1.75LaE/24/01",
    "ProcessValidationProtocol": "PPQP/BTT.206.00-1.75LaE/24/01",
    "BMR": "BTT.206.00-1.75LaE",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "MSN Laboratories Private Limited",
    "Batchsize": "175,000 tabltets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "20.09.23",
    "Due_Date": "31.07.2024",
    "Completed": "08.07.2024",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Teriparatid Heumann 20 Mikrogramm/ 80Mikrolieter Injecktionslösung im Fertigpen",
    "Dosageform": "FSP",
    "MA_No": "2205795.00.00",
    "CMOSite": "GP Pharm / Rechon Life Science AB",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TER-001",
    "ProcessValidationReport": "QGT-300303-01",
    "ProcessValidationProtocol": "QGS-300303-00",
    "BMR": "QVM-300303-00\nQVM-300303-02",
    "Reason_for_validation": "Change in bulk manufacturing (new CMO)",
    "API_Manufacturer": "BCN Peptides",
    "Batchsize": "55 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.05.24",
    "comments": ""
  },
  {
    "Status": "Documents requested",
    "Productname": "Ticagrelor Tablets 60mg",
    "Dosageform": "TAB",
    "MA_No": "",
    "CMOSite": "Torrent Pharmacueticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CR-02677\nCC-19-1982\nCC-19-1983",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.24",
    "Due_Date": "01.06.25",
    "Completed": "",
    "comments": "07.03.25: Nach Protokoll und Bericht angefragt Dfo\n07.03.25: Antwort von Pankaj, Charge wird derzeit erstellt, nach Fertigstellung der Chargen werden PVP,PVR zur Verfügung gestellt Dfo\n14.03.25 Reminder Dfo \n17.03.25 : Antwort von Arun:Batches of Ticagrelor tablets 60 mg and 90 mg are under manufacturing, required documents we will provided to you after completion of three batches."
  },
  {
    "Status": "Documents requested",
    "Productname": "Ticagrelor Tablets 90mg",
    "Dosageform": "TAB",
    "MA_No": "",
    "CMOSite": "Torrent Pharmacueticals Ltd. Dahej",
    "Country": "Non-EU",
    "Reference": "CR-02209\nCC-19-1982\nCC-19-1983",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.24",
    "Due_Date": "01.06.25",
    "Completed": "",
    "comments": "07.03.25: Nach Protokoll und Bericht angefragt Dfo\n07.03.25: Antwort von Pankaj, Charge wird derzeit erstellt, nach Fertigstellung der Chargen werden PVP,PVR zur Verfügung gestellt Dfo\n14.03.25 Reminder Dfo \n17.03.25 : Antwort von Arun:Batches of Ticagrelor tablets 60 mg and 90 mg are under manufacturing, required documents we will provided to you after completion of three batches."
  },
  {
    "Status": "QP Approval",
    "Productname": "Tolterodin Heumann 2 mg/4mg Retardkapseln (Common Bulk)",
    "Dosageform": "REK",
    "MA_No": "N/A",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOL-003",
    "ProcessValidationReport": "MPL/N2/PPV/CB146/1/00",
    "ProcessValidationProtocol": "MPL/N2/PPV/CB146/1/00",
    "BMR": "MPL/BPR/CB146/1/01           Dispensing Part: MPL/BPR/CB146/1-BOM/01\nGranulation Part: MPL/BPR/CB146/1-GP/101",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "44,88 kg",
    "Process": "granules",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2021",
    "comments": "The process validation of Tolterodine Tartrade Prolonged Release Capsules 2 mg/ 4 mg (Common Bulk) was taken against unplanned deviation No. URD/18/060."
  },
  {
    "Status": "QP Approval",
    "Productname": "Tolterodin Heumann 4 mg Retardkapseln",
    "Dosageform": "REK",
    "MA_No": "99315.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOL-001",
    "ProcessValidationReport": "MPL/N2/PPQR/PB14/19/073/00",
    "ProcessValidationProtocol": "MPL/N2/PPQP/PB14/19/073/00",
    "BMR": "MPL/BPR/TE1/B14/5/04\nSection - I: MPL/BPR/TE1/B14/5-S1/02\nSection - II: MPL/BPR/TE1/B14/4-S2/03\nSection - III: MPL/BPR/TE1/B14/4-S3/02",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "100000 Capsules",
    "Process": "misc",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Tolterodin Heumann 4 mg Retardkapseln",
    "Dosageform": "REK",
    "MA_No": "99315.00.00",
    "CMOSite": "Macleods Pharmaceuticals Limited Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOL-002",
    "ProcessValidationReport": "MPL/N2/PPV/TE1/1/00 (filled)",
    "ProcessValidationProtocol": "not available",
    "BMR": "MPL/BMR/TE1/1/02 \nMPL/BMR/TE1/1-BOM/02 - Dispensing part\nMPL/BMR/TE1/1-CFP/1/02 - Capsule Filling and Inspection Part",
    "Reason_for_validation": "Misc",
    "API_Manufacturer": "Macleods Pharmaceuticals Limited Sarigam",
    "Batchsize": "195000 Capsules / 255000 Capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "14.01.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 400 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77520.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "CR-00612",
    "MPVReviewNo": "MPV-TOP-006",
    "ProcessValidationReport": "PPQR/BTT.96.02-1.05E/23/01",
    "ProcessValidationProtocol": "PPQP/BTT.96.02-1.05E/23/01",
    "BMR": "BTT.96.02-1.05E",
    "Reason_for_validation": "new commercial launch",
    "API_Manufacturer": "Torrent Pharmaceuticals Limited Indrad",
    "Batchsize": "105 000 tablets",
    "Process": "entire process",
    "OOX": "NA",
    "Receipt_Date": "29.11.2023",
    "Due_Date": "21.03.2025",
    "Completed": "10.03.2025",
    "comments": "angefragt am 14.11.2024 Dfo, verschiedene Dokumente erhalten zu Change Control\nerneute Anfrage am 25.11.24 Dfo\n04.12.24 erneuten Reminder geschickt dfo\n09.12.24 Bericht und Protokoll geschickt"
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 100 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77518.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOP-003",
    "ProcessValidationReport": "PV/BTT.97.03-1.5E/11",
    "ProcessValidationProtocol": "PV/BTT.97.03-1.5E/11",
    "BMR": "BTT.97.05-1.5E, Edition: 5.5",
    "Reason_for_validation": "new area",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "150,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.02.2021",
    "comments": "Reason: New validation at SBA area with batch size of 1.5 L                             Last released 14/06/2018, Expires May 21"
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77519.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOP-004",
    "ProcessValidationReport": "PVR/BTT.84.02-2E/17",
    "ProcessValidationProtocol": "PV/BTT.84.02E/07",
    "BMR": "BTT.84.07-2E, Edition: 7",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "200,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "15.04.2021",
    "comments": "Last released 18/09/2018, Expires Jan 21"
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77519.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOP-005",
    "ProcessValidationReport": "PRVR/BTT.84.09-2E/22/01-01",
    "ProcessValidationProtocol": "PRV/BTT.84.09-2E/22/01-01",
    "BMR": "BTT.84.09-2E, Edition: 9",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "200,000 tablets",
    "Process": "compression\ncoating",
    "OOX": "NA",
    "Receipt_Date": "NA",
    "Due_Date": "Na",
    "Completed": "29.11.2022",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 25 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77516.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOP-001",
    "ProcessValidationReport": "PVR/BTT.259.01-2.25E/13 – Original validation\nPRVR/BTT.259.06-2.25E/19/01-01 – Validation due to change in coating parameter",
    "ProcessValidationProtocol": "PV/BTT.259.01-2.25E/12 – Original validation\nPRV/BTT.259.6-2.25E/19/01-01 – Validation due to change in coating parameter.",
    "BMR": "BTT.259.07-2.25E, Edition: 7",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "225,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.12.2020",
    "comments": "New validation at site with batch size of 225,000 tablet for commercialization. \nThe re-validation is due to change in coating process parameter."
  },
  {
    "Status": "QP Approval",
    "Productname": "Topiramat Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "77517.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Indrad",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-TOP-002",
    "ProcessValidationReport": "PVR/BTT.92.02-5E/16 (BL070001, BL071001) , PVR/BTT.92.04-5E/16  (BL07C001)",
    "ProcessValidationProtocol": "PV/BTT.92.02-5E/16 – Original Protocol\nPV/BTT.92.04-5E/16 – Protocol for execution of one more batch",
    "BMR": "BTT.92.04-5E, Edition: 5",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "500,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "10.12.2020",
    "comments": "New validation at site with batch size of 500,000 tablet for commercialization."
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost Heumann 40 µg/ml Augentropfen, Lösung",
    "Dosageform": "ATR",
    "MA_No": "2201817.00.00",
    "CMOSite": "Jadran Galenski Laboratorij d.d.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost Heumann 40 µg/ml Augentropfen, Lösung",
    "Dosageform": "ATR",
    "MA_No": "2201817.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "CR-02024",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "09.12.2024",
    "Due_Date": "27.03.2025",
    "Completed": "19.03.2025",
    "comments": "09.12.2024: Balkanpharma = Bulk Product; CMO of Pharmathen Pallini\n21.01.25 an Pharmathen angefragt \n10.02.25 Reminder geschickt Dfo\n03.03.25: enthalten in PVD-Pharmathen-003, aber Draft! MaWa\n20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost Heumann 40 µg/ml Augentropfen, Lösung",
    "Dosageform": "ATR",
    "MA_No": "2201817.00.00",
    "CMOSite": "JGL\nSvilno 20, 5100 Rijeka, Croatia",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost/Timolol Heumann 40 µg/ml + 5 ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "2201818.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "documents received - to be checked",
    "ProcessValidationProtocol": "documents received - to be checked",
    "BMR": "BPRP-R-0198_06",
    "Reason_for_validation": "",
    "API_Manufacturer": "Delta Biotech S.A./FDC Limited",
    "Batchsize": "24.000 vials",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost/Timolol Heumann 40 µg/ml + 5 ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "2201818.00.00",
    "CMOSite": "JGL\nSvilno 20, 5100 Rijeka, Croatia",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Travoprost/Timolol Heumann 40 µg/ml + 5 ml Augentropfen",
    "Dosageform": "ATR",
    "MA_No": "2201818.00.00",
    "CMOSite": "Balkanpharma - Razgrad AD",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "TBD",
    "Productname": "Urso 250 Heumann",
    "Dosageform": "FTA",
    "MA_No": "8349.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "",
    "Reference": "CR-02674",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Urso 250 Heumann",
    "Dosageform": "FTA",
    "MA_No": "8349.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-URS-001",
    "ProcessValidationReport": "VR/BTU.07.01-8.0LaE/17",
    "ProcessValidationProtocol": "PV/BTU.07.01-8.0LaE/17",
    "BMR": "BTU.07.04-8.0LaE/04",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dipharma Francis S.r.l.",
    "Batchsize": "800,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.03.2020",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Urso 400 Heumann",
    "Dosageform": "FTA",
    "MA_No": "8349.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "",
    "Reference": "CR-02674",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Urso 400 Heumann",
    "Dosageform": "FTA",
    "MA_No": "8349.01.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-URS-002",
    "ProcessValidationReport": "VR/BTU.08.01-5.0LaE/17",
    "ProcessValidationProtocol": "PV/BTU.08.01-5.0LaE/17",
    "BMR": "BTU.08.04-5.0LaE/04",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Dipharma Francis S.r.l.",
    "Batchsize": "500,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Valganciclovir Heumann 450 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "98272.00.00",
    "CMOSite": "Bluepharma Industria Farmaceutica, S.A.",
    "Country": "For Sale",
    "Reference": "",
    "MPVReviewNo": "PVD-Bluepharma-01",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "N/A",
    "comments": "QP signature not verified -> comment AH, 11.01.2022: QP is mentioned in TA from 11/2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Valsartan Heumann 320 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "76395.00.00",
    "CMOSite": "Laboratorios Liconsa, S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Liconsa-05",
    "ProcessValidationReport": "N/A",
    "ProcessValidationProtocol": "N/A",
    "BMR": "N/A",
    "Reason_for_validation": "N/A",
    "API_Manufacturer": "N/A",
    "Batchsize": "N/A",
    "Process": "N/A",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "17.06.2020",
    "comments": "This update is done to confirm the validation of the telmisartan with a new API source (Glenmark Sciences LTD.)"
  },
  {
    "Status": "Open",
    "Productname": "Valsartan Heumann 320 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "",
    "CMOSite": "Macleods Pharmaceuticals Limited Daman",
    "Country": "Non-EU",
    "Reference": "CR-01106",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "19.02.25",
    "Due_Date": "25.02.2028",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin  Heumann 37,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65961.00.00",
    "CMOSite": "Cipla Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-022",
    "ProcessValidationReport": "VAL/31004075/0002/REP (Version No.: 02)",
    "ProcessValidationProtocol": "VAL/31004075/0002/PRO (Version No.: 02)",
    "BMR": "31004075 (Production Version No.0002)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "900000 EA / 148.500 kg (lubrication only)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.09.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin  Heumann 37,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65961.00.00",
    "CMOSite": "Cipla Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-027",
    "ProcessValidationReport": "VAL/VEN37.5mg/REP (Version No.: 01) - Batches No. G8331, G8332 and G85333.",
    "ProcessValidationProtocol": "VAL/VEN37.5/PRO (Version No.: 01)",
    "BMR": "CM/VA020/020/A/01",
    "Reason_for_validation": "compression",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "72.250 kg (but same compression as for 148.500 kg)",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.04.2021",
    "comments": "Last released 01/l12/2016, Expires Jul 21"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin  Heumann 37,5 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65961.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-029",
    "ProcessValidationReport": "PPQR/BTV.108.00-11LaE/22/01",
    "ProcessValidationProtocol": "PPQP/BTV.108.00-11LaE/22/01",
    "BMR": "BTV.108.00-11LaE/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "110,000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18/01/2023",
    "comments": "CR-01521: correction of batch size in MPV due to typo in PV report"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin  Heumann 75 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65963.00.00",
    "CMOSite": "Torrent Pharmaceuticals Ltd. Baddi",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-030",
    "ProcessValidationReport": "PPQR/BTV.109.00-5.50LaE/22/01",
    "ProcessValidationProtocol": "PPQP/BTV.109.00-5.50LaE/22/01",
    "BMR": "BTV.109.00-5.5LaE/00",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Torrent Pharmaceuticals Ltd.",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18/01/2023",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-001",
    "ProcessValidationReport": "ALP/F/PVR/2975-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2975-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-002",
    "ProcessValidationReport": "ALP/F/PVR/956-00",
    "ProcessValidationProtocol": "ALP/F/PVP/956-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-003",
    "ProcessValidationReport": "ALP/F/PVR/1825-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1825-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-004",
    "ProcessValidationReport": "ALP/F/PVR/1584-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1584-00",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-005",
    "ProcessValidationReport": "ALP/F/PVR/3025-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3025-00",
    "BMR": "ALPBMR1896-13",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-006",
    "ProcessValidationReport": "ALP/F/PVR/1905-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1905-01",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-007",
    "ProcessValidationReport": "ALP/F/PVR/814-00",
    "ProcessValidationProtocol": "ALP/F/PVP/814-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-008",
    "ProcessValidationReport": "ALP/F/PVR/2838-01",
    "ProcessValidationProtocol": "ALP/F/PVP/2838-00",
    "BMR": "ALPBMR724-11/ ALPBMR724-10/ ALPBMR724-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-009",
    "ProcessValidationReport": "ALP/F/PVR/2039-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2039-01",
    "BMR": "ALP/BMR724-11/ ALPBMR724-10/ ALPBMR724-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-010",
    "ProcessValidationReport": "ALP/F/PVR/773-00",
    "ProcessValidationProtocol": "ALP/F/PVP/773-01",
    "BMR": "ALP/BMR724-11/ ALPBMR724-10/ ALPBMR724-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-017",
    "ProcessValidationReport": "ALP/F/PVR/766-01",
    "ProcessValidationProtocol": "ALP/F/PVP/766-01",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-018",
    "ProcessValidationReport": "ALP/F/PVR/1562-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1562-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-021",
    "ProcessValidationReport": "Validation based on 1.000.000 bath size",
    "ProcessValidationProtocol": "Validation based on 1.000.000 bath size",
    "BMR": "ALPBMR706-12",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 250,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2020",
    "comments": "not separately validated"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-023",
    "ProcessValidationReport": "ALP/F/APVP/3218-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3218-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-024",
    "ProcessValidationReport": "ALP/F/APVP/3220-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3220-00",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-025",
    "ProcessValidationReport": "ALP/F/APVP/3217-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3217-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2021",
    "comments": "Process Re-Validation – Due to incorporation of additional Compression Machine 73 Station ID No. PD/08/COM08 with Multi tip punch parameters for at Compression Stage."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 150 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73200.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-026",
    "ProcessValidationReport": "ALP/PVR/3221-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3156-00 & ALP/F/PVP/3156-00-A1",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.04.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-001",
    "ProcessValidationReport": "ALP/F/PVR/2975-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2975-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-002",
    "ProcessValidationReport": "ALP/F/PVR/956-00",
    "ProcessValidationProtocol": "ALP/F/PVP/956-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-003",
    "ProcessValidationReport": "ALP/F/PVR/1825-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1825-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-004",
    "ProcessValidationReport": "ALP/F/PVR/1584-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1584-00",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-005",
    "ProcessValidationReport": "ALP/F/PVR/3025-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3025-00",
    "BMR": "ALPBMR1896-13",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-006",
    "ProcessValidationReport": "ALP/F/PVR/1905-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1905-01",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-007",
    "ProcessValidationReport": "ALP/F/PVR/814-00",
    "ProcessValidationProtocol": "ALP/F/PVP/814-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-016",
    "ProcessValidationReport": "ALP/F/PVR/1486-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1486-00",
    "BMR": "ALPBMR1832-05",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": 166.666,
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-017",
    "ProcessValidationReport": "ALP/F/PVR/766-01",
    "ProcessValidationProtocol": "ALP/F/PVP/766-01",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-018",
    "ProcessValidationReport": "ALP/F/PVR/1562-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1562-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-023",
    "ProcessValidationReport": "ALP/F/APVP/3218-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3218-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-024",
    "ProcessValidationReport": "ALP/F/APVP/3220-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3220-00",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-025",
    "ProcessValidationReport": "ALP/F/APVP/3217-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3217-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2021",
    "comments": "Process Re-Validation – Due to incorporation of additional Compression Machine 73 Station ID No. PD/08/COM08 with Multi tip punch parameters for at Compression Stage."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-026",
    "ProcessValidationReport": "ALP/PVR/3221-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3156-00 & ALP/F/PVP/3156-00-A1",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.04.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-28",
    "ProcessValidationReport": "ALP/F/PVR/3315-00",
    "ProcessValidationProtocol": "ALP/F/PVR/3315-00",
    "BMR": "MPV still valid for \"F1M00017 -00000002\n\nALPBMR1832-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "166 666 capsules",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "18.10.2021",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "CR-00834",
    "MPVReviewNo": "MPV-VEN-032",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "NA",
    "Completed": "",
    "comments": "13.08.24: please provide ProcessValidationReport and protocol that is applicable for BMR No.: F1\\BMR\\00211-3.0, F1/BMR/00433- 1.0\n29.08.24: reminder\n24.02.25: auf TBD gesetzt MaWa"
  },
  {
    "Status": "Open",
    "Productname": "Venlafaxin Heumann 225 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "93933.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "",
    "Reference": "CR-02425",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "17.02.2025",
    "Due_Date": "14.09.2025",
    "Completed": "",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-001",
    "ProcessValidationReport": "ALP/F/PVR/2975-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2975-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-002",
    "ProcessValidationReport": "ALP/F/PVR/956-00",
    "ProcessValidationProtocol": "ALP/F/PVP/956-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-003",
    "ProcessValidationReport": "ALP/F/PVR/1825-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1825-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-004",
    "ProcessValidationReport": "ALP/F/PVR/1584-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1584-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-005",
    "ProcessValidationReport": "ALP/F/PVR/3025-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3025-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1896-13",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-006",
    "ProcessValidationReport": "ALP/F/PVR/1905-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1905-01",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-007",
    "ProcessValidationReport": "ALP/F/PVR/814-00",
    "ProcessValidationProtocol": "ALP/F/PVP/814-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-011",
    "ProcessValidationReport": "ALP/F/PVR/2834-01",
    "ProcessValidationProtocol": "ALP/F/PVP/2834-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1587-11/ ALPBMR1587-10/ ALPBMR1587-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-012",
    "ProcessValidationReport": "ALP/F/PVR/1154-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1154-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1587-11/ ALPBMR1587-10/ ALPBMR1587-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-013",
    "ProcessValidationReport": "ALP/F/PVR/770-00",
    "ProcessValidationProtocol": "ALP/F/PVP/770-01",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR1587-11/ ALPBMR1587-10/ ALPBMR1587-09",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "1.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-017",
    "ProcessValidationReport": "ALP/F/PVR/766-01",
    "ProcessValidationProtocol": "ALP/F/PVP/766-01",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-018",
    "ProcessValidationReport": "ALP/F/PVR/1562-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1562-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-023",
    "ProcessValidationReport": "ALP/F/APVP/3218-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3218-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALP/BMR703-23",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685).\nMPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-024",
    "ProcessValidationReport": "ALP/F/APVP/3220-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3220-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALP/BMR1896-16",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-025",
    "ProcessValidationReport": "ALP/F/APVP/3217-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3217-00",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALP/BMR703-23",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2021",
    "comments": "Process Re-Validation – Due to incorporation of additional Compression Machine 73 Station ID No. PD/08/COM08 with Multi tip punch parameters for at Compression Stage.\nMPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-026",
    "ProcessValidationReport": "ALP/PVR/3221-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3156-00 & ALP/F/PVP/3156-00-A1",
    "BMR": "MPV still valid for F1M00011-00000002\n\nALP/BMR1896-16",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.04.2021",
    "comments": "MPV still valid for F1M00011-00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 37,5 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73198.00.01",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-031",
    "ProcessValidationReport": "ALP/PVR/3145-00",
    "ProcessValidationProtocol": "ALP/PVP/3093-00-A1",
    "BMR": "MPV still valid for \"F1M00014 -00000002\n\nALPBMR3283-03",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "4000000 capsules",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "25.01.2023",
    "comments": "MPV still valid for \"F1M00014 -00000002"
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75  mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-024",
    "ProcessValidationReport": "ALP/F/APVP/3220-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3220-00",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75  mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-025",
    "ProcessValidationReport": "ALP/F/APVP/3217-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3217-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "compression + coating",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2021",
    "comments": "Process Re-Validation – Due to incorporation of additional Compression Machine 73 Station ID No. PD/08/COM08 with Multi tip punch parameters for at Compression Stage."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75  mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-026",
    "ProcessValidationReport": "ALP/PVR/3221-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3156-00 & ALP/F/PVP/3156-00-A1",
    "BMR": "ALP/BMR1896-16",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "12.04.2021",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-001",
    "ProcessValidationReport": "ALP/F/PVR/2975-00",
    "ProcessValidationProtocol": "ALP/F/PVP/2975-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-002",
    "ProcessValidationReport": "ALP/F/PVR/956-00",
    "ProcessValidationProtocol": "ALP/F/PVP/956-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-003",
    "ProcessValidationReport": "ALP/F/PVR/1825-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1825-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-004",
    "ProcessValidationReport": "ALP/F/PVR/1584-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1584-00",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-005",
    "ProcessValidationReport": "ALP/F/PVR/3025-00",
    "ProcessValidationProtocol": "ALP/F/PVP/3025-00",
    "BMR": "ALPBMR1896-13",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-006",
    "ProcessValidationReport": "ALP/F/PVR/1905-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1905-01",
    "BMR": "ALPBMR1896-13/ ALPBMR1896-12/ ALPBMR1896-11/ ALPBMR1896-10",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "12.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "28.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-007",
    "ProcessValidationReport": "ALP/F/PVR/814-00",
    "ProcessValidationProtocol": "ALP/F/PVP/814-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-007",
    "ProcessValidationReport": "ALP/F/PVR/814-00",
    "ProcessValidationProtocol": "ALP/F/PVP/814-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-014",
    "ProcessValidationReport": "ALP/F/PVR/1214-01",
    "ProcessValidationProtocol": "ALP/F/PVP/1214-01",
    "BMR": "ALPBMR1662-08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "2.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-015",
    "ProcessValidationReport": "ALP/F/PVR/2836-01",
    "ProcessValidationProtocol": "ALP/F/PVP/2836-00",
    "BMR": "ALPBMR1662-08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "2.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "29.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-017",
    "ProcessValidationReport": "ALP/F/PVR/766-01",
    "ProcessValidationProtocol": "ALP/F/PVP/766-01",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "03.02.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "Mini Tablets",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-018",
    "ProcessValidationReport": "ALP/F/PVR/1562-00",
    "ProcessValidationProtocol": "ALP/F/PVP/1562-00",
    "BMR": "ALPBMR703-19/ ALPBMR703-20/ ALPBMR703-21",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "3.000.000",
    "Process": "capsule content",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-019",
    "ProcessValidationReport": "ALP/F/PVR/769-00",
    "ProcessValidationProtocol": "ALP/F/PVP/769-01",
    "BMR": "ALPBMR1662-08",
    "Reason_for_validation": "equipment",
    "API_Manufacturer": "Alembic Limited (API Division I)",
    "Batchsize": "2.000.000",
    "Process": "encapsulation",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "31.01.2020",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Hartkapseln, retardiert",
    "Dosageform": "REK",
    "MA_No": "73199.00.00",
    "CMOSite": "Alembic Pharmaceuticals Limited",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-023",
    "ProcessValidationReport": "ALP/F/APVP/3218-00",
    "ProcessValidationProtocol": "ALP/F/APVR/3218-00",
    "BMR": "ALP/BMR703-23",
    "Reason_for_validation": "API",
    "API_Manufacturer": "Alembic Limited (API Division III)",
    "Batchsize": "3.000.000",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.11.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Venlafaxin Heumann 75 mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": "65963.00.00",
    "CMOSite": "Cipla Ltd.",
    "Country": "Non-EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VEN-022",
    "ProcessValidationReport": "VAL/31004075/0002/REP (Version No.: 02)",
    "ProcessValidationProtocol": "VAL/31004075/0002/PRO (Version No.: 02)",
    "BMR": "31004075 (Production Version No.0002)",
    "Reason_for_validation": "Batchsize",
    "API_Manufacturer": "Cipla LTD",
    "Batchsize": "450000 EA / 148.500 kg",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "30.09.2020",
    "comments": "Due to incorporation of alternate item code of API Venlafaxine\nHydrochloride (Form B) i.e. 30007755 (Change Control – APL/PC200685)."
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin Heumann 50mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": 7005404,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Vildagliptin Heumann 50mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": 7005404,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CC-21-0184\nCR-02665",
    "MPVReviewNo": "MPV-VIL-001",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "18.02.2025",
    "Due_Date": "28.03.2025",
    "Completed": "",
    "comments": "Launch, angefragt 13.11.2024 Dfo\n09.12.24 Laut Launchmeeting CMO Pharmathen, keine Neuigkeiten\n17.02.25: PVR von Pharmathen erhalten; Review gestartet - 4te Validierungscharge unklar (Mixing Stage 3, Compression Stage 4)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin Heumann 50mg Tabletten",
    "Dosageform": "TAB",
    "MA_No": 7005404,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/1000mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004971,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/1000mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004971,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CC-21-0184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "30.09.2024",
    "Completed": "",
    "comments": "Launch angefragt 13.11.2024 Dfo\n09.12.24 Laut Launchmeeting: erste Chargen zerstört, zu alt gewesen\nCMO Pharmathen , keine Neuigkeiten \n03.03.25: Launch on hold (21.02.25 Lauch Meeting)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/1000mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004971,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/850mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004970,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "TBD",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/850mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004970,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "CC-21-0184",
    "MPVReviewNo": "",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "30.09.2024",
    "Completed": "",
    "comments": "Launch, angefragt 13.11.2024 Dfo\n09.12.24 Laut Launchmeeting : erster Chargen zerstört , zu alt gewesen \nCMO Pharmathen , keine Neuigkeiten\n03.03.25: Launch on hold (21.02.25 Lauch Meeting)"
  },
  {
    "Status": "QP Approval",
    "Productname": "Vildagliptin/Metformin Heumann 50mg/850mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": 7004970,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "91997.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-01",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "Not specified",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 200 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "91997.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 200mg Pulver z. Herstellung einer Inf.-Lsg.",
    "Dosageform": "PIF",
    "MA_No": 7012218,
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-02",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "13.11.23",
    "comments": ""
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 200mg Pulver z. Herstellung einer Inf.-Lsg.",
    "Dosageform": "PIF",
    "MA_No": 7012218,
    "CMOSite": "ANFARM HELLAS S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "20.03.2025: CMO ist Pharmathen; Manufaturing Site ausgelagert von Pharmathen"
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "91996.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "MPV-VORI-001\nPVD-Pharmathen-01",
    "ProcessValidationReport": "REP-QA-001-VOR/ADD/50 Version 001 (Interim) + \nREP-QA-001-VOR/ADD/50 Version 002",
    "ProcessValidationProtocol": "QPR-QC-001-VOR/ADD/50 Version 001",
    "BMR": "TDR-PR-022-01102 / Version 3",
    "Reason_for_validation": "new product / intial validation",
    "API_Manufacturer": "Dishman Pharmaceuticals & Chemicals LTD",
    "Batchsize": "300.000 tablets",
    "Process": "entire process",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "06.02.2020\n11.02.2020",
    "comments": "TA resp. Changed from HM to CMO with Appendix 3 Version 4, signed 23.01.2020"
  },
  {
    "Status": "QP Approval",
    "Productname": "Voriconazol Heumann 50 mg Filmtabletten",
    "Dosageform": "FTA",
    "MA_No": "91996.00.00",
    "CMOSite": "Pharmathen International S.A.",
    "Country": "EU",
    "Reference": "",
    "MPVReviewNo": "PVD-Pharmathen-03",
    "ProcessValidationReport": "",
    "ProcessValidationProtocol": "",
    "BMR": "",
    "Reason_for_validation": "",
    "API_Manufacturer": "",
    "Batchsize": "",
    "Process": "",
    "OOX": "",
    "Receipt_Date": "",
    "Due_Date": "",
    "Completed": "19.03.2025",
    "comments": "26.03.25: PVR und PVP angefragt Dfo"
  }
]